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Abstract 
The studies presented in this thesis have examined the requirement for T cell activation in 
primary and secondary anti-viral T cell responses. 
Subclinical infection of mice with vaccinia virus can be converted into lethal disease by prior 
treatment with the immunosuppressive drug, cyclophosphamide. The drug interferes with the 
development of the cytotoxic T cell reponse which is necessary for elimination of virus. Spleen 
cells from the immunosuppressed animals are characterized by a diminished capacity to 
proliferate and produce IL-2 in vitro upon mitogenic stimulation. CTL precursors from the treated 
mice can be stimulated by administering IL-2 in vivo or by culturing the cells in the presence of IL-
2 in vitro. The results suggest that IL-2 produced by T helper cells is necessary for development 
of the primary anti-viral CTL response in vivo. 
During the study of the requirements for activation of memory T cell, it was found that CTL 
primed in vivo with LCMV can be specifically reactivated with phorbol myristate acetate (PMA) 
. 
and calcium ionophore (Cal) in the absence of added antigen. The optimal conditions of this 
stimulation were determined at bulk and clonal levels, and used in further experiments as a 
method for reactivation of memory CTL. The cytotoxic activity of primed CTLp stimulated with 
PMA and Cal was found to be IL-2 dependent although some proliferation occured in the 
absence of T helper cells or exogeneous IL-2. LCMV-specific memory cells are also characterized 
by the expression of the Ly 24 (Pgp 1) glycoprotein. 
The in vitro r&stimulated secondary immune CTL response against a complex antigen 
consisting of mouse alloantigen (H-2~) and vaccinia virus has also been studied. It was found 
probable that distinct T cell clones at similar frequencies are responsible for the anti-allo and anti-
viral immune responses. 
The results discussed in this thesis support the theory of T helper - T cytotoxic cell interaction 
during the development of primary and secondary anti-viral immune responses and reveal that 
memory CTL differ from unprimed virus specific CTLp not only in frequency but also in 
1. V 
requirements for the stimulation of cytotoxic activity and by the appearance of a distinct surface 
marker, Ly 24. 
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Chapter 1 
Literature Review 
1 
1.1 Role of T cells in immunity 
Resistance to infections is based on two lines of defense mechanisms: natural or nonspecific 
protection and adaptive or specific immunity. Since the natural system does not confer immunity, 
the term immune response refers primarily to the response of T (thymus derived) and B (bone 
marrow derived) lymphocytes. 
The first sites of natural immunity are the skin and mucosa, which: a) produce chemical 
disinfectants, b) provide physical defense by rapid turnover of the outer cell layer, c) and in the 
case of mucosa surfaces contains high level of natural antibodies. If pathogens penetrate these 
barriers they are confronted by polymorphonuclear (PMN) leukocytes and macrophages which 
are the hallmark of an acute inflammatory process. 
If invasion by the pathogen is so severe that PMN cells and macrophages are unable to 
contain the infection the third line of defense, adaptive immunity, becomes activated by antigen-
presenting cells, mainly macrophages. The antigen-specific immune response is a complex set of 
reactions involving different types of lymphocytes which mediate their effects both directly and 
indirectly through the production of soluble mediators. B lymphocytes are responsible for the 
humeral immune response, producing antigen-specific antibody upon encountering soluble 
antigen. These antibodies combine with antigen and may: a) promote phagocytosis by acting as 
opson_ins, b) prevent the attachment of microorganisms to cells or mucosa, c) neutralize 
~ 
microbial toxins, d) activate compement-dependent cytolysis, e)activate direct lysis of the 
microorganism by complement, f) cause agglutination of pathogens, g) render microorganisms 
nonmotile, h) inhibit the metabolism and growth of pathogens. 
T cells generate cell- mediated immunity (CMI) and are present in the lymphoid tissues, 
especially around the splenic arterioles and paracortical areas of lymph nodes, also in the blood 
and lymph. Their continual movement through tissues and lymph nodes ensures that antigens or 
microbes entering the body sooner or later come into contact with T cells. T cells recognise 
antigen on the surface of cells and different types of T cells carry out different functions, e.g.: a) 
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release of active substances called lymphokines, b) trigger B cells to make antibody, c) kill host 
cells carrying the foreign antigen in conjunction with the appropiate histocompatibility antigens. 
Although T and 8 cells encounter different forms of antigen (cell surface bound vs. soluble), 
they have some characteristics in common: cell surface expression of a clonally distributed 
antigen receptor molecule, differentiation from a haemopoietic precursors and development of a 
memory state. Furthermore, they do not operate independently: 8 cells must receive signals from 
T cells mediated by growth and differentiation factors or lymphokines. 
Thus, the requirement for T cells in both the cellular and humoral immune responses means 
that they play a central role in the antigen-specific immune response. 
1.2 Cell surface molecules 
T cells can be identified by the expression of certain cell surface molecules; some of these will 
be discussed below: 
1.2.1 Thy 1 
In mice, the Thy 1 antigen was one of the first differentiation antigens to be discovered on 
thymocytes (Reif and Allen, 1964). It was found to have two allelic forms later designated Thy 1.1 
and Thy 1.2. The Thy 1 antigen is coded for by a gene on chromosome nine (Blankenhorn and 
Douglas, 1972) and is a glycoprotein of 25-30 kd found on thymocytes, peripheral T cells, 
fibroblasts, epithelial cells and neurons (Reif and Allen, 1964). In contrast to most cell surface 
proteins that are anchored in the lipid bilayer of the cell membrane by hydrophobic peptide 
domains, Thy 1 has been shown to be attached to the cell surface via a phosphatidylinositol (Pl) 
linkeage (Low_and Kincade, 1985; Malek et al. 1986). The molecule has amino acid sequence 
homology to immunoglobulin (Williams and Gagnon, 1982) implying that it may function in cell 
recognition. Some anti-Thy 1 antibodies mediate T cell activation (Gunter et al. 1984; Konaka et 
al. 1981 ; Jones, 1983) leading to interleukin 2 (I L-2) receptor expression and IL-2 production. 
3 
Cross-linking of murine Thy 1 triggers a rapid rise in the cytoplasmic concentration of free 
calcium not only in murine T cells but also in Thy 1.2 transfected human cells and murine B-
lymphoma cells (Kroczek et al. 1986). 
These results suggest that Thy 1 may have a critical role in the activation of T lymphocytes not 
expressing functional antigen receptors, [(T3jTCRf T cells]. In (T3/TCRf cell lines monoclonal 
antibodies against Thy 1.2 can induce a rise in cytoplasmic free calcium, but fail to stimulate IL-2 
production. In the absence of co-expressed T3/TCR, stimulation of the Thy-1 molecule results 
only in increased Ca2 + concentration but not IL-2 production (Gunter et al. 1987; Schmitt-
Verhulst, 1987). Therefore it is possible that !he interaction of Thy-1 on the surface of (T3/TCRf 
cells with its natural ligand in vivo (perhaps in the thymus) leads to an increase in Ca2 + 
concentration and subsequent differentiation events. 
1.2.2 TCR associated recognition structures 
1.2.2.1 CD3 {T3) 
The CD3 antigen of mice, equivalent to the human CD3 molecule, has recently been identified 
and consists of 25 kd (1) and 21 kd (8) glycoproteins and 2 non-glycosylated polypeptides of 26 
kd (t:) and 16 kd (g), the latter forming a 36 kd heterodimer (Samelson et al. 1985a). The molecule 
is closely associated but non-covalently bonded to the et/3 heterodimer or the ,-chain of the TCR. 
There seems to be an obligate requirement for the co-expression of CD3 and TCR on the cell 
surface. 0Neiss and Stobo, 1984; Ohashi et al. 1985). CD3 has been identified on the surface of 
all mature T cells (Bluestone et al. 1987; Brenner et al. 1986), on CD8-/ CD4-TCR 18 + early fetal 
and adult thymocytes (Bank et al. 1986; Lew et al. 1986) and on 'double positive' (CD8 + / CD4 +) 
fetal and adult cortical thymocytes (Bluestone et al. 1987). CD3 bearing cells, present early in 
thymic ontogeny, express functional TCR and, therefore may be important in development of the 
T cell repertoire (Bluestone et al. 1987; Pardall et al. 1987). 
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A monoclonal antibody specific for murine CD3-£ reacts with all mature T cells. The interaction 
is followed by surface capping of CD3;TCR complexes and by their persistent (48-72h) 
disappearance (Meuer et al. 1983; Moretta et al. 1987; Pantaleo et al. 1987a), indicating 
involvement of CD3 in the transduction of activation signals. Antibodies to human CD3 can 
induce mitogenic responses (Van Wauwe et al. 1980) or inhibit T cell mediated cytolysis (Meuer 
et al. 1982 / a; Leo et al. 1987), but can also induce nonspecific cytotoxic reactivity of CTL (Spits 
et al. 1985; Mentzer et al. 1985). The latter has been shown to depend on Fe-receptor expression 
on target cells, which can cause a physical association between T cell and target cell. (Van 
Seventer et al. 1987). 
The 8-chain of the CD3 complex is known to be phosphorylated following T cell activation by 
antigen. In contrast, both 8 and £ are phosphorylated in response to treatment of the cells with 
phorbol myristate acetate (PMA) (Samelson et al. 1985b). The functional importance of CD3, 
based on the finding that immune activation of T cells is also associated with downregulation of 
the surface levels of CD3;TCR complex (Ando et al. 1985; Ledbetter et al. 1986) could be to 
control the expression and function of the TCR . 
. 
The role of the CD3;TCR complex in T cell activation will be discussed in detail later. 
1.2.2.2 CDS (Lyt 2) 
Murine CDS (Lyt 2), equivalent to the human CDS antigen, is a disulphide bonded glycoprotein 
of 70 kd composed of heterodimeric units of 2 polypeptide chains, a (38 kd) or a '(35 kd}, and /3 
(30 kd}. The two forms of the a chain result from alternative splicing of pre-mRNA (Zamoyska et al. 
1985). 
The a and f3 chains are encoded by different, linked loci found on chromosome 6, and were 
originally called Lyt 2 and Lyt 3 (Ledbetter et al. 1981; Walker et al. 1983}. The thymic form of CD8 
antigen expresses both a and a' subunits , but a' appears to be present at a lower level in 
peripheral T cells (Walker, 1984). Lyt 2 is expressed on a subset of T cells which are in most 
cases cytotoxic or suppressor cells (Cantor and Boyse, 1976). The vast majority of CDS + cells 
5 
recognize antigen in association with a class I MHC gene product (rev. by Zinkernagel and 
Doherty, 1979). The correlation between CDS expression and class I MHC restriction is far more 
striking than that between CDS expression and any other function. 
Antisera to CDS can block the induction and effector phases of alloreactive CTL activity 
(Nakayama et al. 1979; Hollander et al. 1981; Sarmiento et al. 1980). This inhibition is clonally 
heterogeneous, i.e. the monoclonal antibody (mAb) concentration required to produce a given 
degree of inhibition varies markedly between different CTL clones (Glasebrook, et al. 1983). 
Based on these findings it was proposed that CDS molecules stabilize the low affinity interaction 
between T cell receptor and antigen. It was considered therefore that resistance to inhibition by 
mAb would indicate a high affinity interaction between antigen and its receptor, so inhibition 
studies with anti-CDS mAb would reflect the "receptor affinity" of different T cell lines. The theory 
has been confirmed by Shimonkevitz and colleauges (1985): alloreactive T cell clones which 
needed high levels of MHC class I expression on target cells for optimal lysis (so probably had 
low affinity T cell receptors) were more effectively blocked by anti-CDS mAb than those that 
required lower amounts of MHC. In contrast, Swain et al. (1984) proposed a model in which the 
Lyt 2 molecules function by directly binding to monomorphic determinants of the MHC class I 
molecule on target cells. Transfection of the Lyt 2 gene into cos- cells facilitated the interaction 
of cytotoxic T cells with their targets, although the transfected cell line had lost its original 
specificity (Dembic et al. 1987). Transfection of T cell receptor Ct,/3 genes from a MHC class !-
specific, CDS+ T cell clone endowed the host cell with the specificity of the donor cell type only if 
the same cell had also been transfected with the Lyt 2 gene (Gabert et al. 1987). 
So, the view that Lyt 2 molecules are enhancers of receptor avidity is confirmed by these 
findings and suggests that CDS molecules may also play a role in transmembrane signal 
transduction (Emmrich et al. 1986). 
6 
1.2.2.3 CD4 (L3T 4) 
The CD4 molecule is another nonpolymorphic member of the immunoglobulin gene 
superfamily, expressed on the surface of a functionally distinct population of T lymphocytes. 
These cells are known as helper - or inducer - T cells, and show specificity for class II MHC 
molecules on cells ('v\lilde et al. 1983; Dialynas et al. 1983). The CD4 glycoprotein is also 
expressed on cells other than T lymphocytes such as bone marrow-derived macrophage-like 
cells, some B-cells, granulocytes and a shorter transcript on brain parenchymal cells (Shaw et al 
1985; Koenig et al. 1986; Maddon et al. 1987; Gorman et al. 1987). 
Unlike CD8, which is remarkably different in mouse and human, CD4 has been found as a 55 
kd monomer in both species (Dialynas et al. 1983; Terhorst et al. 1980). It has strong 
evolutionary conservation in its 40 amino-acid cytoplasmic tail (Littman and Gettner, 1987a) 
suggesting that this region is essential for CD4 function. 
Monoclonal antibodies against CD4 have been shown to block numerous T cell functions, 
such as antigen-specific proliferation, mixed lymphocyte reaction and induction of helper activity 
('v\lebb et al. 1979; Wilde, 1983; Swain et al. 1984). The antibodies probably act either by 
preventing the formation of cell:cell conjugates (Spits et al. 1986) or by transmitting a negative 
signal (Bank and Chess, 1985; Greenstein and Burakoff, 1987; Tite et al. 1986). As in the CD8 
system, the amount of anti-CD4 antibody required to block T cell activation correlates inversely 
with the amount of antigen required to obtain a particular level of activation (Marrack et al. 1983). 
The importance of CD4 density has been studied using a murine T cell line expressing human 
CD4 (Sleckman et al. 1987). This cell line can produce 6-20 fold more IL-2 in response to the 
appropiate antigen, than the control cell lines. Furthermore, when antigen levels are suboptimal, 
the response of the cells is entirely CD4 dependent. 
While several studies have attempted to confirm that CD4 interacts with MHC class II gene 
products ('v\latts et al. 1984; Greenstein et al. 1984 & 1985; Swain, 1984; Gay et al. 1987), some 
other results suggest that CD4 may not solely be involved in MHC recognition but may have an 
active role in transmembrane signaling. Anti-CD4 monoclonal antibodies inhibited Con A induced 
7 
IL-2 production by a number of antigen-specific T cell hybridomas in an assay system that was 
free of MHC class II bearing cells ('Nassmer et al. 1985). In addition, perturbation of certain 
epitopes of CD4 molecules by antibodies could inhibit anti-T3 activation even under experimental 
conditions in which the accessory cells were devoid of MHC class II molecules (Bank and Chess, 
1985). 
In a similar model, in the absence of class II MHC molecules, Owens and Fazekas de St Groth 
(1987) have confirmed that CD4 interacts with the T cell receptor during T cell activation. Anti-
CD4 antibodies sterically hindered the formation of TCR complexes preventing activation. 
However, by increasing the epitope density of the activating ligand, the avidity of T cell-ligand 
interaction could be increased sufficiently to prevent this disruption, which explains the 
observation that stimuli with superoptimal doses of both soluble or solid-phase coupled F23 
(anti-TCR antibody) or with antigen were not inhibited. 
Recent studies have also demonstrated that human CD4 is internalized following stimulation 
with phorbol esters (Hoxie et al. 1986; Solbach, 1982), and that this is accompanied by 
phosphorylation of a cytoplasmic serine residue (Acres et al. 1986). Parallel downregulation of 
CD4 and CD3 glycoproteins has been demonstrated ('Neyand et al. 1987) following antigenic or 
PMA stimulations, suggesting that both markers might be members of a multi-molecular complex 
mediating T cell activation. Further evidence was provided by Saizawa et al. (1987), who showed 
that the TCR-class II MHC-antigen-CD4 complex is 30-100 fold more effective in T cell activation 
than cross linking of the T cell receptor complex alone. This experiment also suggests that CD4 is 
a physical part of the T cell receptor for the antigen - class II MHC-complex. 
1.2.3 Function associated molecules 
1.2.3.1 CO2 and LFA-3 
CO2 (also known as T11 or erythrocyte rosette receptor or LFA-2) is a functionally important T 
lymphocyte surface glycoprotein of a relative molecular mass 45-50 kd on human lymphocytes 
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(Krensky et al. 1984); a similar molecule probably also exists in mice (Sewell et al. 1987). It is 
present early in thymocyte ontogeny and on all mature T cells (rev. by Haynes, 1981 ). 
Monoclonal antibodies to CO2 inhibit CTL-mediated killing by binding to the T lymphocyte and 
blocking adhesion to the target cell (Sanchez-Madrid et al. 1982; Krensky et aJ. 1983 & 1984). 
Such antibodies also inhibit T helper cell responses including antigen-stimulated proliferation, IL-
2 secretion and IL-2 receptor expression (Sanchez-Madrid et al. 1982; Van Wauwe and 
Goossens, 1981; Palacios and Martinez-Maza, 1982; Krensky et al. 1983; Reed et al. 1985b; 
Tadmori et al. 1985). Certain combinations of monoclonal antibodies to CO2 epitopes trigger 
proliferation of peripheral blood T lymphoc',tes (Meuer et al. 1984), cytotoxic effector function 
(Siliciano et al. 1985) and expression of IL-2 receptors by lymphocytes (Fox et al. 1985) probably 
through the phosphoinositide breakdown pathway (Pantaleo et al. 1987b). These results suggest 
that CO2 can function in signalling as well as being an adhesion molecule. Its naturaJ ligand is 
probably LFA-3 (lymphocyte function associated antigen-3). 
LFA-3 has a molecular mass of 55-70 kd and has a broad tissue distribution including 
expression on endothelial, epithelial and connective tissue cells in most organs studied and on 
most blood cells including erythrocytes (Krensky et al. 1986; Selvaraj et al. 1987). MAb to LFA-3, 
like mAb to CO2, also inhibits a number of T helper dependent functions and inhibits conjugate 
formation between CTL and target cells (Krensky et al. 1984; Shaw et al. 1986; Mentzer et al. 
1987). The binding between CO2 and LFA-3 is of high affinity and can mediate adhesion of 
lymphoid cells (Selvaraj et al. 1987). CO2 and LFA-3 dependent, antigen independent, CTL-target 
conjugation does not result in increased cytoplasmic [Ca2 +] levels in contrast to the antigen-
dependent interaction (Mentzer et al. 1987). Thus, CO2 and LFA-3 appear to act strictly as an 
avidity enhancing mechanism in this CTL system. 
A role in thymic ontogeny has recently been proposed for these molecules. It appears that the 
adherence of thymocytes to epithelial cells depends largely on the interaction between CO2 and 
LFA-3. This conclusion is based on the ability of anti-CO2 mAb and anti-LFA-3 mAb to block 
rosetting of thymic epithelial cells with thymocytes (Singer et al. 1986). Because it is known that 
the CO2 pathway can be triggered in the absence of the C03/TCR complex (Moretta et al. 1987), 
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this interaction might be important in driving proliferation of immature CO2+ ;TCR- thymocytes 
(Vollger et al. 1987). 
1.2.3.2 LFA-1 and ICAM-1 
LFA-1 (lymphocyte function associated antigen-1) is a member of a family of molecules, called 
integrins, found on many tissues of mice (Davignon et al. 1981) and man (Sanchez-Madrid et al. 
1982; rev. by Hynes, 1987). Their tissue distribution, structure and function is similar in the two 
species. LFA-1 is expressed by all leukocytes with the exception of some macrophages. There 
are 15-40000 LFA-1 surface sites per peripheral blood lymphocyte with more abundant 
expression on T than B lymphocytes and increased expression on T blasts (Kurzinger et al. 
1981 ). LFA-1 is a heterodimer consisting of an a subunit of 180 kd and a noncovalently associated 
f3 subunit of 95 kd (Sanchez-Madrid et al. 1983). Monoclonal antibody to LFA-1 blocks CTL 
mediated killing by acting at the adhesion stage rather than the lethal hit delivery step (Springer et 
al. 1982). MAb also inhibits induction of T cell proliferation in response to a wide variety of 
stimulants (rev. by Dongworth et al. 1985; Springer et al. 1987). The physiological mechanism of 
activation of LFA dependent adhesion has been hypothesized by Springer et al. (1987) to be that 
binding of the antigen receptor during the initial contact of T cell with antigen presenting cell or of 
effector T cell with target cell releases diacylglycerol and stimulates LFA-1 to increase adherence. 
The putative LFA-1 ligand, intercellular adhesion molecule-1 (ICAM-1) is widely distributed on 
cells of both hemopoietic and non-hemopoietic origin. It can be upregulated by IL-1 and IFN-"(, 
with expression being greatest during inflammation (Dustin et al. 1986; Rothlein at al. 1986). 
Further studies are needed to clarify whether LFA-1 is the sole ligand or just a member of a family 
of related ligands. The exact molecular basis of lymphocyte adhesion and signal transduction is 
also unknown. 
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1.2.4 Differentiation/ activation antigens 
1.2.4.1 Activating proteins of the Ly-6 locus 
The murine Ly-6 locus controls multiple cell surface molecules with distinct cellular and tissue 
disribution. Although the function of Ly-6 antigens are unknown, several of these antigens 
represent markars of T cell differentiation and activation. The original Ly-6 locus was identified by 
a monoclonal antibody and is now called Ly-6A (Kimura et al. 1980, 1984). Recent studies have 
demonstrated that Ly-6 encoded antigens play a role in physiological T cell activation: TAP (T cell 
activating protein) is a 15-17 kd membrane protein which is anchored in the cell membrane via a 
phosphatidylinositol group (Reiser et al. 1986). Binding of monoclonal antibodies to TAP can 
result in extensive antigen-independent T cell proliferation (Rock et al. 1986). It is expressed on 
10% of mouse thymocytes which are mainly cortisone-resistant and mature. It is also expressed 
on 70% of peripheral T cells but not on resting 8 cells (Yeh et al. 1986). All CD4 + cells are TAP+ , 
but only 50% of CD8 + lymphocytes express detectable amount of TAP. Unstimulated CTL 
precursors are TAP-. Upon activation all T and B cell became TAP+ (Yeh et al. 1986). 
During the initial characterization of TAP, a second protein, TAPa was identified (Rock et al. 
1986) which is molecularly distinct and coordinately expressed on cells with TAP (Reiser et al. 
1986). 
Another antigen mapped in the Ly-6 locus having the characteristics of an activation marker is 
34.2.11, which has a distinct development and tissue distribution from TAP and TAPa (rev. by 
Shevach et al. 1986). 
Ly-6A2 antigens appear on T cells after stimulation with mitogenic lectins (Kimura et al. 1984). 
8482 recognizes a subpopulation of approximately 40% of CDS + T cells which is declines with 
age (Fichtner et al. 1987). 
More recently Shevach et al. (1986) postulated that Ly-6 B.ntigen represents an important 
alternative pathway for T cell activation, because an anti-Ly-6 monoclonal antibody can act 
synergisticaJly with phorbol ester as a potent T cell mitogen. These find ings were supported by 
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Havran et al. (1988) who found that anti-Ly-6 mediated stimulation of cloned CD8 + cells cannot 
be inhibited by anti-CD8 or anti-lL-2 receptor antibodies. 
1.2.4.2 Ly 24 (Pgp-1) 
The Ly 24 antigen is a 95 kd glycoprotein found on adult mouse thymocytes (Trowbridge et al. 
1982). Its functional role is undefined but some evidence suggests that it is associated with the 
cytoskeleton and may be involved in cell-cell adhesion (Jacobson et al. 1984a and b). The 
molecule is expressed not only on immature (CD4-/CD8l thymocytes (Lesley et al. 1985a and b) 
but also on some cos+ /CD4- and coa-;coa+ 'mature' T cells in the thymus (rev. by Lynch and 
Ceredig, 1987). Its implications in thymus biology has been reviewed by Lynch and Ceredig 
(1987). Furthermore its expression appears to distinguish in vivo primed peripheral T cells from 
unprimed cells (see Chapter 5). 
1.2.4.3 J11d 
This marker distinguishes differentiation stages of both T and B lymphocytes. It is expressed 
on most thymocytes but not on peripheral T cells, and on primary but not on memory B cells 
(Bruce et al. 1981; Symington and Hakomori, 1984). In the thymus it distinguishes functionally 
incompetent (J11d+) from functionally competent cells (J11d-/Lyt2+ / L3T4l (Crispe and Bevan, 
1987). J11 d +, 'double negative' thymocytes represent probably the main line of T cell 
differentiation, while J11 d-, 'double negatives' have very limited diversification potential in vitro 
and in vivo and are probably not precursor T cells (Crispe et al. 1987). 
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1.3. T cell receptor for antigen 
1.3. 1 Structure 
Progress in the search for the T cell antigen/MHC receptor came first in the form of clonotypic 
antibodies (Meuer et al. 1983; Lancki et al. 1983; Haskins et al. 1983). Evidence that these 
antibodies recognise T cell receptors was based on their ability to interfere with the binding and 
antigen-specific effector function of only T cells against which the antibodies were produced. 
These antibodies could inhibit specific lysis by CTL clones and IL-2 production by T helper 
clones. They were also capable of activating the T cells when rendered polyvalent by coupling 
with Sepharose (Meuer et al. 1983). 
At the present stage of knowledge there are two types of TCR. Most T cells express a TCR that 
is a complex comprising a highly variable Ct and /3 chain. These are disulphide linked and non-
covalently associated with the three monomorphic subunits of a T3 molecule (Meuer et al. 1983; 
Borst et al. 1983). Another type of receptor complex has recently been identified, comprising a 1-o 
heterodimer which is also associated with a T3 molecule (Brenner et al. 1986 & 1987). 
In the mouse, the Ct and f3 chains have a similar molecular weight (38-44 kd), but in man the 
two chains are easily distinguishable (et: 44-52 kd, acidic; /3: 37-44 kd, basic) (Kappler et al. 1983; 
Kaye and Janeway, 1984). The loci encoding the mouse et and /3 TCR chains are located on 
chromosomes 14 and 6, respectively (Dembic et al. 1985; Lee et al. 1984). Both Ct and /3 chain 
mRNA-s code for a protein with L (hydrophobic leader), V (variable), C (constant), 
transmembrane and cytoplasmic domains. (rev. by Adkins et al. 1987). The TCR 1 chain genomic 
locus has been mapped to mouse chromosome 13 (Kranz et al. 1985) and is essentially similar in 
structure to those encoding the Ct and /3 chains, although it has significantly less variability (Saito 
et al. 1984). The polypeptide product has a relative molecular mass 55 kd, and is found with 
another polypeptide, o, (40 kd) in association with the T3 glycoprotein on the cell surface (Brenner 
et al.1986 & 1987). The T3 has a functional role in the 18 TCR complex, but is structurally distinct in 
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that there is differential glycosyfation of the T3 o chain on these T lymphocytes (Krangel et al. 
1987). 
Chien et al. (1987) recently reported the identification of a new T cell receptor gene, thought to 
encode the o chain molecule. It preserves many of the characteristics of T cell receptor genes 
with an extra cysteine residue after the first domain, probably for heterodimer formation, and a 
conserved lysine residue in the transmembrane region. It has also been sequenced and cloned, 
the predicted molecular weight of the protein derivative is 37-40 kd (Chien et al. 1987). 
It was suggested that there may be an association between antigen specificity of a particular 
TCR and use of particular Va. and/or V/3 genes. Experiments with a helper and a cytotoxic T cell 
clone which have completely different antigen and MHC specificity revealed that they both use 
identical Va. and V/3 segments but different D-J segments for their TCR-s. This suggests that the D 
and J regions may play a key role in specificity for antigen and MHC (Rupp et al. 1987). 
The other type of receptor seems to be present on only about 3% of peripheral 
CD3 + /CD8 + /CD4- T ·cells and on less than 1 % of neonatal thymocytes (Lanier et al. 1986) which 
have CD3 + /CD8-/CD4- 'immature' phenotype. They exhibit non-MHC restricted cytotoxicity 
(Brenner et al. 1987; Borst et al. 1987). Recent studies on the ontogeny of 1 expression have 
revealed a putative role for this receptor (see 1.3.2). 
1.3.2 Ontogeny 
The ontogeny of et.,/3 and 'Y gene rearrangement and expression in fetal and adult cells has been 
studied by several groups. Two major issues have been addressed by these studies. First, do 
rearrangements occur in a sequence of steps, as is the case of the three immunoglobulin 
families? Second, when and where in development are these genes first expressed? 
The mouse has a gestation period of 20 days and immunocompetent thymocytes can be 
detected shortly before birth (Widmer et al. 1981 ). Analysis of transcripts present in the fetal 
thymus indicates that 'Y RNA appears first, on day 14 (Haars et al. 1986; Raul et et al. 1985; 
Snodgrass et al. 1985). At this stage the thymus contains mainly CD4-/ CD8- cells which express 
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Thy-1 (van Ewijk et al. 1980) and IL-2 R (Ceredig et al. 1983; Habu, 1984). COB is expressed at 
day 16, closely followed by CD4 (Ceredig, 1983). 
D/3J/3 rearrangements are also detected but transcripts of V/3 genes are present first at day 15 
(Haars et al. 1985, Snodgrass et al. 1985). T3 molecules may also be found in these cells and 
they are present throughout fetal development and in adult thymus (Bluestone et al. 1987). On 
day 16 a relatively large amount of /3 gene RNA is present, and Ct gene transcripts can be 
detected. On day 17 complete Ct and /3 gene transcripts forming et/3 heterodimers appear on the 
cell surface and the quantity of 'Yo gene products is decreasing. The latter cannot be detected by 
day 20 (Lew et al. 1986; Bluestone et al. 1987; Pardall et al. 1987). 
Experiments on selected populations of adult Lyt2-/L3T4- (double negative) thymocytes have 
yielded similar results to those obtained with fetal thymocytes of day 14-16 gestation. About 50% 
of these thymocytes spontaneously express IL-2 receptor and their anatomical localization is 
random (Ceredig et al. 1985). These double negative cells have large amounts of I RNA (Raulet et 
al. 1985) and very little Ct RNA (Samelson et al. 1985). A subpopulation of these cells express the 
cell surface antigen Pgp-1, which is also found on day 14-15 fetal thymocytes (Trowbridge et al. 
1982). 
The cells having nonproductive 'Y and/or o gene rearrangements can further develop and 
rearrange et/ /3 genes (Brenner et al. 1987), but the cells carrying nonproductively rearranged Ct 
and/ or /3 genes probably die in the thymus. There are conflicting estimates of the fraction of cells 
in this category that express et/3 heterodimers (Royer et al. 1984; Acuto et al. 1985). 
The development of a self MHC-restricted repertoire of TCR is also thought to take place in the 
thymus. According to this thymic education model of T cell differentiation, T cells with particular 
antigen receptors are selected in the thymus in the absence of antigen (Zinkernagal 1978; Fink 
and Bevan, 1978). This selection is believed to depend upon MHC molecules expressed by 
certain thymic cells. Medullary stromal cells express high levels of both H-2K and H-20 antigens, 
whereas cortical epithelial cells express mainly H-20 allodeterminants (Rouse et al. 1979; Van 
Ewijk et al. 1980). MHC class II , or la,is expressed at a very high levels on cortical epithel ium, 
medullary epithelium and medullary dendritic cells (Rouse et al. 1979; Barclay and Mayrohofer, 
1981 ). Cells expressing la antigens are present in medullary regions at 14 days of fetal 
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development. Class I MHC expression is first detected at day 16, by which time levels of la are 
high throughout the thymus (Jenkinson et al. 1981 ). Experiments with radiation-induced bone 
marrow chimeras and thymus reconstituted nude mice, or even with unmanipulated nude mice, 
demonstrated that the self-MHC restriction specificity of class II-restricted T cells is determined 
strictly intrathymically (Singer et al. 1982; Kruisbeek et al. 1983) while the specificity of self class I-
restricted T cells can not only result from intrathymic interactions (Zinkernagel and Doherty, 1979; 
Kruisbeek et al. 1981) but also from extrathymic events (Doherty et al. 1981; Ando and Hurme, 
1981 ; Kruisbeek et al. 1983). Furthermore, experiments with neonatal mice, treated with anti-la 
antibody show, that medullary thymic antigen presenting cells (APC) not only determine class II-
restriction specificity of CD4 + cells but in fact play a crucial role in the development of the CD8-
/CD4 + lineage (Kruisbeek et al. 1983; Kruisbeek and Longo, 1985). 
Despite accumulating results concerning T cell differentiation in the thymus, the exact 
mechanism of self-tolerance, intrathymic differentiation, and repertoire selection is still not clear. 
1.3.3 MHC restricted recognition 
1.3.3.1 MHC molecules 
T cells recognize antigen on the cell surface only if the appropiate allele of a polymorphic 
MHC molecule is also expressed. Thus, T cells have a dual specificity, recognizing both antigen 
and allele specific determinants of the MHC molecule and this recognition of antigen is said to be 
restricted by the MHC molecule (Zinkernagel & Doherty, 1974a and b). 
The murine MHC antigens are members of a large family of closely related genes located in 
separate, but closely linked regions on chromosome 17. Cell surface MHC gene products can be 
divided into two classes on the basis of their structure. Class I loci (H-2K, H-20 and H-2L) code 
for membrane bound glycoproteins with a molecular weight of 44 kd. The glycoprotein molecule 
is 350 amino acid long, contains three external domains each about 90 residues in length, a 
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transmembrane region, and a cytoplasmic domain. The third external domain is noncovalently 
associated with ,82-microglobulin (12 kd), a 100 amino acid long polypeptide that shows 
homology to the constant region domains of immunoglobulins and is not encoded in the MHC 
(rev. by Hood et al. 1983). Two allelic forms of ,82M exist among the common laboratory mouse 
strains, ,82M-A and ,82M-B which are represented in Salb and C5781 mice, respectively (Goding 
and Walker, 1980). CTL raised across certain H-3 incompatibilities are specific for ,82M, 
suggesting that ,82M is a minor H antigen (Rammense et al. 1986). 
Sequence studies indicate that the class I heavy chains are among the most polymorphic 
molecules encoded in the mouse genome. In contrast, ,82-microglobulin is relatively invariant. 
Two alleles of the MHC I-region have been shown to contribute to class II antigens, namely A and 
E. The products of these loci are often called la antigens. Each la molecule consists of two 
noncovalently associated glycoproteins. The heavier chain, known as the a chain, has a Mw of 
approximately 35 kd and the lighter chain, designated the .B chain has a Mw of approximately 28 
kd. Unlike the class I antigens, for which only the heavy chain is encoded by genes in the MHC, 
both chains of the class II antigens appear to be encoded within the I region. The .B chains of both 
I-A and 1-E antigens are encoded within the A region, whereas the a chains are encoded in the 
regions carrying the appropiate letter designations. Furthermore it appears that the 
polymorphism of a chain is very limited, whereas that of .B chain is extensive, suggesting that 
alloantigenic specificities are predominantly a function of beta chains. Not all H-2 haplotypes 
express E region antigens. No E antigens have been detected in H-2b, H-2s and H-2q (rev. by 
Klein, 1981 ). 
The tissue distribution of MHC class I and class II antigens is different. The class I antigens 
encoded by the Kand D regions are distributed on all tissues, though some neurons may remain 
class I MHC negative (Wong et al. 1984a and b) , while the tissue distribution of la antigens is 
more restricted. Among peripheral lymphoid tissues, which are the richest source of MHC 
antigens in general, la antigens are expressed predominantly on B cells, dendritic cells and on 
certain macrophages. The amount (.)t la antigen detectable on other tissues is quite small. 
Whether or not this is of functional significance remains to be determined (rev. by Klein, 1981 ; 
Hood, 1983 et al.). It has been shown that expression of MHC class I and class II antigens is 
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upregulated by interferon-"( and a/~ (Steeg et al. 1982; Wong et al. 1984a and b), with -y being 
much more effective in this regard. 
Different subsets of mature T cells are restricted by different classes of MHC molecules. In 
general, CDS+ / CD4- cells, usually cytotoxic T cells, recognize antigen in association with class I 
MHC gene products, whereas CD4 +/CDs-cells, usually helper T cells recognize antigen in the 
context of class II gene products (la antigens) (Biddison et al. 1978; Meuer et al. 1982b). 
1.3.3.2 Antigen presentation 
One of the major controversies in immonology in the last few years is the nature of and 
requirement for processing of antigen for T cell activation. Physiologycally, the antigen presenting 
cell (APC) may generally use proteolysis, because the processing can be blocked by inhibitors of 
lysosomal function (Unanue, 1984). However, in some cases unfolding of the protein may be 
sufficient, and in the case of short peptides or intrinsic membrane proteins, no processing may 
be required (Streicher et al. 1984; Allen and Unanue, 1984; Walden et al. 1985; rev. by Allen, 
1987). In these experiments which used unilamellar or multilamellar lyposomes, the density of 
antigen could be significantly greater than that present on the surface of APC, making direct 
comparisons with systems using APC difficult. Different types of APC process and present 
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antigen to different extents, and different antigens require greater or lesser amounts of 
processing. 
There now appears to be strong evidence that processed antigens and MHC molecules can 
interact with measurable affinities (Babbitt et al. 1985; Buus et al. 1986; Schwartz, 1985; Watts et 
al. 1986; Allen et al. 1987). Antigen processing can be defined as the biochemical events, during 
which a protein antigen undergoes structural changes which allow it to associate with an MHC 
molecule and than to form the determinant recognized by the T cell. According to De Lisi & 
Berzofsky (1985), the native secondary structure of antigen might not be important, instead the 
antigen presenting cell may induce and maintain an a helix-like structure of the antigen segment 
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which provides the antigenic stimuli for TCR. The theory predicts that the antigenic sites have to 
be amphipathic. The model has been confirmed by some observations (Takano, 1977; Berkower 
et al. 1985a and b), but other results are not consistent with it. Sette et al. (1987) studied an 
immunogenic peptide of ovalbumin, consisting of eleven residues and did not find segregation 
between residues interacting with la and TCR, respectively. Their data suggest a two-dimensional 
planar formation (,8-sheet) of the peptide and with this structure each residue could interact with 
the la molecule or with the TCR. 
The question of antigen-MHC complex formation in the case of nonresponders is also 
controversial: affinity binding studies have shown low affinity binding (Kd = 1 o-3 to 1 o-6 M) of an 
antigenic peptide to high responder but not low responder la (Allen et al. 1985/a). However, 
photoaffinity labelling studies have demonstrated nonspecific binding between antigen and la 
(Abbas et al. 1985; Watanabe et al. 1986). 
Work done by Phillips et al. (1986) raises the question of whether the antigen-MHC complexes 
form extracellularly and/or intracellularly. They have shown that class II molecules located 
intracellularly bind antigenic peptides better than those located on the cell surface. Perhaps the 
cell surface class II molecules already have their binding sites occupied by a peptide ligand and 
those in the golgi and endoplasmic reticulum do not. An MHC molecule may constantly be 
cycling between the surface and the interior of the cell. Each time it is taken into the cell, it may 
shed the peptide ligand and pick up another, in which case most of the cell surface located MHC 
molecules would be 'occupied' and the intracellular, including newly synthesized molecules, 
would be 'free'. It is not known, where in the cell MHC molecules associate with antigen. It might 
happen in the lysosome (Buus et al. 1986), in extralysosomal acidic vesicles (Allen, 1987) , in the 
golgi or pre-golgi apparatus (Cresswell, 1985; Phillips et al. 1986). 
Protein-gold conjugates showed that the antigen is internalized after 0.5h by adsorptive 
pinocytosis into endosomes of an antigen-nonspecific APC B cell. (Pernis and Axel, 1985). These 
conjugates are recycl?d to the surface membrane in 3-4 h. These kinetics are compatible with the 
times required to pulse an APC with antigen and for an APC to function in antigen presentation. In 
the case of antigen, specific APC receptor mediated endocytosis has been proposed (Pernis and 
Axel, 1985). Their study suggests, that processing and presentation of antigen are no longer the 
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exclusive capacity of certain cells of the immune system. Any cell which can express MHC class 
II molecules appears to have the capacity to process and present antigen to helper T cells. (Most 
cells already express class I molecules and might present antigens in association with these to 
cytotoxic T cells.) T cells have been shown spontaneously internalize approximately 20-40% of 
their cell surface class I molecules mainly through coated pits and vesicles, although B 
lymphocytes have not been shown to internalize class I molecules in this way (Machy et al. 1987). 
An important question that remains to be explored is what determines which antigens are seen 
with class II and which with class I MHC determinants. One possible explanation lies in the time it 
takes a newly synthesized class I or class II molecule to reach the membrane. The class I transit 
time seems to be brief, approx. 20 min, while for class II it may take as much as 60-90 min. 
(Pernis, 1985). Molecules existing at high concentrations intracellularly and in equilibrium with the 
endocytic system (e.g. endogeneous membrane proteins and viral proteins produced during 
active infection) may be able to interact efficiently with either the rapidly cycling class I or slower 
class II molecules. However, exogeneous soluble proteins accumulated sporadically at low 
concentration may only form a large number of complexes with the slower cycling class II MHC 
molecules (Germain, 1986; Kourilsky et al. 1987). 
The distinction might be based on different trafficing characteristics of vesicles that contain 
either class I and class II molecules. Vesicles that contain class II might intersect with the 
endosytic pathway and present peptides from fragmented proteins. Class I-containing vesicles 
might receive the peptide products from endogeneously synthesized proteins (rev. by Bevan, 
1987). 
The most important findings on antigen - class I MHC interaction result from crystallography 
experiments by Bjorkman et al. (1987a and b) , who showed that a large 'groove' exist between 
the a helices of a1 and a2 domains. This grove provide a binding site for processed foreign 
antigens. 
1.3.4 Models of T cell recognition of antigen 
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Two types of models have been proposed to explain the dual specificity of TCR for antigen 
and MHC product. The first hypothesizes that a single T cell antigen receptor binding site 
recognizes a combined determinant formed by the restricting MHC molecule and antigen 
(Zinkernagel and Doherty, 1974a and b; 1978 & 1979; Matzinger, 1981; Schrader et al. 1982). The 
antigen and the MHC molecule might interact physically with sufficient avidity to form a complex 
antigen, either before or after encountering the T cell antigen-specific receptor (Schwartz, 1986; 
Sherman, 1982). It has been shown that a peptide fragment of lysozyme capable of stimulating T 
helper cells can bind to an appropiate responder (but not the nonresponder) 1-A molecule with 
significant affinity (Babbitt et al. 1985). Furthermore, transfection experiments (Dembic et al. 
1986) provided strong evidence that the et/3 heterodimer is critical in the formation of a TCR 
complex which recognizes both antigen and MHC and that a second receptor is not necessary 
for MHC restricted recognition. The a and /3 chain genes from a CTL clone specific for fluorescein 
(FL) and I-Ad were isolated and transfected into another CTL clone, the specificity of which was 
against a different hapten ~nd MHC type. The resultant transfectants obtained both the antigen 
and MHC restriction characteristics of the donor CTL clone. 
In recent work Allen et al. (1987) using a 1 O amino acid long stimulatory HEL peptide, 
determined that 3 amino acids comprise the T cell contact residue (epitope) and also that 3 
amino acids form the la contact residue (agretope). The peptide probably forms an a helix during 
the interaction with the la molecule, before becoming accessible for recognition by the T cell 
receptor. It also appears, that there is a single binding site for many unrelated peptides on the la 
molecule. Other results suggest that the antigen-specific receptor can bind antigen in the 
absence of MHC molecules (Siliciano et al. 1985; Rao et al. 1984). 
The second model proposes that the T cell receptor, composed of either two separate 
molecules or two binding sites in the same molecular complex, provides separate binding sites 
for the antigen and MHC molecule (Parham, 1984; Pernis, 1985; Cleveland and Elanger, 1985). 
The problems with this model are the following: firstly, independent segregation of antigen and 
MHC recognition was not found in somatic T cell hybrids expressing two distinct antigen MHC 
specificities (Kappler et al. 1981 ). Secondly, when an anti-clonotypic antibody specific for 
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ovalbumin-reactive hybridomas was used to select particular T cells from a large pool of 
hybridomas, two hybridomas were found to have the same antigen/MHC specificity plus allo 
MHC crossreactivity. They used the same a and f3 chains as that of the original clone to which the 
antibody had been made (Marrack et al. 1983). This result strongly suggests that the same 
heterodimer mediates both antigen and MHC recognition. Thirdly, the structure the T cell 
receptor itself argues against a model in which the a and f3 chains constitute two independent 
binding sites (Kronenberg et al. 1986). 
The latest crystallographic studies (Bjorkman et al. 1987a and b) presented evidence that a 
groove between the two a helices of the a1 and a2 domains of the human HLA-A2 antigen, located 
on the top of the molecule is the likely candidate for the binding site for the foreign antigen that is 
recognised together with HLA by a T cell receptor. The dimensions of the site are consistent with 
the expectation that class I molecules bind a processed antigen, probably a peptide. These 
studies also suggest that a peptide is always bound to histocompatibility antigens and its 
displacement is an essential feature of cellular immunity. The model can be useful to analyse 
other class I and class II histocompatibility antigens. 
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1.4 T lymphocyte subsets and their functions 
1.4. 1 Cytotoxic T cells (CDS+ /CD4j 
The CDS+ /C04- phenotype is primarily associated with MHC class I recognition and 
cytotoxic function (Cantor and Boyse, 1976; Doherty et al. 1976; Sprent, 1978; Meuer et al. 
1982b). CDS+ /CD4- cells appear in the thymus just prior to birth (day 18-20 in mouse) and 
comprise about 3-8% of total thymocytes (Ceredig et al. 1983; Mathieson and Fowlkes, 1984) and 
about 25% of peripheral lymphocytes. 
Specific activation of resting cytotoxic T cells consists of consecutive steps such as antigen 
recognition, interleukin 2 receptor (IL-2 R) expression and proliferation leading to the 
development of fully mature lytic capacity. In a simplified model, proposed by Gromo et al. 
(1987), the naive, resting CTL are IL-2 R-, nonproliferating and noncytotoxic. They become IL-
2R + in response to stimulation with antigen, but still do not proliferate and do not have cytotoxic 
capacity. The conclusion from numerous in vitro experiments, is that these lymphocytes proceed 
to proliferate only in the presence of IL-2 (Erard et al. 1985a and b; Vohr and Hunig, 1985; Simon 
et al. 1986; MacDonald and Erard, 1986; Ochoa et al. 1986) or IFN "f (Chen et al. 1986; Gromo et 
al. 1987) and subsequently become cytotoxic effector cells. 
The first step in CTL activation after encountering antigen is the upregulation of IL-2 R 
expression. Binding studies with isotope labelled IL-2 have revealed that T lymphocytes express 
two classes of binding site (Robb et al. 1984; Smith and Cantrell, 1985). The high affinity receptor 
(Kd = 10-11 M) consists of at least one 75 kd a chain and one 55 kd ~ chain (Dukovich et al. 1987), 
probably encoded by separate genes. The a chain has a long cytoplasmic tail. The chains are not 
covalently associated and both are necessary to form the high affinity binding site (Smith, 1987; 
Tsuda et al., 1987; Brandhuber et al. 1987). They bind to different, but perhaps overlapping, 
amino acid residues on the IL-2 molecule (Robb et al. 1987). The chains have also been detected 
separately on the surface of some cells (Robb and Greene, 1987). The~ chain alone (also known 
as Tac antigen) forms homodimers which can bind two IL-2 molecules with low affinity (Kd = 1 o-
8M) (Robb et al. 1981) whereas the a chain alone represents a medium affinity binding site (Kd = 
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1 o-9M) and is probably capable by itself of mediating signal transduction and rapid internalization 
of membrane bound IL-2 (Dukovich et al. 1987; Bich-Thuy et al. 1987; Wang and Smith, 1987). IL-
2 itself can induce expression of the~ chain but not of the high affinity receptor in resting (G 0 ) T 
cells (Smith and Cantrell, 1985; Bismuth et al. 1985). The biological significance of low affinity 
binding is not known, although it has been suggested to have a negative influence on T cell 
growth (Kumar et al. 1987). The simultaneous expression of a and ~ chains seems to be restricted 
to T cells stimulated via the TCR-antigen complex (Meuer et al. 1984). 
The expression of IL-2 receptor after stimulation is transient, being greatest at 3-7 days, 
followed by a continous decrease (Cantrell and Smith, 1983). After 10-12 days in culture, 
repeated antigen stimulation can upregulate the expression of high affinity receptors (Robb, 
1984; Reske-Kunz et al. 1986). The binding of IL-2 to a high affinity receptor is followed by rapid 
internalization via coated pits and degradation in lysosomes (Robb et al. 1981; Kumar et al. 
1987). Although the nature of the signal transmission is not known, the effect of IL-2 binding is to 
cause the cell to progress from the late G1 into the S phase (Robb et al. 1981 & 1984). 
The CTL lytic process has been studied since the 1970s. It has three basic stage-s. These are: 
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a, specific binding to target cells, b, Ca-dependent programming for lysis, c, the 'lethal hit' and 
killer independent lysis. The initial cell contact is mediated by accessory molecules, such as LFA-
1, CO2, LFA-3 and ICAM-1 (Springer et al. 1982; Krensky et al. 1983) but specific recognition via 
the TCR is necessary for the killing (Lanzavecchia, 1986). Electromicroscope (EM) studies have 
revealed that membrane bound cytoplasmic granules are present in CTL (Sanderson et al. 1977; 
Grossi et al. 1983) containing lysosomal enzymes (Masson et al. 1986). It has been shown that 
cell contact is followed by calcium dependent processes (rev. by Russel, 1983), such as 
cytoplasmic rearrangement of cell organells (Ryser et al. 1982), interdigitation of cytoplasmic 
processes between effector and target cell (Barber and Alter, 1978) and secretion of acid 
phosphatase and serine est erase (Pasternak et al. 1986; Takayama et al. 1987). Simone and 
Henkert (1980) provided evidence for pore formation in the target membrane at the lethal hit 
delivery stage, an observation confirmed later by Tschopp et al (1986). Finally, CTL kill targets by 
triggering an internal disintegration process which causes rapid cleavage of target cell nuclear 
DNA (Russel, 1983). Killing always occurs in one direction only and CTL once triggered, can also 
.. 
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lyse 'third party' targets (Lanzavecchia, 1986). After killing, CTL are able to kill further targets 
(Henkart, 1985). 
1.4.2 T helper cell (CD4 + /CD8l 
The CD4 + /CD8- phenotype is associated primarily with MHC class II recognition, helper and 
0TH function (Cantor and Boyse, 1975; Dialynas et al. 1983). CD4 'single positive' cells appear in 
thymus just before birth (at day 18-20 in mouse), and represent about 5% of thymic and 15% of 
peripheral lymphocytes, respectively. 
Specific activation of helper T cells requires interaction with accessory cells presenting antigen 
in the context of MHC class II molecules and also requires the presence of interleukin-1 (IL-1) 
which is produced by macrophages (Larsson et al. 1980; Williams et al. 1984; Smith et al. 1980). 
The activated T helper subset is the major source of IL-2 and other lymphokines, such as IFN r, 
IL-3, IL-4 and GMCSF (Mosmann et al. 1986a and b; Tite et al. 1985; Mosmann and Coffman, 
1987). However it is clear that some Lyt 2 + cells make IL-2 and other lymphokines. IL-2 was one 
of the first T cell derived growth factors to be identified (Gillis et al. 1978). It has been identified as 
a molecule with 15-17 kd molecular weight (Paetkau et al. 1985) and shows structural and 
functional similarities in different species. (Robb et al 1981 ). Human IL-2 consists of 133 amino 
acids arranged in a right-handed, fourfold a helical structure (Cohen et al. 1986) containing a 
single molecular disulphide bridge, which is necessary for maintainance of bioactivity (Taniguchi 
et al. 1983; Robb et al. 1984). Although IL-2 is a necessary factor for T cell proliferation, it also 
activates B cells (rev. by Robb, 1984) and induces IFN-r secretion by T cells (Farrar et al. 1982; 
Klein and Bevan, 1983). T helper cells have recently been shown to produce IL-4 (previously BSF-
1: B cell stimulatory factor 1) which is a costimulator for proliferation of resting B lymphocytes 
(Howard et al. 1982) and also stimulates T lymphocytes, immature thymocytes and mast cells to 
proliferate (Zlotnik et al. 1987; Mosmann et al. 1986a; Widmer and Grabstein, 1987; Trenn et al. 
1988). IL-3 is a lymphokine which stimulates growth of mast cells (Tertian et al. 1981; Nabel et al. 
1981) and multi potential hemopoietic cells (Ihle et al. 1983). Interferon r can also be produced by 
25 
both CDS+ or CD4 + cells (Kelso et al. 1982). It inhibits viral replication (rev. by Merigan, 1981 ), 
enhances macrophage function (Kelso et al. 1982), induces expression of MHC class I and class 
II antigens (rev. by Wong, 1984a and b) and inhibits the effect of IL-4 on B cells (Massmann et al. 
1986b). Granulocyte-macrophage colony stimulating factor (GMCSF) has been shown to support 
the growth and differentiation of neutrophil granulocytes and macrophages . It stimulates 
phagocytosis and antibody dependent killing (ADCC) by T cells and large granular lymphocytes 
(LGL) (rev. by Shrader et al. 1983) 
The T helper subset can be further divided into sub-types by function and spectrum of 
lymphokines produced (Mosmann and Coffmann, 1987; Lichtman et al. 1987): the first type of 
helper T cell clone synthesizes IL-2 and IFN-'Y (and lymphotoxin) but not IL-4, whereas the second 
type synthesizes IL-4 but not IL-2 or IFN--y. Both types of T helper clones synthesize IL-3 and 
GMCSF. 
1.4.3 Cellular interactions during T cell activation 
The importance of interactions between different cell types is likely to vary at different stages 
of the development of the immune response. Presentation of antigen on the surface of APC and 
possibe interactions between T cell and APC have been discussed above, however the question 
of T-T help leading to the development of CTL response needs more detailed analysis. The 
functional distinction between CD4 + ; cos-helper and CDS+ / CD4- cytotoxic cells is not rigid 
and there are numerous exceptions, creating a more complex picture of co-operation between 
these subsets. 
The generally accepted and simplified model , is that IL-2 produced by MHC class II-restricted 
T helper cells is necessary and also sufficient for differentiation of antigen primed CTL (Nabholz et 
al. 1978; Smith et al. 198Gb; MacDonald and Erard, 1986). However, the results of some other 
groups indicate that IL-2 alone might not be adequate to support CTL g:-owth and that other 
factors are also necessary (Wagner and Hardt, 1986; Hardt et al. 1985; Raulet and Bevan, 1982; 
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Kanagawa, 1983). Furthermore, there is debate concerning whether la-restricted T helper cells 
are the only source of IL-2 necessary for the development of CTL response. 
In vivo experiments revealed that vaccinia immune H-2b effector cells, negatively selected for 
alloreactivity to H-2k, can produce strong CTL response to the virus presented in the context of 
H-2Db molecules and in the complete absence of MHC class II homology (lak stimulators) 
(Bennink and Doherty, 1978; Doherty and Bennink, 1979). Similarly, depletion of CD4 + cells did 
not prevent the development of an effective anti-ectromelia CTL response in vivo, whereas the 
production of neutralizing antibody was impaired (Buller et al. 1987). These results are 
comparable with findings in LCMV infected mice (Moskophidis et al. 1987). Experiments with 
MHC class I incompatible and minor mismached skin grafts have also shown that in vivo 
depletion of CD4 + cells did not prevent graft rejection and development of cellular cytotoxicity 
(Woodcock et al. 1986; Qin et al. 1987). Furthermore, nude mice reconstituted with CD8 + cells 
show rapid, specific rejection of MHC class I disparate skin grafts (Rosenberg et al. 1987). These 
findings are in accord with the result of Rosenberg et al. (1986) who found that the CDS + / CD4-
IL-2 producing T cell subset is the critical cell type determining the in vivo rejection rate of MHC 
class I disparate skin grafts. 
Some in vitro experiments also indicate that there may be different subpopulations among 
CTL (Andrus et al. 1981 ; Mizuochi et al. 1985; Guimezanes and Schmitt-Verhulst, 1985). Heeg et 
al. (1987) found a frequency of IL-2 producing CD8 + cells in the class I MHC-restricted response 
similar to that shown for IL-2 producing CD4 + cells in the class II MHC-restricted response. The 
vast majority of CD8 + cells segregate into IL-2 producing non-cytotoxic, or IL-2 non-producing, 
cytotoxic clones. There is a remarkable difference between the kinetics of IL-2 secretion by CDS + 
(peaks at day 4, ceases at cay 7) and by CD4 + cells (peaks at day 7), respectively. 
Taken together, these results do not exclude the possibility and significance of specific T-T 
collaboration, but suggest that for some antigens the early phase of CTL response is Th -
independent this may progress to a later Th - dependent phase. The ratio between the Th -
-
independent and Th - dependent stage could be different from antigen to antigen and may be 
genetically determined (Sprent and Schaefer, 1985 ; Sprent et al. 1986a and b). 
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1.5 Aims of this thesis 
The theme of this thesis is to study the requirements of cytotoxic T cell activation and to 
characterize the CTL response during the anti-viral T cell response. 
The early experiments were designed to study the role of IL-2 in the development of a primary 
anti-viral T cell reponse (Chapter 3). Then, in vitro experiments to optimize the conditions for 
generating secondary anti-viral CTL response revealed that memory CTL can be re-activated in 
the absence of added antigen by a combination of phorbol ester and calcium ionophore (PMA 
and Cal). The specificity of this activity and characteristics of the activated cells at the clonal and 
subpopulation levels were determined (Chapter 4). This method is used in Chapter 5 to examine 
the activation requirements of CTL stimulated in the absence of accessory and stimulator cells. 
The possibility that Ly 24 antigen may be present on memory but not naive T cells is examined in 
Chapter 5. The phenotypic characterisation of memory T cells was carried out with Felicity Lynch. 
Ly 24 + cells from in vivo primed mice were sorted by FAGS. This population gave rise to all the 
specific cytotoxicity following in vitro stimulation. 
The experiments in Chapter 6 deal with the specificity and characterictics of the secondary 
CTL response against a complex antigen c;:onsisting of the ~ alloantigen and vaccinia virus. 
Chapter 2 
Materials and methods 
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2.1 Animals 
Inbred female and male mice (Table 2.1) were bred and maintained under specific pathogen 
free (S.P.F) conditions at the John Curtin School of Medical Research. The mice were removed 
from S.P.F facilities at about 6 weeks of age and conventionally maintained until use, generally at 
8-15 weeks of age. 
2.2 Tissue culture media 
2.2.1 RPMl-1640 
For maintenance of continuous cell lines, RPMl-1640 medium was used; The powder (Gibco, 
430-1800) was dissolved in distilled, deionized water and supplemented with 2g/l NaHC03 
(Gibco, 895-1810), the pH adjusted to 7.2 and the solution filtered through a 0.22 µ,m GS type 
Millipore filter, aliquoted into 500 ml bottles and stored at 4°C. Before use bottles of RPMI were 
supplemented with 5% foetal calf serum (Flow, 29-101-49) and with antibiotics to give a 
concentration of 100 i.u. penicillin, 100 µ,g streptomycin and 50 µ,g neomycin per ml. 
2.2.2 DMEM 
Dulbecco's modified Eagle's medium (DMEM) (Gibco, 430-2100) was used for culturing 
lymphocytes.It was prepared as described for RPMI, but in addition was supplemented with 
6mg/l of folic acid, 36mg/l of L-asparagine, 116 mg/I of L-arginine and 2g/l NaHC03 (Cerottini 
et al. 1974). Before use 1 O mM Hepes (1 M solution of N-2-hydroxyethyl piperazine N-ethane 
sulphonic acid (CSL, Melbourne), 5x1 o-5 M 2-mercaptoethanol, 216 mg/I L-glutamine (Gibco, 
320-5039), antibiotics and 10% FCS were added. This medium will be referred as MLR medium. 
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Table 2.1 Genetic composition of mouse strains 
strain haplotype MHC composition 
K A E D 
C57BL/6J (86) H-2b b b b b 
C57BL/10 (810) H-2b b b b b 
B10.A(5R) H-215 b b k d 
B10.A(2R) H-2h2 k k k d 
810.HTG H-29 d d d b 
B10.BR H-2k k k k k 
CBA/J H-2k k k k k 
Balb/c H-2d d d d d 
C3H.OH H-202 d d d k 
(Balb/c x B6)F1 H-2db db db db db 
(CSA x 86)F1 H-zkb kb kb kb kb 
(Balb/c x CBA)F1 H-zdk dk dk dk dk 
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2.2.3 Conditioned medium 
Lymphocyte cultures were supplemented with a source of IL-2. This was obtained as a 
supernatant from Con A activated mouse or rat spleen cells (2x1 O 7 cells were pulsed with 5 
µg/ml Con A for 2 h and incubated for 18-24 h in serum-free medium) and concentrated on an 
Am icon PM 1 O membrane (Andrus and Lafferty, 1980) or as a supernatant from EL-4 cells 
stimulated with 1 o ng/ml phorbol myristate acetate (PMA, Sigma, St Louis, Mo) for 24-48 hr. PMA 
was removed by incubation with dextran-coated charcoal tablets f:Nest Chem. DCC 404) (Farrar 
et al. 1980). Highly purified human recombinant IL-2 was obtained from Amersham (ARN 1010) 
or Cetus corporation (Emeryville, Ca). 
2.3 Maintenance of tumor cell lines 
The cell lines listed in Table 2.2 were stored in liquid N2 in 0.5 ml volumes in RPMI containing 
10% FCS and 10% dimethy1sulphoxide (DMS04) (Fluka, 41650). For culture, cells were thawed 
rapidly at 37 °c and washed in 1 o mis of warm medium and transfered into tissue-culture flasks. 
The cell lines were maintained in vitro by passaging approximately twice a week. Fibroblasts, 
grown as monolayers were first trypsinized (0.1 % trypsin diluent containing EDTA) for 1 O min at 
37 °c to give a single cell suspension, than washed at 300g for 7 min (a Beckman T J-6 
refrigerated centrifuge was used throughout the experiments) and resuspended in fresh medium. 
2.4 Screening for mycoplasma 
Cultures were checked regularly for mycoplasma contamination by culturing cells for 2-3 days 
in antibiotic-free medium. Samples of cells were ftxed with 3: 1 methanol:acetic acid solution and 
stained with Hoechst-stain (DNA-ftuorochrome 33258) and examined for mycoplasma as shown 
by cytoplasmic fluorescence using a UV-microscope. 
cell line 
L929 
MC57 
P815 
EL-4 
YAC-1 
KD2SV 
KHTG.SV 
K5R.SV 
VERO 
143 B 
BHK 
origin 
mouse 
mouse 
mouse 
mouse 
mouse 
mouse 
mouse 
mouse 
monkey 
human 
hamster 
Table 2.2 Tumor cell lines 
cell type 
fibroblast 
fibroblast 
mastocytoma 
thymoma 
lymphoma 
fibroblast 
fibroblast 
fibroblast 
fibroblast 
Tl-\ fibroblast 
kidney 
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MHC composition 
H-2kk 
H-2bb 
H-2dd 
H-2bb 
H-2dk 
H-2dd 
H-2db 
H-2bd 
32 
2.5 Viruses 
2.5.1 Preparation of virus stocks 
Lymphocytic choriomeningitis virus (LCMV). 
The Armstrong E350 (neurotropic) and WE-3 (viscerotropic) strains of LCMV virus were originally 
obtained from Dr F. Lehmann-Grube (Univ. of Hamburg, Germany) and have been maintained at 
the John Curtin School of Medical Research since 1974. WE-3 strain grown in L929 cells was 
used to infect cells in vitro. Confluent L929 cells monolayers were washed with phosphate-
buffered saline (PBS pH 7.4)) and infected with 1 ml of virus suspension at a m.o.i. (multiplicity of 
infection) of 2-3. The flasks were incubated for 1 hour at 37°C and then incubated in SO ml of 
RPMI/ 2% FCS until approximately 80% of the cells were destroyed by the virus. The flasks were 
than stored at -7o0 c. After thawing, cells and supernatant were centifuged at 1 OOOg for 1 o 
minutes. The pellet was resuspended in about 10 mis of the supernatant and cells were sonicated 
for 3x20 sec at 4 °c. Cell debri was pelleted at 1000 g for 1 O min at 41hC. Supernatant was 
aliquoted in 200 µI volumes and stored at -70 °c. 
The WE-3 strain for immunization was propagated in BHK cells and virus stocks were prepared in 
a similar fashion to L929-passaged virus. BHK-passaged WE-3 virus was administered 
intravenously (i.v.) at 1000 L050 per mouse unless otherwise stated. 
~ 
Armstrong strain of LCM virus was grown in suckling mouse brain, prepared as a 10% 
homogenate and titrated i.e. as described in section 2.5.2. 
Vaccinia virus 
Vaccinia virus WR strain was propagated in L929 monolayers in roller bottles containing 100 ml 
medium. Otherwise the procedures were similar to those described above. Cells were sonicated 
in 15 ml of supernatant. Titration was performed on L929 cells as described below (section 2.5.2). 
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Recombinant (VV-H2~-6 and W-TKl vaccinia viruses 
The W-H2~-6 virus strain was prepared by and obtained from Ors Coupar, Boyle and Andrew 
(CSIRO,Animal Health Laboratory,Geelong, Victoria). A recombinant plasmid vector containing 
an oligonucleotide adaptor at the 5' end of the coding sequence of the H-2~ cDNA and also the 
vaccinia virus promoter was used to transfect TK" cells infected with vaccinia virus WR strain. 
Homologous recombination between the vaccinia virus flanking sequences in the plasmid and 
the thymidine kinase (TK) gene of the infecting virus resulted in a TK" recombinant virus (VV 
H2~-6) with the chimeric promoter H-2~ sequence interrupting the vaccinia virus TK gene. 
Recombinants were selected in the presence of 5-bromodeoxyuridine (Coupar et al. 1986). The 
TK" vaccinia virus WR strain was originally provided by B. Moss (National Institutes of Health, 
Bethesda, MD). The virus strains were propagated in CV 1 and titrated in the 1438 TK" human cell 
line, basically as described for the vaccinia virus WR strain. 
On each occasion virus from a fresh vial was used and thawed rapidly at 37°C just before use. 
2.5.2 Titration 
Virus stocks were titrated on L929 monolayers, grow in 24 or 6 well trays. The monolayers 
were washed 3x with PBS. Virus preparation was serially diluted 1 :5 in serum-free medium from 
1 o-3 and 100 µI volumes were added to four wells for each dilution. The plates were incubated 
with frequent shaking for 1 hour at 37 °c, then the fluid was removed by Pasteur pipette and a 
mixture of 1 ml of 1.5% agar and 1 ml of 2x concentrated RPMl / 2% FCS/ PSN was added to each 
well. Plaques were counted 48-72 h later under light microscope (Olympus, Japan) after staining 
the monolayer with 1 % methylene blue containing 1 O % formalin. 
The titers of BHK-passaged WE-3 virus and in vivo passaged Arm viruses were determined in 
vivo by intracerebral injection..into of serial 10-fold dilutions of virus into groups of adult mice and 
the titre expressed as the 50% lethal dose (L050), as calculated by the Kaerber equation: 
log LD50 = 0.5 + log max ca - (sum % of dead animals : 100) 
where a) is the logarithm of the highest concentration of the virus used. 
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2.6 Preparation of cell suspensions 
For removing lymphoid organs, mice were killed by cervical dislocation, whereas for collecting 
cells of cerebrospinal fluid (CSF) the animals were anaesthetized with avertin (2-methyl-2-butanol, 
containing 1 g 2,2,2 tri-bromoethanol, Fluka, Switzerland) and exsanguinated. 
The viable cell number of single cell suspensions was determined by the trypan blue dye 
exclusion method using a Neubauer haemocitometer. 
2.6.1 Spleen and lymph node cells 
Spleens or lymph nodes (inguinal and axillary) were removed aseptically into ice-cold DMEM, 
then fragmented with scissors and gently squeezed through a stainless steel sieve The cell 
suspension was then thoroughly aspirated by Pasteur-pipette and large clumps removed by rapid 
filtration through nylon gauze. After washing at 300g for 7 min at 4 °c cells were resuspended and 
kept at 4 °c until use. 
2.6.2 Thymus cells 
To avoid contamination by parathymic lymph nodes, only parts of thymic tissue far from the 
isthmus were removed. Single cell suspension was prepared as described for spleen cells. 
2.6.3 Peritoneal cells 
Unstimulated or thyoglycollate-induced (3ml of 3% w / v thyoglycollate i.p. , 3-4 days before cell 
collection) peritoneal cells were collected by washing the peritoneal cavity with 3 mis of ice-cold 
Hank's balanced salt solution (HBSS) . The suspension was removed aseptically through a 
syringe without opening the interior abdominal wall. 
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2.6.4 CSF cells 
Samples of CSF were collected from the cisterna magna by the method of Carp et al. (1971 ) 
adapted by Doherty (1973). The dura mater covering the cisterna magna was exposed by 
removing the skin and muscles from the atlanto-occipital region. After perforating the membrane 
with a 26 gauge needle, the CSF was aspirated with a 20 µ,I pipette (Microcaps, Drumond, 
Philadelphia). CSF samples were diluted in 0.1 % trypan blue and counted in a hemocytometer. 
2. 7 Separation of lymphoid cell populations 
2.7.1 Ficoll-Hypaque density gradient centrifugation 
Ficoll-Hypaque (1.08 g/ml) was used to remove cell debris and red blood cells from cell 
suspensions, (Davidson and Parish 1975). This was prepared by mixing 12 parts of 14% Ficoll 
400 (Pharmacia 17-0400-01) with~ parts of hypaque (32.8 % metrizoic acid, Sigma, m-4762). 
Cells in 5 mis (up to 2x108) were layered onto 4mls of Ficoll-Hypaque and centrifuged at 3000 g 
for 20 mins at 22°c. Cells at the interface were collected by Pasteur pipette, resuspended in MLR 
medium and washed. 
2. 7 .2 Nylon wool column 
Lymphocytes were separated on nylon wool columns as described by Julius et al. (1973). 
Briefly, 1-1 .Sx 108 cells were loaded onto a nylon wool column, allowed to adhere for 45 mins at 
37 °c, then nonadherent cells were recovered by washing the column with 20 mis of warm 
medium. This protocol resulted in a population of spleen cells containing approximately 70% T 
cells, as checked by FMF. 
2.7.3 Treatment with antibody and complement 
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Monoclonal antibodies used during the experiments are summarized in Table 2.3. Antibodies 
were obtained by collecting the supernatants from hybridoma cells growing in MLR medium. For 
depletion of cell populations single cell suspensions at a concentration of 5x106- 2x1 O 7 cells/ml 
in serum-free medium were incubated with the optimal amount of antibody at 37 °c for 20 mins. 
Low cytotoxicity rabbit complement prepared by the agarose absorption technique (Cohen and 
Schlesinger, 1970) of serum from selected rabbits was then added at 1 / 24-1 / 30 and the cells 
incubated for a further 45-60 minutes. Cells were then washed and the effectivity of depletion 
checked by FMF. The optimum concentrations of antibody preparations were determined by 
incubation of dilutions (serial 2-fold) of antibody with normal thymocytes followed by treatment 
with complement. 
2.8 In vitro stimulation of the secondary immune response 
2.8.1 Specific stimulation with antigen 
For antigen-specific restimulation of in vivo primed virus-immune lymphocytes, thyoglycollate-
induced peritoneal macrophages or spleen cells were used as antigen presenting cells. The cells 
were depleted with anti-Thy.1 monoclonal antibody and complement as described above (section 
2.7.3). They were infected with vaccinia virus for 1 hour at a multiplicity of infection (m.o.i.) = 2.0, 
or with LCMV WE-3 for 48 hours at a m.o.i. of 0.1. Peritoneal cells were dispensed at a 
concentration of 5x1 o5 per well in I ml volumes in 24 well trays (Linbro, 7606305). The cells were 
allowed tc adhere for 1-4 hours then the supernates were removed and the virus was inactivated 
by i:-radiating the wells with 1200 µW / cm2 UV light for 1 O minutes (7200 J/m2) using a 30 W 
Phillips germicidal lamp. Spleen cells were dispensed in 0.1 ml volume/well and irradiated. 
Responder cells were then added at a 1 O: 1 ratio (5x106 / well) and the cultures were 
supplemented with 10% EL-4 supernatant unless otherv.iise stated. Cells were harvested after 3-5 _ 
days, counted and their cytotoxic activity determined in a 6 hr 51 Cr-release assay (see section 
13.1 ). In some experiments virus infected stimulator cells were irradiated with "(-ray (2000 rad, 
60co-source). 
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Table 2.3 Monoclonal antibodies 
mAb origin subclass specificity reference 
GK1 .5 rat lgG2b L3T4a D ialynas, 1 983 
AT83A rat lgM Thy1 .2 Sarmiento, 1980 
RL 172 rat lgM L3T4 Ceredig, 1985 
3.168.8 rat lgM Lyt2 Sarmiento, 1980 
J11d rat lgM B cells, Bruce, 1981 
thymocytes 
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2.8.2 Stimulation with PMA and Cal 
Cells were cultured at 0.5-1.0x106 /ml in 24 well trays or tissue culture flasks. They were 
stimulated with 1 ng/ml phorbol myristate acetate (PMA), (Sigma, St.Louis, Mo). and 100 ng/ml 
of calcium ionophore (Cal), (lonomycin, Calbiochem, Behring Diagnostics, La Jolla, Ca). These 
reagents were stored at -7o0 c as stock solutions of 10 µg/ml (PMA) and 100 µg/ml (Cal) in 
absolute ethanol. The cultures were routinely supplemented with 2% EL-4 sn and cultured for 3-4 
days. 
2.9 Limiting dilution analysis of CTL precursor frequency 
2.9.1 Specific stimulation 
Antigen presenting cells were obtained and processed as described in section 8.1 and 
dispensed at 1 o5 cells/well in 96 well U bottomed microtiter plates (Linbro, Flow, Va 76-042-05). 
Graded numbers of responder lymphocytes were added into 16 wells for each responder cell 
dilution. Each culture was supplemented with 10% v /v EL-4 sn, added on days 0, 2, and 5. The 
cultures were incubated for 8 days at 37 °c and the cytotoxic activity of cells in each well was 
determined after resuspending and dividing each culture in half. Virus- infected and uninfected 
51 Cr-labelled target cells were added at a concentration of 5x1 o3 in 100 µI /well and the assays 
incubated for 6-8 hours at 37°c. Cultures were considered as positive for CTL activity when 51 Cr 
release exceeded the mean spontaneous 51 Cr release from targets incubated with stimulators 
alone by at least 3 standard deviations, or if this was less than 5% lysis, the latter was chosen as 
the cut-off point. 
2.9.2 Stimulation with PMA and Cal 
Graded numbers of nylon-wool enriched lymphocytes were cultured in 1 ng/ml PMA and 
1 OOng/ml Cal in 96 well U-bottom microtiter trays at 200µ1 / well for 7-8 days. EL-4 sn (10% v / v) 
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was added at the initiation of incubation with a further 5% v /v being added every 48 hours. The 
contents of individual wells were divided in two at the end of the culture period and assayed as 
described in 2.9.1. A level of 5% specific 51 Cr release was considered to be positive. 
2. 1 o Clonal assay of CTL specificity 
Effector cells were cultured in 96 well U-bottom trays for 8-1 O days. The initial cell number was 
chosen to be at or near to clonal level (i.e. probability of clonality was >80%) Cells were 
stimulated with PMA and Cal and supplemented with EL-4 sn as described for LOA (2.9.2). The 
contents of individual wells were divided in two at the end of the culture period and assayed for 
cytotoxic activity on different target cells as described. For each group 16-48 individual wells 
were tested. 
2.11 Proliferation assay. 
2.11.1 [3H]-thymidine uptake 
Cells stimulated either with antigen or mitogen were cultured at 1 o5 cells/well in microtiter 
trays for 2-3 days. Each well was pulsed with 1 µCi (3H]-thymidine (New England Nuclear, 
Boston, Mass.) for 6 hr. The cells were harvested onto glass fibre filter paper using a PhD cell 
harvester. Scintillation fluid (1 ml) was added into each scintillation vial (Bunzl, 505) and (3H]-
thymidine uptake was measured using a Packard scintillation counter and expressed as cpm. 
2.11.2 Colorimetric MTT (tetrazolium) assay 
In some experiments tetrazolium salt has been used to measure proliferation as described by 
Mosmann (1983). MTI (3-(4,5-dimethyltiazol-2-yl)-2,5-diphenyl tetrazolium brcmide (Sigma, 
M2128) was dissolved in PBS at 5 mg/ml and filtered to sterilize and remove any insoluble 
residue of MTI. At the end of the culture period 1 OµI stock MTI solution was added into the wells 
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containing cells in 100 µI volumes and the plates were incubated at 37 °c for 4 h. Acid-
isopropanol (100 µI of 0.04N HCI in isopropanol) was added to all wells and resuspended until the 
crystals dissolved. Plates were read within an hour on a MR 600 Microelisa plate reader 
(Dynatech) using a test wavelength of 570nm, a reference wavelength of 630 nm and a calibration 
setting of 1.99 or 1.00 if the samples were strongly coloured. 
2.12 Assay for IL 2 production 
Serial, two-fold dilutions of IL 2 containing supernatant from stimulated cells (50 µI/well) were 
added to 1-5x1 o4 IL 2- dependent CTLL-2 cells (Gillis et al. 1978). Dilutions of an IL-2 containing 
supernatant was used as a positive control. Cells were incubated for 24 hours and their 
proliferation measured as described (section 2.11 ). Cells were also incubated in medium alone to 
check that they were IL-2 dependent. 
2. 13 Assay of cytotoxic activity 
The cytotoxic activity of immune spleen cells, or in vitro restimulated cells was determined 
using virus-infected or uninfected continuous cell lines or thioglycollate- induced peritoneal 
macrophages. In all experiments target cells were preincubated for 48 hours with LCM virus and 
for 1-4 hours with vaccinia virus, respectively. 
2. 13. 1 51 Cr release assay 
Target cells were labelled with 51 Cr as originally described by Brunner et al.(1968). The 
isotope was obtained as a Na51 cra4 solution (Amersham, England.) Target cells at 107 cells/ml 
were incubated for an hour at 37 °c with 100 µCi/ml Na51 CrO 4. then washed 3 times (300g, 7 
min). Target cells at 5x1 o4 / ml, (5000 cells/well} were dispensed into 96 well U-bottomed trays. 
Two-fold diluted effector cells were then added in triplicate and incubated for 6-8 hr at 37°C prior 
to taking 100 µI of supernate from each well for assay of 51 Cr-release. 
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In the case of macrophage targets, thioglycollate-induced peritoneal macrophages were 
plated at 8x1 o4 cells/well, (Mullbacher and Blanden, 1979). After they had adhered each well was 
washed 2x with 150µ1 serum-free medium, finally about 1 µ.Ci Na51 CrO 4 was added in 50 µ.I to each 
well. Trays were incubated for an hour at 37°C, washed twice with 150µ.I MLR medium/ well , 
incubated for a further 1-2 hr and washed twice again. The medium was then replaced with 200 µ.I 
MLR media containing diluted effector cells. The assay was harvested as described above. 
The minimum and the total 51 Cr release were determined by incubating the target cells in 
medium without adding effector cells and adding 100 µI 0.2% Triton-x/well, respectively. Results 
are expressed as % specific 51 Cr release, calculated as: 
% release induced by effector cells - % spontaneous release 
X 100 
% total release - % spontaneous release 
2.13.2 Colorimetric assay. 
In the colorimetric cytotoxic assay (Parish and Mullbacher, 1983) 8x1 o4 thioglicollate-induced 
peritoneal macrophages in 200 µI DMEM containing 1 % FCS were plated into 96 well U-bottom 
trays. After 1 hr incubation at 37°C, 100 µI of serially diluted (two-fold) effectors were added in 
triplicate. Trays were incubated for 6 hr then the supernates were replaced with 100 µI warm 
0.036% neutral red in HBSS (Hank's balanced salt solution) / well. After 20 mins incubation at 
37°C plates were washed twice with PBS and neutral red was released from live cells with 200 µI 
0.1 N acetic acid + 0.5% SOS solution/ well. After mixing the optical density (OD) of each well was 
measured by a Microelisa plate-reader. The machine was blanked on wells that were stained with 
neutral red but did not contain any macrophages, and control wells consisted of macrophage 
targets which were cultured with medium alone. Results were expressed as percent lysis of 
targets at each effector:target ratio based on the formula: 
% lysis = C-T x 100 
C 
where C = OD of control wells, T = OD of wells containing T cytotoxic cells. 
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2.14 FMF analysis 
2.14.1 Phenotypic analysis 
For indirect staining of lymphoid cells the antibodies and fluorochrome conjugates detailed in 
Table 2.4 were used. The antibodies marked with (*) were also used in a purified, biotinylated 
form, obtained by the method described by Heitzmann and Richards (1974). Both first and 
second step reagents were titrated for optimal staining before use. 
Lymphocyte populations for analysis by FAGS were separated on Ficoll before staining, to 
give as high a concentration of viable cells as possible. Although dead and red blood cells can be 
gated out.this is less efficient if the proportion of live cells is low. 
Aliquots (106) of lymphoid cells were incubated for 20 minutes at 4°C in 100 µI of monoclonal 
antibody then centrifuged (300g, 1 O min) through an underlay of 0.5 ml cold FCS. The pellet was 
resuspended in 100 µI of fluorescein conjugate. Control samples were stained with the second -
step reagent only. Following a further 20 mins incubation at 4 °c and washing, cells were 
resuspended in 0.5 ml medium for FMF analysis. 
In the case of F23 and 2C11 antibodies, cells were first incubated for 20 mins with antibody at 
37°C in the presence of 100 µI 0.02% Na-azide according to the method of Leo et al. (1987). 
For the determination of DNA content cells were stained with 50µg/ml of the DNA binding dye 
propidium iodide (Pl) in the presence of 0.05% Triton X-100. Cells were analysed immediately by 
flow cytometry or fixed if analysis was to be done at a later date. Only samples containing less 
than 5% dead cells were fixed to avoid false positive results. For fixations cells were resuspended 
in 0.5 ml PBS after the last wash and the same volume of paraformaldehyde (2 %) solution 
(Sigma, St.Louis, Mo) was added. Samples were kept at 4°C and run with in the next few days on 
a Becton Dickinson FAGS 440 microfluorometer (Mountain View, Ca) linked to a Consort 40 
computer. In general, 20000 gated events were collected for each sample. The data were 
~ollected and presented as the size and fluorescence of cell populations in the form of one 
dimensional histograms in which the horizontal axis shows units of fluorescence or light scatter 
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Table 2.4 Antibodies and fluorochrome conjugates for FMF 
mAb origin 
AT83* rat 
53.6.7* rat 
PC61* rat 
H-129* rat 
C71* rat 
RAM* rat 
1M7* rat 
Mel 14 rat 
F23 mouse 
KJ16 rat 
2C11* hamster 
Fluorochrome conjugates 
Sheep anti-rat lg-FlTC 
Sheep anti-mouse lg-FlTC 
Sheep anti-hamster 
FITC conjugated avidin 
subclass 
lgM 
lgG2a 
lgG 
lgG2a 
lgM 
lgM 
lgG2b 
lgG2a 
lgG2a 
specificity 
Thy1 .2 
Lyt.2 
IL-2R 
L3T4 
Pgp1.2 
Pgp1 .1 
Pgp1 
homing rec. 
TCR V f3a, 1 ,2,3 
TCR V/38_ 1 _2 
T3-£ 
Obtained from 
Silenus, Melbourne 
Silenus, Melbourne 
Jackson.Imm.Res.Prod. 
Tago, lnc. ,Burlingame 
reference 
Sarmiento, 1980 
Ledbetter, 1979 
Ceredig, 1985 
Pierres, 1984 
-· 
Lesley, 1982 
Lesley, 1982 
Trowbridge, 1982 
Gallatin, 1983 
Staerz, 1985 
Haskins, 1984 
Leo, 1987 
dilution 
1 / 20 
1/ 10 
1/ 20 
1 / 30 
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(size) per cell and the vertical axis shows frequency of cells. The percentage of stained cells was 
calculated by subtracting the value for control cells incubated with second step reagent alone. 
14.2 Cell sorting 
Staining of cells for sorting on FACS was performed as described above. Cells positive or 
negative for that specific antibody were collected at the same time into sterile tubes under sterile 
sorting conditions. Small samples of the sorted populations were re-run to check the 
effectiveness of the separation. The extent of contamination (frequency of undesired cells) was 
usually <5%. 
2. 15 Statistical evaluation of data 
Minimal estimates of CTL precursor frequency according to the Poisson distribution were 
obtained as the slope of the line relating to the number of responder cells per well (plotted on 
linear x axis) and the percentage of non-responder cultures (plotted on logarithmic y axis) fitting 
the data by the least squares method (Taswell et al. 1981 ; Ryser and MacDonald, 1979). The data 
were analysed on a Texas 74 calculator, the frequency ot precursors and the correlation 
coefficient is given. Unear regression analysis was also calculated using the inbuilt programs of 
the Ti-7 4 calculator. 
Chapter 3 
Requirements for the development of a primary anti-viral cytotoxic 
T cell response in vivo. 
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3.1 Introduction 
Recovery from poxvirus infection depends essentially on the cell-mediated immune (CMI) 
response initiated by class I MHC-restricted T lymphocytes (Blanden et al. 1975). When cells are 
infected with poxviruses, viral antigens appear on the surface of infected cells and they then become 
susceptible to immune lysis. Effector cells which kill mouse pox (ectromelia) virus-infected target 
cells in vitro, and trigger virus clearance in vivo, are detectable by day 4 and reach peak activity in 
the spleen by days 5-6 (Blanden and Gardner, 1976). 
In this chapter, the requirements for the development of an in vivo anti-vaccinia CMI response are 
described based on observations using an immunosuppressed model. This model involved 
pretreatment of mice with a high dose of cyclophosphamide (CY) which converts the subclinical 
infection with vaccinia virus into a lethal disease. The clinical outcome of infection parallels with 
impairement of the CTL response measured in vitro. The possible roles of different factors necessary 
for the development of the T cell response are studied. 
CY has found extensive use as a cytotoxic agent in tumor therapy and for manipulation of the 
immune response in both clinical and experimental situations (Goodman and Gilman, 1975; Anon, 
1981; Turk and Parker, 1982). This short-acting drug is activated in the liver microsomal system to 4-
hydroxycyclophosphamide, which in turn gives rise to the cytotoxic species phosphoramide 
mustard and acrolein: the former binds nucleic acid, preferentially guanine, while the latter binds to 
protein (Anon, 1981; Hemminki, 1985). The effect of CY on the immune system depends on the 
amount of drug given and the time of administration relative to antigen stimulation. Proliferating cells 
are much more susceptible (Goodman and Gilman, 1975; Anon, 1981; Turk and Parker, 1982), so 
quite small doses are highly immunosuppressive if administered after antigen (Allan and Doherty, 
1985). Injection of mice with larger amounts of CY (200-300 mg/kg) prior to antigen kills more than 
80% of spleen cells (Taswell et al. 1979; Doherty and Allan, 1984) with different mouse strains 
showing varying levels of susceptibility (Pevnitsky et al. 1985). The remaining lymphocytes may, 
however, be able to mediate some aspects of the immune response (Doherty and Allan, 1984). In 
general, T cells are slightly less susceptible than B cells (Turk and Parker, 1982; Wilmer et al. 1984), 
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but different types of lytic function mediated by cytotoxic T cells (CTL), natural killer cells (NK) and 
lymphokine activated killer cells (LAK) are all suppressed for a time following administration of a 
large dose of CY (Taswell et al. 1979; Doherty and AJlan, 1984; Hurme et aJ. 1982; Ballas, 1986; AJ lan 
and Doherty, 1986). 
As demonstrated below, the lethal disease that is induced by high doses of CY is associated wtth 
both a massive decrease in the total number of effector cells available to combat the infection and 
ith heritable changes in the properties of the surviving T lymphocytes. 
This model proved useful for analysing the importance of T cell prolrferation, interleukin 2 
production and expression of T cell antigens during the development of an anti-viral T cell response 
in vivo. 
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3.2 Results 
3.2.1 Consequences of CY pretreatment 
Administration of 300 mg/kg of CY to 86 mice prior to infection with vaccinia virus (following the 
protocol shown in Fig 3.1) induces a disease that is lethal within 1 O days (Fig. 3.2). 
This is accompanied by a dramatic drop in the number of spleen cells obtained at different times 
after the treatment with the drug (Fig. 3.3). However, by day 8 after immunosuppression, the number 
of spleen cells from non-immune animals exceeds those of the virus-immune and untreated animals, 
showing that the recovery after immunosuppression is greatly inhibited in the virus infected-animals. 
3.2.2 Cytotoxic activity of acute virus-immune spleen cells 
The CTL response in ectromelia and in vaccinia infection, peaks at about day 6 after infection 
(Bland en et al. 1976). CY pretreatment greatly diminishes this activity on a cell-for-cell basis (Table 
3.1 ). Lysis of the NK sensitive YAC target cells, which normally peaks at day 4 after infection, is also 
generally low in immunosuppressed mice: the slight increase observed here on day 6 might reflect a 
delay in this activity (Table 3.1, last column) . Lower doses of CY (200 or 100 mg/ kg) have a less 
marked immunosuppressive effect on anti-viral cytotoxicity (Fig. 3.4). 
3.2.3 Frequency of vaccinia-immune precursor CTL 
Virus-immune spleen cells cultured under limit dilution conditions (see Chapter 2, section 9), have 
a vaccinia-specific precursor CTL (pCTL) frequency of about 1/ 1000 - 1 / 1800. Unlike the marked 
loss of CTL activity, there is only a minor decrease in pCTL frequency following suppression with CY 
(Figs.3.5 & 3.6). In three separate experiments the decrease was 1.5, 2.6 and 1.3-fold (Table 
3.2) .When the results of a representative experiment are calculated to express primary cytotoxicity 
as lytic units (LU) per spleen, and the number of pCTL is also given on a per spleen basis, the 
discrepancy between acute effector function and the size of the potential pool of responders 
day o 
day2 
days 
Fig. 3.1 Experimental protocol 
300 mg/kg CY intraperitoneally (i.p.) 
5 x 106 PF~ vaccinia virus (i.p.) 
l 
Assay of CTL activity 
or 
initiation of in vitro cultures 
day2 day 5-8 
assay of CTL activity 
assay of IL-2 production or 
limit dilution analysis (LOA) 
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Fig. 3.2 Mortality of immunosuppressed mice after virus infection 
Mice were injected with 300 mg/kg CY i.p. and with 5 x 106 PFU vaccinia virus 2 days later 
(continuous line). The dotted line represents r,on-immunosuppressed mice, given the virus only. 
Fifteen mice were tested per group. 
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Fig. 3.3 Cellularity of spleens after virus infection 
Mice were injected with virus only ( D ) or following CY treatment ( fLJ ) 
as described at Fig. 3.2. Recovery of spleen cell number 8 days after immunosuppression in 
uninfected mice is represented by (*). Mean spleen cell number from 5-20 mice is shown. 
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Table 3.1 Primary cytotoxic activity of spleen cells after vaccinia infection 
in vivoa 
treatment 
Vacc. 
CY+Vacc. 
Nil 
E/T ratio 
100:1 
.50:1 
.25:1 
12:1 
100:1 
50:1 
25:1 
12:1 
100:1 
50:1 
25:1 
12:1 
% specific lysisb 
MCS7G+vacc MCS7G 
77.7 
66.3 
54.1 
33.0 
16.4 
11.0 
10.1 
8.4 
8.3 
5.4 
5.8 
5.2 
7.5 
8.7 
8.2 
6.5 
13.0 
8.7 
7.3 
7.8 
8.9 
6.9 
5. 
9.0 
L929+vacc 
10.4 
3.9 
5.3 
4.7 
8.0 
4.0 
4.7 
3.8 
4.7 
3.9 
2.4 
2.8 
a) 86 spleen cells tested 6 days after infection. In vivo treatment as described in Fig. 3.2. 
b) 4 h 51 Cr-release assay for YAC targets, 6 h for the other targets. 
Spontaneous release of targets: 31.2%, 18.4%, 23%, 21.6%. 
YAC 
12.9 
9.0 
5.8 
4.9 
21.7 
16.7 
11.6 
8.6 
9.0 
8.4 
5.2 
4.0 
Results are expressed as the mean of triplicate samples. S.E. of results per targets; < 5.5%, 3.0%, 
3.6%, 3.5%. 
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Fig. 3.4 Suppression of CTL activity by different amounts of CY. 
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86 mice were treated in vivo as described at Fig. 3.2. Spleen cells were harvested 6 days after viral 
infection. Spontaneous release was 18.3% for vaccinia-infected MC57G targets and 19.6% for 
uninfected MC57G cells. The results are shown as mean of triplicate samples on infected targets, the 
S.E. being less than 5%. Cytotoxicity measured on uninfected targets was less then 10% in each 
group at 100: 1 ratio, with S.E. being less than 1.5%. 
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Fig. 3.5 Cytolytic activity of LOA microwells 
Graded number of spleen cells from in vivo treated (as Fig. 3.2) or untreated animals were cultured 
with 1 o5 T cell-depleted , virus-infected macrophages inactivated by UV irradiation, in 96 well trays 
for 8 days. Cytotoxicity from individual wells was measured on virus-infected MC57G target cells in 
an 8 hr 51 Cr-release assay. 
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The frequency of pCTL was calculated by linear regression from the percentage of nonresponding 
wells expressed as log value (showing less than 3 x S.E. of cytotoxic activity from wells containing 
stimulator cells only, Fig. 3.5), (y axis) at each concentration of responder cells (16 wells/ dilution) (x 
axis). Frequency of pCTL= 1, when 37% of the wells are negative for cytotoxicity by Poisson 
distribution. 
Table 3.2 Consequence of treatment with 300 mg/kg CY for 
CTLp frequency. 
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Exp. Treatmenta CTLp (f; r)b 
1 
2 
3 
CY 
+ 
+ 
+ 
Vacc 
+ 
+ 
+ 
+ 
+ 
+ 
a) In vivo treatment, see Fig. 3.2 
MC57G + vacc. 
1/ 1199; 0.97 
1 / 1780; 0.94 
1/ 1036; 0.86 
1 / 2733; 0.81 
1 / 1775; 0.91 
1 / 2343; 0.98 
1 / 30921 ; 0.93 
b) f: frequency of pCTL~ r: correlation coefficient 
c) not done 
MC57G uninf. 
1 / 21938; 0. 76 
< 1 / 30700; 
< 1 / 25000 ; 
< 1 / 47695 ; 0.87 
NOC 
ND 
ND 
56 
becomes even more apparent (Table 3.3).Administration of CY diminishes the number of LU per 
spleen by a factor of SO-fold, while the decrease in CTLp per spleen is only 7-fold (Table 3.3). This 
difference reveals that the majority of CTLp fail to develop into effector T cells in vivo in the 
immunosuppressed animals. 
3.2.4 Expression of cell surface glycoproteins 
The results of the limit dilution assays suggest that no selective loss of the pCTL subset occurs 
due to the immuno-suppression. The ratio of different subsets of lymphocytes in the spleen of CY 
treated or untreated immune or normal mice was measured by flow microfluorometry (FMF). As a 
consequence of infection with vaccinia virus, the proportion of Thy-1 + and Lyt-2+ cells in the spleen 
is increased above the levels for normal controls, while there is little difference in the level of 
expression of L3T4 + (top two panels, Fig. 3.8). However, the intensity of staining and the proportion 
of positive cells for all three cell-surface glycoproteins is greatly diminished on spleen cells from the 
CY-pretreated, vaccinia-infected mice (bottom panel, Fig. 3.8). This drop in the level of expression of 
Thy-1, Lyt 2 and L3T4 subsequent to CY-suppression and infection was confirmed in further 
experiments and was also found for mice that were given CY but no virus (Fig. 3.9). The decrease in 
Thy-1, Lyt 2 and L3T4 is not due to a relative increase in B cell numbers, as the second antibody 
used for Thy-1 staining (first column in Fig. 3.8) will also bind to mouse immunoglobulin: any B cells 
would thus be included in the background staining for Thy-1 (Fig. 3.8). 
The fact that individual cells are expressing less Thy-1, Lyt 2 and L3T4 in the drug-treated mice 
was further demonstrated by culturing spleen cells in vitro under conditions that cause selective 
proliferation (Ceredig, 1986; Erard, 1985) of all T lymphocytes. Again, after 4 days in culture, FMF 
profiles for lymphocytes from mice that were given CY alone, or CY + virus, show much lower levels 
of L yt 2 and L3T 4 (Fig. 3.10), though the effect on Thy-1 is not quite so apparent as that found for 
cells takei1 directly from spleen (compare Fig. 3.1 O with 3.8 & 3.9). The overall conclusion is, 
however, that CY-treatment causes decreased expression of Lyt 2, L3T4 and Thy-1 , with this effect 
Table 3.3 Effect of CY-immunosuppression on vaccinia-immune 
cytotoxic activity and pCTL frequency 
Lytic unitsb per CTLpc frequency 
57 
300 mg/kg 
Cya 1 o 7 cells spleen vaccinia-targets uninfected 
+ 
395 
39 
11266 
221 
f No./spleen 
1 /1199 0.97 23.8x104 
1/1780 0.94 3.2x104 
a) Cy was given 2 days before virus. Cells were harvested 6 days after infection. 
> 1 /21938 
>1/30700 
f 
b) Calculated as the number of cells necessary to cause 30% specific lysis of vaccinia virus-infected 
MC57G targets in a 6hr 51 Cr release assay. 
c) Determined by culturing the 6 d immune spleen cells under limiting dilution conditions for a further 
8d in the presence of excess IL-2. 
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Fig 3.8 Phenotypic analysis of freshly isolated spleen cells 
Animals were treated as described in Fig 3.2 and the phenotype of spleen cells was analysed 6 days 
after infection. The mAb to Lyt 2 (53.6.7) and L3T4 (H-129) but not Thy-1 (AT83) were biotinylated. 
The dotted lines represent the binding of second antibody (sheep anti-rat FITC for Thy-1 and avidin-
FITC for the others). The percent value represents the difference between the contrci (staining with 
second antibody) and experimental results. The last column shows the ratio of cyctlng cells stained 
with propidium iodide (P.I.). a.u. = arbitrary units 
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Fig. 3.9 Phenotypic analysis of freshly isolated spleen cells. 
Spleen cells were tested from normal animals (first row) and from immunosuppressed mice treated 
with 300 mg/kg CY 8 days before analysis. Biotinyiated antibodies (AT83 for Thy-1, 53.6. 7 for Lyt 2, 
H-129 for L3T4 and PC61 for IL-2 receptor) followed by labelling with avidin-FITC were used. The 
percent of stained cells is expressed after subtracting the value of control samples stained with 
second antibody alone (dotted line). DNA content was determined by P.1.staining. 
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Fig. 3.1 o Phenotypic analysis of spleen cells after mrtogenic stimulation 
Mice were treated as described at Fig. 3.2. Spleen cells were incubated for 4 days in the presence of 
100 ng/ ml Cal , 1ng/ ml PMA and 10 U/ ml EL-4 supernatant. Staining for FMF analysis was 
performed as described previously (Figs. 3.8 & 3.9) . Control samples stained wrth the second 
antibody are shown in the las! column. 
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persisting through successive cycles of cell division. The additional involvement of vaccinia virus 
does not modify this pattern. 
Cell surface expression of the IL-2 receptor was also examined by FMF. The results of this 
analysis are variable, and did not in any consistent ways parallel the decrease in levels of Thy-1, Lyt 
2 or L3T4 (Figs. 3.9 & 3.10). Increased IL-2 receptor expression in spleen at 8 days after CY-
treatment of otherwise normal mice is shown in Fig. 3.9. Similarly, expression of the IL-2 receptor 
tends to be higher on spleen cells from CY-pretreated than from normal immune mice 6 days after 
infection (Fig. 3.11, second column). The amount of IL-2 receptor on cultured T cells may be 
decreased in the CY-treated group (Fig. 3.1 O). The variability in the amount of IL-2 receptor 
expression could result from the use of inappropriate antibody: PC61 which was used throughout 
these experiments stains only the 55 kd chain of the I L-2 receptor, which has been shown to be 
expressed on the cell surface in the presence or in the absence of the 75 kd chain. Thus the results 
do not necessarily reflect the expression of the functionally important high affinity IL-2 receptor, 
which consists of both chains. 
3.2.5 Restoration of CTL activity 
A major difference between the assays for CTL function and CTLp frequency is that the CTLp are 
cultured in vitro in the presence of excess IL-2. There is ample evidence from other experimental 
systems that the immunodeficiency associated with CY treatment may, at least in part, be corrected 
by administering IL-2 either in vitro or in vivo (Ballas, 1986; Merluzzi et al. 1983 & 1984; Walker et al. 
1985). Injection of mice with a single dose of IL-2 causes an obvious increase in primary cytotoxicity 
(Table 3.4 & Fig. 3.12) but augments pCTL frequency by a factor of less than two-fold (Table 
3.4).Similarly, bulk culture of spleen cells in vitro in the presence of added IL-2 results in enhanced 
CTL activity (Fig. 3.13) with a very small increase in NK-like or LAK activity tested on uninfected 
syngeneic 0r Y AC targets (Fig. 3.14). 
Stimulation of the virus-immune cells with PMA & Cal in the presence of IL-2 (the protocol is 
known to stimulate cytolytic activity of primed T cells while maintaining their original specificity, 
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Fig. 3.11 IL-2 receptor expression on freshly isolated 
spleen cells 
Mice were treated with CY and vaccinia (first row) or with the virus only (second row) as described 
(Fig. 3.2). Spleen cells were harvested 3 days (first column) or 6 days (second column) after 
infection with virus. Cells were stained with biotiny1ated PC61 antibody and avidin-FITC. The percent 
stained cells was calculated as in Figs. 3.8 and 3.9. 
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Table 3.4 Consequences of in vivo administered IL-2 for 
CTL activity and CTLp frequency of CY immunosuppressed animals. 
Exp Treatmenta 
CY Vacc. IL-2 
1 + 
+ 
+ + 
2 + 
+ + 
+ .J..c 
' 
+ 
cytolytic activityd 
E/T 25:1 
42 
0 
14 
32 
8 
13 
50:1 
49 
0 
33 
39 
12 
17 
CTLpe 
MC57G+vacc uninf. 
1/ 1036 <1 / 25000 
1/ 2733 
1/ 1640 
1/ 1755 
1/ 2343 
1/ 1780 
< 1 / 47000 
< 1 / 25000 
ND 
ND 
ND 
a) in vivo treatment see Fig. 3.2. IL-2 was injected i.p. 4 hrs before infection with virus. 
b) 800 U / mouse, EL-4 sn 
c) 200 U/ mouse, human recombinant IL-2 
d) Effector cell s were harvested 6 days after virus infection and their lytic activity was measured on 
vaccinia- infected MCS7G target cells in a 6 hr 51 Cr-re1ease. Spontaneous release is 22%, S.E. < 5%. 
e calcu lated by linear regression as described in Fig. 3.6. 
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e-e IL-2 (in vivo) CY vacc. 
0-0 CY vacc 
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12.5: 1 Z5:1 50:1 100: 1 
Effector/Target ratio 
Fig. 3.12 Restorative effect of in vivo administered interfeukin-2. 
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Mice were treated in vivo as described at Fig. 3.2 and one group ( •-• ) was also 
injected with human recombinant IL-2 i.p., 4 hours before the virus. Cytotoxic activity of spleen cells 
6 days after priming on virus-infected MC57G targets is shown. Spontaneous release = 31 %, S.E. < 
5%. 
r.tJ 
r.tJ 
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() 
2 
:: 8 
() 
Q,) 
a. 
r.tJ 
* 60 
65 
vaccinia uninfected 
IL-2 
Fig. 3.13 Restorative effect of IL-2 on the lytic activity of cultured spleen cells. 
Vaccinia-immune spleens from normal (B) or CY-treated (A) mice were incubated with virus- infected 
stimulator cells as described at Fig. 3.5, in the absence ( ~ ) or in the presence ( 0 ) 
of graded amounts of EL-4 sn (20, 40, 60 U /ml) or 25 U /ml highly purified human recombinant IL-2 ( 
[ill] )for 4 days. Vaccinia-infected (1-5 col.) or uninfected (6-1 O col.) MC57G cells were used as 
targets at 40:1 effecto: target ratio. ,:he results are expressed as the mean of triplicate samples, the 
S.E. being less than 5%. 
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Target,__: ____ M_C_S_?_G ________ Y_A ___ C _ _. 
60 
40 
20 
~100 
a. 
en 
cf!. 80 
60 
40 
20 
uninfected . . vacc1n1a 
Fig. 3.14 Restorative effect of IL-2 on the lytic activity 
of cultured spleen cells 
Normal (A) and CY-treated (B) immune spleen cells were cultured and tested for cytotoxicity as 
described in Fig. 3.13. Non-specific activity was also tested on NK-sensitive YAC target cells 0ast 
column). Cells were grown in vitro in the absence ( ) or in the presence of 50 
U/ ml ( D ) or 100 U/ ml ( ) IL-2. Effector:target ratio was 50:1. · 
.t , 
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Chapter 4) also greatly increases (by a factor of 9.1) the CTL activity of CY pretreated splee.i cells 
(Fig. 3.15) .Lyt 2 + enriched cells were obtained by negative selection (L3T4 + cells were eliminated 
with mAb and complement treatment, see Chapter 2, section 7.3) and stimulated with PMA+ Cal+ IL-
2 show an increased sensitivity to IL-2 in Cy-treated in comparison to vaccinia-immune non-
suppressed mice (Fig.3.16). This might be due to increased IL-2 receptor expression as discussed 
above. 
3.2.6 IL-2 production and cell proliferation 
A possible reason for the need to add IL-2 to promote CTL activity (Table 3.4, Figs 3.13 - 3.16) is 
that there is a high level of IL-2 consumption in CY-suppressed mice, perhaps associated with the 
restoration of normal immune function. The FMF profiles for both virus-infected and uninfected CY-
suppressed mice show evidence of enhanced cell proliferation when compared with the relevant 
controls (P.I. profiles, Figs. 3.8 & 3.9). An.alysis of cell size indicates that there are more large cells in 
the CY-treated group (Fig. 3.17). Perhaps these blasts are consuming IL-2 and there is thus less 
growth factor available for the generation of the virus-immune CTL response. Furthermore, when 
lymphocytes were cultured with mitogen it was found that spleen cells from mice given CY 4 or 8 
days previously were producing less IL-2 (Fig. 3.18). Defective IL-2 production was especially 
apparent for mice given CY 4 days previously, with the effect being closely paralleled by decreased 
proliferation of this cell population (Figs. 3.19 & 3.20). 
It thus seems that administration of a single, large dose of CY leads to lower levels of IL-2 
production and diminished cell-surface expression of Thy-1 , Lyt 2 and L3T4. These effects persist for 
at least 8 days of drug treatment and interfere with the ability of lymphoid cells to develop a CTL 
response. 
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tZ] vacc. 
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20 
Target: MC57G vaccinia MC57G uninfected 
Fig. 3.15 Res1orative effect of PMA & CA-l on lytic activity. 
Spleen cells from normal mice ( 
or with CY and vaccinia ( 
D 
[] . . . . 
) ; mice treated with vaccinia ( 
) (as described in Fig. 3.2) were haNested 6 days 
after infection and cultured for 4 days in the presence or absence of 3 ng/ ml PMA, 500 ng/ ml Cal 
and 1 O U / ml IL-2. Cytotoxic assay was performed as described. Spontaneous release for targets: 
25.2% and 24.0%, respectively. E/T ratio = 40: 1, S.E. < 5%. 
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__ .. 
0 10 
0 
50 
U/ml IL-2 
6 D vaccinia unaep. 
rzl vacc-CY unsep. 
0-0 vaccinia L3T 4 -
..-. norm L3T4-
6-'6CY+vacc. L3T4-
100 
Fig. 3.16 Restoration of the lytic function of the Lyt 2 + 
subset by IL-2. 
69 
Spleen cells from immunosuppressed or non-suppressed virus-immune mice were treated with RL 
172 (anti-L3T4) antibody and complement. The effectiveness of depletion was checked by FMF 
(contamination with L3T4 + cells was < 1.0%). Cells were then incubated in the presence of 1 ng/ml 
PMA, 100 ng/ml Cal and in the presence or absence of graded amounts of EL-4 sn for 3 days. 
Cytotoxicity on vaccinia-infected MC57G targets was measured in 51 Cr-release assay at different 
E:T ratios. The% specific lysis at 15:1 E:T ratio is shown, calculated by linear regression of the 
slopes (S.E. < 4.7%, r >0.9). Killing of uninfected MC57G targets was always less than 5%. 
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Forward light scatter intensity (a.u.) 
Fig. 3.17 Relative cell size after CY treatment 
Spleen cells from normal or in vivo treated (Fig. 3.2) mice were analysed by FMF. Forward light 
scatter intensity (FLS) is shown on the figure versus cell number, reflecting the presence of more 
blasts cells in the two CY-treated groups. 
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Fig. 3.18 Effect of CY treatment on IL-2 production upon 
mitogenic stimulation 
Mice were treated with 300 mg/kg CY and their spleen removed 2 ( 
.&--£ 
•---· or 8 days ( O··· ·O ) after treatment. Untreated control ( 
71 
). Cells 
were incubated with 1 ng/ml PMA and 100 ng/ml Cal for 2 days at 1 o5 cells/well then so µI 
supernatant was removed from each well, serially diluted and tested for the capacity to induce 
proliferation of IL-2 dependent CTLL cells in a 24 h assay. 
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Fig. 3.19 Effect of CY-treatment on mitogen induced proliferation 
Spleen cells from normal ( 
, 4 days D . . . or 8 days 
D § 
) or CY treated mice (injected 2 days ~ 
before the assay) were treated with 1 ng/ml PMA 
and 100 ng/ml Cal (A panel) or with 3 µg/ml Con A (B panel) for 2 days. No exogeneous IL-2 was 
provided. Cells were pulsed with 1 µCi/well (3H]-thymidine for 6 hrs and thymidine uptake was 
measured as described in Chapter 2, section 11. 1. 
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Fig. 3.20 Con A s1imulation of CY treated spleen cells 
Untreated ( £- • ) or CY-treated spleen cells ( injected 2 days, o--o 
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; 4 days, 
~-~ ; 6 days e---- ·• or 8 days <) " 111 • <) before the assay) were stimulated with 
increasing amount of Con A for 72 hours. Cells were pulsed with [3HJ-thymidine for the last 6 hrs of 
the incubation and the isotope uptake was measured as described. Mean of triplicate samples is 
shown. 
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3.3 Discussion 
Prior treatment of C57BL/6J mice with 300 mg/kg of CY converts a subclinical infection with 
vaccinia-virus to a lethal disease. This is accompanied by a loss of more than 80% of spleen cells 
and a decreased capacity on a cell-for-cell basis to develop virus-immune cytotoxic T lymphocytes, 
though the frequency of CTL precursors among surviving T cells is not greatly modified. 
The inability of pCTL to develop into cytotoxic effectors in vivo parallels the inability of T cells to 
kill virus-infected target cells in vitro. This is in accord with the theory established from adoptive 
transfer experiments (Zinkernagel and Doherty, 1979; Ho, 1980; Ada et al. 1981) that the CTL subset 
plays an important role in the elimination of the virus during an acute infection. It has been shown 
that T cell-depleted spleen cells are unable to control replication of ectromelia virus and recovery 
from infection (Blanden, 1970). Furthermore, transfer of immune T cells to influenza- (Yap et al. 1978; 
Wells et al. 1981) and cytomegalovirus- ( Starr and Allison, 1977; Ho, 1980) infected mice has proven 
to be successful in reducing virus titres from different organs. 
The frequency of virus-specific CTL itself suggest that antigen recognition was unaffected by the 
drug. The defect in the differentiation of pCTL is probably not caused by insufficient macrophage 
function. Macrophages are important in the initiation of the immune response: they can present 
antigen to T cells in association with class II MHC molecules (Rosenthal, 1978; Unanue, 1981) and 
release I L-1, a co-factor, necessary for T cell stimulation (Oppenheim et al. 1979; Farrar et al. 1980; 
Smith et al. 1980b; rev. by Durum et al. 1985). In addition it has been shown that they are most 
susceptible to CY-treatment immediately after administration of the drug (Schlick et al. 1985) and are 
able to contribute substantially to the development of a virus-induced inflammatory process whithin 
3 or 4 days of drug treatment (Ceredig et al. 1987). Thus, the early steps in the development of T cell 
response seem to be less affected in our model. 
The most obvious explanation for the inhibited differentiation of pCTL is the lack of T cell growth 
factor, interleukin 2, which has been shown to be essential and sufficient to mediate differentiation of 
T cell precursors (Erard et al. 1985a and b; Smith, 1980a; also see Chapter ~, S8ction 4.3). 
Experiments in vitro with "deactivated" T cell clones have shown that provision of IL-2 induces 
cytolytic capacity (Orosz et al. 1985). Also, in vivo reconstitution of immunocompromised mice with 
' ., 
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IL-2 restored their immune response against pichinde (Walker et aL 1985) and influenza A (Merfuzzi 
et al. 1984) viruses. Our results, that spleen cells from CY-suppressed, uninfected mice produce 
substantially less IL-2, especially at the stage when T cell differentiation should occur (>3days after 
infection), provides an explanation for the relative lack of cytotoxic activity following CY-suppression 
and infection with vaccinia virus. However the recovery is only partial, even when high amounts of 
IL-2 are provided in vitro or large doses of IL-2 were given 3 times in vivo (data not shown). 
As the L3T 4 + population is the major subpopulation of cells which produces interleukin 2 and 
also other lymphokines, it seems likely that production of interferon 'Y, IL-4 and other factors is also 
affected. Interferons play a very important role in anti-viral defence, as will be discussed in Chapter 7, 
(Stewart, 1981; Nathan et al. 1983) and endogeneously produced IFN 'Y ·is probably also important in 
T-cell differentiation (Klein and Bevan, 1982; Simon et al. 19e6). 
The spleen cells from Cy-treated mice express low levels of cell surface Thy-1, Lyt 2 and L3T4 
and this defect is inherited through successive generations, as lymphocytes proliferate either during 
the response to virus or as a consequence of exposure to mitogens (Allan and Doherty, 1985; 
Denizot et al. 1986). This may reflect defective, or diminished, synthesis of these glycoproteins. As 
discussed in Chapter 1 (Section 1.2), the Lyt-2 and L3T4 ~olecu!es play an important role in T cell -
antigen recognition, as enhancers of specific cell-cell interaction and also as components of multi-
molecular complexes mediating transduction of signals. Thus, decreased amounts of these 
molecules, expressed on the surface of T cells could lead to insufficient binding to the APC or target 
cells, resulting in impaired effector function. 
The exact mechanism governing low T cell surface glycoprotein expression following CY 
treatment is not known, though this could result from the capacity of CY derivatives to cause genetic 
lesions (Takeshita and Conner, 1984; Wilmer et al. 1984). Cells may survive damage to regions of 
DNA which are not essential for the basic replicative mechanism of the cell. Downregulation of T cell 
antigens has also been shown, following non-cytopathic human immunodeficiency virus (HIV) 
infection (Stevenson et al. 1987). Infection of a human lymphoid cell line with HIV resulted in loss of 
not only the CD4 marker, which is the receptor for the virus, but also a parallel decline in CD3, CDS 
and CO2 surface marker expression. As a consequence, the cell were unable to respond to the 
infection. The molecular basis and significance of this "multireceptor-downregulation", which is 
' 
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accompanied by unresponsiveness is not yet known but might have some similarities with the 
immunosuppressed system. 
Expression of the IL-2 receptor did not show the pattern of consistent depression that was found 
for Thy-1, Lyt 2 and L3T4. The limitation of the present approach based on assaying for the 55kd 
chain of the IL-2 receptor has already been discussed. Others have also found that the relationship 
between the amount of IL-2 receptor on cell suriace and cell proliferation is not simple or direct (Mills 
et al. 1985; Smith and Cantrell, 1985). 
The model system used here shows that IL-2 plays an essential role in the development of the 
primary anti-viral CTL response in vivo, and is probably necessary for both T cell proliferation and 
differentiation. Furthermore, the results suggest that decreased expression of cell suriace molecules 
involved in cell-cell interactions and signal transduction by lymphocytes may explain the impaired 
responsiveness of CTL 
...... · 
Chapter 4 
Requirements for the development of a secondary anti-viral 
cytotoxic T cell response in vitro. 
- . .· 
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4.1 Introduction 
One of the hallmarks of an immune response is the phenomenon of specific immunological 
memory. This is most easily demonstrated by the rapid and strong increase in levels of antibody 
following re-exposure to antigen. However, cytotoxic T cell memory responses are measured 
indirectly since it is difficult to detect CTL activity by assay of cells from animals that are re-
infected with the same pathogen. It is possible that in many cases the memory T cell response is 
not activated due to the rapid removal of the inoculum by antibody and also antibody-dependent 
cell-mediated cytotoxicity (Dunlop and Bland en, 1976). 
The presence of primed CTL has been demonstrated following infection with most commonly 
studied animal viruses e.g. influenza, pox and LCM viruses, by restimulating the in vivo primed 
cells with antigen for several days in culture (rev. by Zinkernagel and Rosenthal, 1981 ). This 
method generates highly potent, specific T cells although it requires the addition of an 
exogeneous cell population, namely antigen-presenting or stimulator cells, for optimal 
stimulation. These memory T cells differ from unprimed T cells both quantitatively and 
qualitatively. They are present at higher frequencies (generally > 1 /60 000 in naive and 
approximately 1/1000 in immune spleen) and show evidence of higher affinity for appropriate 
target cells, (Ryser and MacDonald, 1979; MacDonald et al. 1981 & 1982). The relative resistance 
of the CTL progeny of primed CTL precursors to inhibition by anti-CDS mAb is generally regarded 
as a characteristic of CTL carrying high avidity antigen receptors (MacDonald, 1981 & 1982; 
Malissen et al. 1982; Moretta et al. 1984; Shimonkewitz et al. 1985). 
It has also been proposed that memory T cells maintain increased levels of I L-2 receptors on 
the cell surface (Lefrancois et al. 1984) although this has not been confirmed by studies which 
examined expression of the 55 kd chain of the IL-2 receptor with anti-Tac antibody (Siegel et al. 
1987). However, memory CTL have been shown to have increased reactivity to IL-2. Re-
expression of specific CTL activity has been achieved in the absence of antigen by incubating 
resting long-term MLR cells with secondary MLC supernatant (Ryser et al. 1978; Wagner and 
Rollinghoff, 1978; MacDonald et al. 1980). More convincingly it has been shown that T cell 
clones and also positively selected Lyt 2 + cells re-express specific cytolytic activity on culture 
. ...... 
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with recombinant IL-2. In addition it was found that, in the presence of IL-2, only the Lyt-2 + cells 
are necessary for the development of cytotoxic activity (Devos et al. 1984; Yoshimoto et al. 1985; 
Ochoa et al. 1986; Lefrancois et al. 1984). IL-2 induces the expression of the /3 chain of its own 
receptor (Reem and Yeh, 1984; Malek and Ashwell, 1985; Smith and Cantrell, 1986). Thus, if 
memory T cells continuously express the a chain of IL-2 receptor (as proposed recently by Siegel 
1987 et al.), IL-2 could then induce the formation of high affinity IL-2 receptors which would 
mediate signal transduction and lead to the re-activation of these T cells. 
It has been found, that activation of T cells, whether through interaction of TCR with antigen-
MHC or by binding of mAb to some cell surface proteins results in the turnover of membrane 
phosphoinositides (Pl). As shown in Fig. 4.1, binding of antigen to its receptor results in 
hydrolysis of PIP 2 by phospholipase C. The products of this hydrolysis are diacylglycerol (DG) 
and inositol 1,4,5-trisphosphate (IP3). DG activates a Ca2 + -dependent enzyme, protein kinase C 
(PKC) which can phosphorylate a wide range of protein substrates by using ATP as phosphate 
donor. IP3, the other product of the PIP3 hydrolysis releases Ca
2 +, probably from the 
endoplasmatic reticulum, which may provide a sufficient concentration of intracellular Ca2 + for 
the activation of PKC which then ·phosphorylates numerous substrates. In T cells, the substrates 
for PKC activity include the IL-2 receptor which becomes phosphorylated at Ser 247 on the /3 
chain (Shackelford and Trowbridge, 1984) and the gamma chain of the TCR-T3 complex (Cantrell 
et al. 1985; Nel et al. 1987; Samelson et al. 1985b & 1987). 
The two crucial signals for the stimulation of T cells, namely activation of PKC and increase in 
intracellular Ca2 + concentration can be achieved by the combined effects of phorbol esters (DG 
analogues) and calcium ionophores. This stimulation is mitogenic for both T and B lymphucytes 
(KrOnke et al. 1985; Roitman et al. 1987). Activation of T cells involves a series of cellular and 
intracellular reactions, which culminate in lymphocyte differentiation, proliferation, lymphokine 
production and cytolytic activity. The early effects on cells stimulated with phorbol esters and Cal 
include an increase in intracellular Ca2 + -concentration (Imboden et Stobo, 1985), internalization 
of the TCR-antigen complex (Reinherz et al. 1982; Ando et al. 1985;Pantaleo et al. 1987a; Takada 
and Engleman, 1987) and expression of the nuclear proto-oncogenes c-fos and c-myc (Kr6nke et 
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Fig. 4.1 Biochemistry of T cell activation 
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al. 1985; Reed et al. 1985a; Kumagai et al. 1987). These oncogenes may play an important role in 
the control of the proliferative responses (Greenberg and Ziff, 1984; Muller et al. 1984). 
In this chapter the requirements for activation of resting, in vivo primed LCMV-immune T cells 
are studied. Re-expression of immune T cell function was analysed at both the bulk and cl onal 
levels. In addition, use of PMA and Cal provided an antigen-independent stimulation protocol, 
which was used to estimate the frequency of LCMV-specific pCTL in primed mice. Finally, some 
of the possible applications of this method of T cell activation are discussed. 
- -··· 
4.2 Results 
4.2.1 Specific stimulation of LCMV-immune spleen cells in 
vitro. 
81 
Following the method shown in Fig. 4.2, LCMV-infected peritoneal macrophages, T cell-
depleted spleen cells and L929 fibroblast cells were compared for their ability to stimulate the in 
vitro secondary CTL response of LCMV-immune spleen cells (Fig. 4.3). Cells were also infected 
with the two most often used strains of LCMV, WE-3 (viscerotropic) and ARM (neurotropic) and 
compared for their ability to act as stimulators. 
The WE-3 strain is cytopathic in vitro, and has, therefore, to be inactivated before adding 
responder cells to the cultures. As shown on Fig. 4.3, stimulating the WE-3 primed memory cells 
with WE-3 LCMV infected, UV-irradiated cells resulted in a more effective secondary CTL 
response than that found following the use of ARM LCMV to infect stimulator cells. This was also 
true when the animals were primed with the ARM strain of the virus. (Fig. 4.4). Furthermore, 
based on the results of several experiments, e.g. fig. 4.3, thioglycollate-induced peritoneal 
macrophages were more effective stimulators than T cell-depleted spleen cells or persistently 
infected L929 fibroblasts. In the latter the recovery of effector cells from the culture was especially 
low ( <20%). 
The differences in the resulting secondary lytic activity using different strains of viruses and 
cell types, may be explained by quantitative or qualitative differencies in the expression of MHC 
molecule-antigen complexes on the surface of antigen presenting cells (APC). 
Taken together, in this experimental model, WE-3 infected, thioglycollate-induced peritoneal 
macrophages were the most effective stimulators of LCMV-immune memory CTL-response. This 
system was than used routinely. 
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Fig. 4.2 Protocol for restimulation of LCMV immune T cells in vitro. 
Infection of mice with LCMV 
4-6 weeks 
Spleens removed 
Single cell suspension prepared 
(infection of stimulators with LCMV) 
48 h 
UV-irradiation 
2° in vitro stimulation 
(Stimulator: responder ratio = 1 : 10) 
4 - 5 days 
CTL assay 
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Fig. 4.3 Secondary immune response of WE·J primed LCMV·immune spleen cells 
restimulated in vitro with different LCMV·infected cell populations. 
CSA mice were primed with WE-3 virus (1000 LD50) 2 months before assay. Spleen cells were 
stimulated with WE-3 ( 0-0 ) or Armstrong ( •-•) infected, Thy-1 depleted, 
thioglycollate-induced CSA peritoneal cells, or with WE-3 ( D D ) or Armstrong ( •- • ) 
- ' -
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infected, Thy-1 depleted CSA spleen cells. l929 cells persistently infected with LCMV ( •-• ) 
were also used as stimulator cells. WE-3 infected cells were irradiated with UV-light (see Chapter 
2) 48 h after virus infection, prior to initiation of the cultures. After 4 days in culture, cells were 
collected and counted, the recovery was usually less than 25%. Cytotoxic activity of the effectors 
was measured in a 6 hr Cr-release assay on WE-3 infected CSA macrophage target cells. The 
mean of triplicate sample~. is shown, S.E. <5%. Killing_of uninfected target cells was the highest In 
group ( 0- 0 ) being 20%, but was less then 8% for the other groups (E:T =40: 1 ). 
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Fig. 4.4 Secondary immune response of LCMV-Armstrong primed 
spleen cells, restimulated in vitro. 
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Balb/c mice were primed with Armstrong-strain of LCMV (100 LD50/ mouse) 2 months before the 
assay. Their spleen cells were stimulated with WE-3 ( A A ) or Armstrong ( 0 - 0 ) 
infected, Thy-1 depleted, thioglycollate-induced Balb/c peritoneal cells. WE-3 infected cells were 
irradiated with UV-light before culture. Cytotoxic acttvity of effectors was tested 5 days later in 
51 Cr-release assay using LCMV WE-3 infected P815 targets. Mean of triplicate samples is shown, 
S.E. being less than 1.5%. 
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4.2.2 Stimulation of LCMV-immune spleen cells in vitro in the absence of antigen. 
4.2.2. 1 Effect of different concentrations of PMA and Cal on the proliferation and cytotoxic 
activity of immune spleen cells. 
To determine the optimal conditions for stimulation with PMA and Cal, cells were cultured with 
different amounts of the drugs, and proliferation of cells (Fig. 4.5) or recovery from 3 day cultures 
(Fig. 4.6) were measured, respectively. As shown in Fig. 4.5, spleen cells at different stages of 
activation (I. 'naive', II. 'acute', Ill. 'memory') show varying maximum levels of proliferation but 
similar relative patterns of dose sensitivity to the different concentrations of the drugs. The most 
intense proliferation was found in the normal and in the memory groups. Maximal proliferation 
was obtained for each group of spleen cells, when the concentration of PMA and Cal was 
relatively low: 1 ng/ml of PMA and 100 ng/ml of Cal (Fig. 4.5). A similar conclusion can be drawn 
from the experiment shown on Fig. 4.6, where the relative recovery from the cultures was 
estimated. Higher doses of PMA (3 and 9 ng/ml) and Cal (500 ng/ml) were less effective in 
stimulating proliferation, resulting in lower recovery of cells. 
To check whether the optimum levels of proliferation and specific lytic activity could be 
achieved by the same combination of doses of the drugs, groups C and F (Fig. 4.5), representing 
the highest and the lowest proliferation induced by PMA and Cal were also tested for their 
specific lytic activity in a 51 Cr-release assay (Table 4.1 ). According to the results of the 
proliferation assay, higher concentrations of PMA and Cal were less effective at inducing specific 
lytic activity by memory CTL (Groups A and B; C and D, Table 4.1 ). High concentrations also 
inhibited the lytic activity of acutely primed LCMV-immune spleen cells (Groups E and F). 
Importantly, however, neither low nor high combinations of the drugs induced cytolytic activity by 
unprimed spleen cells (Groups G and H). 
4.2.2.2 The effect of IL-2 on PMA and Cal stimulated cultures. 
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Fig. 4.5 Proliferation of spleen cells upon PMA and Cal stimulation. 
Spleen cells from normal 86 ( ~ ), acute, LCMV immune (6 day) 86 ( D ) and 
memory LCMV-immune (86 x CBA)F1 (6 weeks) ( filill ) mice were cultureG in the 
absence (A) or in the presence of 0.5 ng/ml PMA & 50 ng/ml Cal (8) , 1 ng/ml PMA & 100 ng/ml 
Cal (C) , 1.5 ng/ml PMA & 150 ng/ml Cal (D) , 2 ng/ml PMA & 200 ng/ml Cal (E), 3 ng/ml PMA & 
300 ng/ml Cal (F) for 3 days in the presence of 5 % EL-4 sn. Proliferation of 1 o4 cells / well was 
measured by MTI assay. Mean of triplicate samples is shown. 
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Fig. 4.6 Cell recovery upon PMA and Cal stimulation. 
106 LCMV primed Balb/c spleen cells/well were cultured for 3 days in 24 well trays in the 
presence of PMA, Cal and 5 % EL-4 sn. The cells were collected and counted at the end of 
incubation, percent recovery per group is shown. 
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Effector 
cellsa 
A memory 
B 
C memory 
D 
E acute 
F 
G normal 
H 
Table 4.1 Effect of high and low concentration of PMA and 
Cal on cytotoxic activity and specificity of the lysis. 
PMA+Cal % specific lysisd 
lowb highc MC57G+LCMV EL-4 P815 
., 
+ 29.2 0 2.3 
+ 15.1 0.2 1.6 _ 
+ 53.6 0.8 7.7 
+ 25.9 0.2 4.2 
+ 50.0 0.4 13.2 
+ 20.5 0.1 1.9 
+ 2.7 0.8 3.7 
+ 0.9 0 1.1 
88 
YAC 
0.3 
0 
0.4 
0 
2.4 
0.3 
1.7 
0 
a) spleen cells were harvested from 86 mice, infected with LCMV 6 weeks before the assay 
(Groups A & B), from (CSA x B6)F 1 mice, infected with LCMV 6 weeks before the assay (Groups 
C & D), from 86 mice, 7 days after infection (groups E & F), and from normal 86 mice (groups G 
& H). 
b) effector cells were cultured in the presence of 1 ng/mlPMA and 100 ng/ml Cal for 3 days. 
c) effector cells were cultured in the presence of 3ng/ml PMA and 300 ng/ml Cal for 3 days 
d) Effector:target ratio is 1 o : 1. Spontaneous lysis of targets is less than 26%, mean of triplicate 
samples is shown, S.E. is less than 3.6%. 
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The necessity for, and effect of, adding IL-2 to PMA and Cal stimulated cultures was studied. 
Proliferation of spleen cells in the presence of 5 U/ml highly purified recombinant IL-2 was more 
intense in the initial period (48h) of culture for both memory and normal cells (Table 4.2, groups 
C,D and G,H). Later, (4 days in culture) this difference was less marked, probably due to 
sufficiently high levels of endogeneously produced IL-2. Treatment with IL-2 alone resulted in 
much lower levels of proliferation (Table 4.2, Groups Band F). IL-2 itself, without the presence of 
the original priming antigen, can induce re-expression of CTL function, as summarized in Table 
4.3. The lytic activity induced by IL-2 seemed to depend on the amount of IL-2 added (Table 4.3, 
groups Band C), but the level of non-specific lysis also increased in these groups. However, 
-
when the same amount of IL-2 was added in the presence of PMA and Cal, re-expression of lytic 
activity proved to be highly specific (Table 4.3, groups D, G and J). The recovery of cells was 5-
1 o times higher than that after IL-2 stimulation, or even from cultures stimulated with virus (200% 
vs 30-50%). Exogeneous IL-2 also increased both the level of cytolytic activity and the number of 
cells recovered from PMA and Cal stimulated cultures (Table 4.3 I and J; Table 4.4 A and B). 
PMA and Cal separately-are inefficient at stimulating the re-expression of the lytic activity of 
immune T cells (Table 4.4 C and D). They also cause only very minor, if any, proliferation of cells 
as measured by% recovery from the cultures (Table 4.4 C and D vs F). However, when 
exogeneous IL-2 was provided to these cultures, lytic activity was detected. This seemed to be 
more specific than that induced by the same amount of IL-2 alone, but less intense than that 
caused by the application of the drugs together (Table 4.4 Hand I vs E). 
4.2.2.3 The effect of the incubation time of PMA and Cal stimulated cultures. 
The length of incubation was also studied to determine its effect to the magnitude and 
specificity of killing. As shown in Table 4.3 Group J, specific lytic acti':ity appears as early as 24 h 
after initiating the cultures. A longer incubation does not seem to result in more effective CTL 
activity from high density cultures (Fig. 4. 7). It is hard to interpret such experiments, since either 
- __ .. -
,,, 
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Table 4.2 Effect of exogeneous IL-2 on PMA and Cal induced proliferation. 
Group 
A 
B 
C 
D 
E 
F 
G 
H 
Effector 
normal 
memory 
Treatment 
nil 
IL-2 
PMA+Cal 
PMA+Cal+IL-2 
nil 
IL-2 
PMA + Cal 
PMA + Cal + IL-2 
[3H]-thymidine uptake (cpm) 
48 h 
433 ± 73 
904 ± 122 
6956 ± 2442 
19561 ± 1541 
411 ± 24 
1293 ± 152 -
22730 ± 7027 
37193 ± 7178 
96 h 
NDa 
ND 
ND 
105265 ± 3249 
1153 ± 170 
4859 ± 1215-
1 09679 ± 3326 
11 5435 ± 4224 
Effector cells are 86 spleen cells from uninfected (normal) or LCMV infected (memory) mice 
(i njected 5 weeks before the assay) 
5 U/ ml rec. IL-2 was added in groups 8,0 ,F & H. 
a) Not done. 
.....-
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Table 4.3 Effect of exogeneous IL-2 on the PMA and Cal induced lysis. 
Exp. Effectors 
1 A 
B 
C 
D 
2E 
F 
G 
3H 
86 spleen 
C8Ax 86 
CBAx 86 
In vitro 
treatment 
nil 
5 U/ml IL-2 
10 U/ml IL-2 
PMA+Cal+IL-2 
nil 
10 U/ml IL-2 
PMA+Cal+IL-2 
5 U/ml IL-2 
PMA+Cal 
J PMA+Cal +IL-2 
K (unprimed) PMA+Cal+IL-2 
% specific lysis 
a 
9 
42 
45 
33 
9 
34 
27 
69 
47 
69 
16 
b 
0 
16 
21 
0 
1 . 
33 
8 
27 
1 
12 
2 
C 
0 
9 
17 
0 
1 
34 
7 
recovery 
d 
0 
ND 
8 
1 
16% 
26% 
21% 
210% 
29% 
43% 
195% 
Mice were primed with WE-3 LCMV 4-7 weeks before the assay and their spleen cells were 
cultured for 3 days (Exp 1 & 2) and for 24 h (in Exp. 3), respectively, in the absence (A,E) or in the 
presence of added rec.lL-2 (B,C,F and H groups). In groups D, G, J and H, 1 ng/ml PMA, 100 
ng/ ml Cal and 10 U / ml IL-2 (rec.) was added. 
The targets are: a) MC57G + LCMV, b) MC57G uninf., In Exp.1 c)P815, d)YAC. E:T ratio was 20:1. 
In Exp.2 the target c) is KD2SV+LCMV. E:T ratio was 40:1.ln Exp.3 E:T ratio was 80:1. 
- __ .. -
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Table 4.4 Stimulation of secondary CTL response by PMA and Cal applied separately. 
Exp. Group Stimulation % recovery % specific lysis 
* * PMA Cal IL-2 MC57G MC57G KD2SV 
1 A + + + 195 26.9 8.3 7.5 
B + + 159 26.1 7.8 8.6 
C + 45 9.2 3.2 5.2 
D + 43 10.4 5.4 0.6 
E + 47 33.8 34.0 33.0 
F 39 9.3 0.8 1.0 
2 P815 
G + .... + + 100 30.7 - 0 0 
H + + 22 21.4 0 ND 
+ + 22 15.3 0 ND 
J 16 9.4 0 0 
* target cells infected with LCMV 
Exp.1 . (CSA x 86) F 1 mice were primed 1 O weeks before the assay. For in vitro stimulation of 
spleen cells 1 ng/ ml PMA, 100 ng/ ml Cal and 10 U/ ml rec.l l-2 was added. Cells were incubated 
for 3 days, and cytotoxicity measured at 40: 1 effector:target ratio. 
Exp.2. Spleen cells from (86 x Balb / c)F 1 mice, primed with LCMV 1 O weeks before the assay 
were stimulated as above. E:T ratio 20:1. 
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Fig. 4. 7 Effect of incubation time wi1h PMA and Cal on the 
specificity of killing by LCMV-immune CTL 
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LCMV primed 6 day immune ( 0--0 ) and 6 weeks immune( .. " .. + ) spleen cells, or 
cerebrospinal fluid (CSF) cells from i.e. injected (CSA x 86) F 1 mice ( ~ - ~ ) were 
cultured for 3 (A), 4 (8) or 5 (C) days in the presence of 100 ng/ml Cal and 1 ng/ml PMA. Lytic 
activity on different targets was measured in 51 Cr-release assay. 
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the effector or the target cells have to be derived from pools of cells prepared on different days. 
But, as a conclusion from numerous experiments, incubation of immune spleen cells under high 
density culture conditions (0.5-1 .0 x 106 cells / ml) with PMA and Cal for more than 3 days, does 
not result in increased lytic activity by effectors on a cell for cell basis. It is interesting, that even 
during the longer incubation time, non-specific lysis by LCMV-memory spleen cells does not 
emerge (Fig. 4. 7, 2nd and 3rd columns), in contrast to the situation found for spleen cells from 
acutely infected mice or CSF cells (Fig. 4. 7), which have been shown to have high non-specific 
cytolytic activity (Welsh and Zinkernagel, 1977; Welsh et al. 1979; Stitz et al. 1985; Yang and 
Welsh, 1986; Allan and Doherty, 1986). 
4.2.2.4 Characteristics of CTL activity, generated by PMA and Cal. 
The specificity of killing by effectors stimulated with PMA and Cal has been analysed in 
numerous experiments against allogeneic, NK-sensitive ~ AC cells) and non-MHC restricted 
targets, respectively., as shown in Tables-4.1- & 4.3 and Fig. 4.7. Table 4.5 reproduces the 
previous observations and attempts to determine the characteristics of the lytic activity obtained 
in the PMA and Cal stimulated system compared with that of cytotoxic cells stimulated by other 
ways. 
Thus, the cytotoxicity of memory cells restimulated by PMA and Cal proved to be highly 
specific: the procedure did not cause any significant allo- or other non-specific killing by these 
cells. Furthermore, the lytic pattern is distinct from that of NK or LAK cell mediated lysis, in that 
both systems show high levels of killing of YAC cells and allogeneic target cells (Table 4.5, Group 
C vs A & B). The lytic cells induced by IL-2 seemed to differ from those with NK activity. Cells 
collected on day 3 after infection, when there is high activity against YAC cells, did not show 
lectin-dependent cytotoxic (LDC) activity (Table 4.5, group A, last column), while quite potent 
LDC activity was found for the other two groups (8 and C): this presumably reflects that 
lymphokine-activated killer (LAK) effectors and activated CTL (B), or activated CTL alone (C) , are 
responsible for lysis. 
--., 
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Table 4.5 Specificity of PMA and Cal stimulated killing. 
Effectors Treatment % specific lysisa 
MC57G+LCMV P815 YAC L929 P815 + PHA 
(b) (d) (a) (k) (d} 
A)CBA(k) 3d nil 41 12 73 16 4 
. 8)86x8alb/c IL-2b 50 25 69 - 21 100 
(bd) (6 weeks) 
C)B6xBalb/c PMA+Cal+IL-2 39 5 7 - 2 60 
,, 
(bd) (6 weeks) 
a) Spontaneous lysis of targets was between 14.6 and 30%. E:T ratio = A) 60:1 , 8) 40:1 
b) 100 U/ ml EL-4 sn, 3 days incubation 
Group C: 1 ng/ml PMA, 100 ng/ml Cal, 5 U / ml EL-4 sn, 3 days incub. 
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Taken together, the results of these experiments suggest that stimulation of memory spleen 
cells with PMA and Cal can result in the appearance of a functionally homogeneous CTL 
population, which does not have the characteristics of LAK or NK cells. 
4.2.3 Studies on PMA and Cal stimulated secondary CTL response at the clonal level. 
Memory spleen cells were cultured under limiting dilution conditions in the presence of 1 
ng/ml PMA, 1 oo ng/ml Cal and IL-2. As for bulk cultures, these concentrations provided the 
optimal stimulus for proliferation of cells in low density cultures. The frequency of LCMV-specific 
-
CTLp determined under these conditions was greater than 1: 1000 for primed spleen cells, tested 
with LCMV-infected targets, while effectors lytic for uninfected targets were not detectable at the 
1 :30 000 level (Fig. 4.8). In addition, LCMV-specific CTLp were present at a higher frequency in 
spleen than in lymph node (Table 4.6, A and C) and LCMV-immune cells were also detectable in 
the thymus of mice primed with the virus 6 weeks previously (Table 4.6, Group D). In the latter 
case, immature thymocytes...were depleted with J11 d antibody and comr;,lement treatment (see 
Chapter 2, section 7.3). The same depletion resulted in some enrichment of pCTL frequency 
measured in spleen (Table 4.6, Group B). 
The specificity of these CTL clones for virus-infected, but not for uninfected syngeneic or 
allogeneic targets was confirmed in a further experiment (Fig. 4.9, panels A and B). Furthermore, · 
~ 
the culture conditions did not lead to the generation of natural killer cells (Panel C, Fig. 4.9). The 
distribution of lectin-dependent cytotoxicity paralleled that of the LCMV-specific CTL (Panels D 
and A, Fig. 4.9). Culture of LCMV memory spleen cells in the presence of PMA, Cal and low levels 
of exogeneous IL-2 thus leads to the specific stimulation of virus-reactive, MHC-restricted CTL 
clones. 
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Fig. 4.8 Stimulation of secondary immune response with PMA and Cal at the clonal level. 
Spleen cells from (CSA x 86) F 1 mice were cultured for 8 days under LOA conditions (see 2. ) in 
the presence of 1 ng/ml PMA, 100 ng/ml Cal and saturating amounts of IL-2. Cells from 
individual wells were resuspended, split 1 :2 and their lytic activity checked on LCMV-infected (A) 
or uninfected (8) L929 target cells. Released 51 Cr (cpm) from 16 individual wells per group is 
shown. The dotted line represents 5% specific lysis of targets calculated by the formula in 
Chapter 2, section 13. 
,, 
group effectors 
A) spleen 
B) J11 d- spleen 
C) lymph node 
D) J11 d- thymus 
Table 4.6 Precursor CTL frequency in different lymphoid 
organs of LCMV-immune mice. 
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pCTL frequency (f; r) 
MC57G+LCMV MC57G uninf. 
1 / 639 (0.888) 
1 / 424 (0.968) 
1 / 3028 (0.900) 
1 / 2690 (0.990) 
<1 / 30 000 
<1 / 30 000 
< 1 / 55 000 
< 1 / 100 000 
86 mice were primed with LCMV 5-7 weeks previously. The cells were incubated as described at 
Fig. 4.8 and in Chapter 2, section 9.2. 
Wells were considered positive if specific killing was above 5%. pCTL frequency was calculated 
as described in Chapter 2, section 13. 
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Fig. 4.9 Specificity of the PMA and Cal stimulated clonalsecondary CTL response. 
B6 spleen cells were cultured (1 o3 per well) as described In Fig. 4.8. After 8 days In culture, 
individual wells were split 1 :2 and their lytlc activity tested against a panel of target cells. Dots 
represent the released 51 cr (cpm) induced by effector cells from lndividulal wells. 
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4.2.4. Inhibition of PMA and Cal stimulated proliferation and lytic activity of CTL clones by 
monoclonal antibodies 
Proliferation of CTL precursors is necessary during LOA experiments to achieve detectable 
killing of target cells. This proliferation was reduced considerably when insufficient IL-2 was 
added (Fig. 4.1 O, 8). It was completely inhibited by co-culturing the cells with purified monoclonal 
antibody, PC61, which is specific for the 55 kd f3 chain of the IL-2 receptor (Fig. 4.10, D). 
When purified anti-Lyt 2 antibody was added to individual LOA wells, originally containing 5 x 
1 o3 immune spleen cells, no functional inhibition of CTL activity occured (Fig. 4.11, panel B). The 
same dilution of antibody considerably decreased the lytic activity of 'acute' (6 d LCMV-immune) 
spleen cells at a 60:1 E:T ratio (Fig. 4.11, panel A). 
Since CTL activity of PMA and Cal restimulated LCMV-immune CTL was relatively resistant to 
inhibition by anti-CDS mAb, this suggested that these effector CTL derived from 'primed' 
precursors whose TCR were of high affinity for antigen. 
4.2.5 Adoptive transfer of PMA and Cal treated cells. 
As described in Sections 4.2.2 and 4.2.3, stimulation of T cells with PMA and Cal results in the 
re-expression of highly specific lytic activity and intensive proliferation of precursors in the 
absence of antigen. These characteristics could be very useful for obtaining sufficient numbers of 
effector cells for adoptive immunotherapy. Therefore, experiments were designed to determine 
the effectiveness of PMA and Cal stimulated LCMV-immune cells in adoptive cell transfer 
protocols. The cell transfer· models have been discussed in greater detail elsewhere (Doherty et 
al. 1986; Ceredig et al. 1987). Briefly, two experimental models were used, using 
immunosuppressed and unsuppressed recipients, respectively, as summarized in Fig. 4.12. 
The results of two experiments using the Cy-immunosuppressed model are shown in Table 
4.7. In these experiments the extravasation of effector T cells into the CSF can be considered to 
be a function of the CTL mediated immune response, since specific interaction between virus-
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Fig. 4.10 Effect of anti-lL-2 receptor antibody on the proliferation of clones of LCMV-
immune CTL stimulated by PMA and Cal. 
Spleen cells (800/well) from 86 mice primed 6 weeks previously with LCMV were cultured in the 
presence of 1 ng/ml PMA, 100 ng/ml Cal and saturating amounts of IL-2 (group A). Group B 
wells were supplemented with IL-2 (20 µI/well) only once at 48 h after initiation of the culture. In 
group C, cultures were set up as usual (as group A) and 50 µg/ml purified PC61 antibody was 
added. Clonal expansion was estimated 7 days later by light microscopy. For each group 96 
wells were tested. 
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Fig. 4.11 Inhibition of primary but not PMA stimulated 
secondary CTL response by anti-Lyt-2 antibody. 
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Cytotoxicity of spleen cells of acutely infected (6 day immune) (A) or 1 O week immune mice 
. 
stimulated with PMA and Cal (8) as described at the previous figures, was measured in the 
absence (striped area) or in the presence of purified 53.6. 1 (anti-Lyt-2 antibody) on LCMV-
infected MC57G target cells. E/T ratio for A is 60: 1. For 8, 5 x 1 o3 cells were cultured per ~ ell in 
vitro for 8 days. The mean and SD of quadruplicate samples are shown. 
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Fig.4.12 Adoptive transfer models used to induce acute cerebral LCM 
immunosuppressed model 
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injection of mice i.e. with a. 
1000 LD50 of Armstrong virus 
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l:. 
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samples of CSF taken 
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t\_, 1<-l-t.•ple ... t W\tLL f\?r bof~ t°h(... \W\~V\..-,OS'-"'~~t"~S.sc.J.., :,,...(. 
\A,Y',h-•\or;L-.>S~J.. moil c...\~ 
104 
immune Lyt-2 + cells and virus-infected cells must occur (Doherty and Allan, 1986; Baezinger et 
al. 1986). The level of extravasation correlated with the number of transferred cells (Table 4. 7, 
groups A-C and D-F). Transfer of PMA/Cal/lL-2 stimulated cells (groups A-F) resulted in a 
considerably higher cell number in the CSF, although the meningitis was not as severe as that 
following the transfer of spleen cells from donors infected with LCMV 7 days previously (groups 
D,E,F vs H,l,J). This protocol probably allowed sufficient time for reactivation in vivo of memory 
cells in groups which had not been treated with PMA and Cal (groups Land M vs E and F). 
Therefore the PMA+Cal + IL-2 treatment may have stimulated T cell clones with different 
specificities equally, i.e. precursors primed to other (environmental) antigens may also became 
activated by PMA and Cal. However due to the high recovery of cells from PMA and Cal treated 
cultures, the stimulation protocol resulted in a 2-3 fold increase in the number of lytic units 
available for cell transfer. 
The onset of the inflammatory process is known to be paralleled by the generation of potent 
CTL, which are mainly of donor origin (Doherty et al. 1986), in the spleen of recipients. Spleens 
collected on the day when the CSF cells were c.ounted showed variation in lytic activity (Table 
4. 7, last column). The activity of these cells was found to correlate with the number of cells 
transferred. However, transfer of PMA/Cal/lL-2 stimulated cells resulted in the highest lytic 
activity in the spleens of the recipients (Table 4.7 A,B,C and D,E,F vs G,H,I). The protocol would 
also stimulate freshly isolated, transferred memory cells in the spleen, however lytic activity from 
spleens of these recipients was lower than that after transfer of PMA/Cal / lL-2 stimulated memory 
cells (Table 4.7, groups Land M vs E and F). The observation that the extent of extravasation of 
transferred cells into the CSF did not directly correlate with their lytic activity in the spleens of 
recipients 4 days after cell transfer could be explained by differencies in homing properties of the 
intravenously injected cells. 
In the unsuppressed model, the experiments were manipulated to minimize the time available 
for in vivo activation of transferred cells and also to avoid any limitations due to homing, by 
injGctirig the donor cells i.e .. The results of these experiments are summarized in Table 4.8. The 
use of the unsuppressed model and the i.v. route of cell transfer resulted in only a slight increase 
in the number of infiltrating cells in each group except when acute spleen cells were injected 
Exp. Group 
1 A 
B 
C 
2 D 
E 
F 
G 
H 
J 
K 
L 
M 
Table 4.7 Adoptive cell transfer of PMA/Cal/lL-2 stimulated 
LCMV-immune spleen cells: immunosuppressed model. 
.a CC>I l~ log10 cells p.1. 
~"'"\-o t" ~-'lfirrelv 
-- (x10') )rt oFCSF ell\, t'v'-""C. 
8wk + 0.4 2.87 ( 31x)c 
+ 0.8 3.25 ( 74x) 
+ 1.6 3.62 (174x) 
11 wk + 2.0 3.81 (282x) 
+ 1.0 2.94 ( 38x) 
+ 0.5 2.37 (9.3x) 
Nil + 2.0 1.18 ( < 1x) 
1 wk 2.0 4.40(1096X) 
1.0 4.08 (525x) 
0.5 3.27 ( 81x) 
Nil 2.0 1.61 (1.8x) 
11 wk 1.0 3.1 O ( 55x) 
0.5 2.37 ( 10x) 
105 
% spec.lysis 
71.3 
82.4 
84.8 
85.1 
80.4 
65.6 
16.0 
45.7 
50.4 
45.5 
0.4 
68.1 
46.3 
a) B6 mice primed with 1000 LD50 WE-3 virus i.p. Time in weeks between priming and assay is 
shown. p.i.: post infection. 
b) Donor cells were cultured in the presence of I ng/ml PMA, 100 ng/ml Cal and 10% (v /v) EL-4 
sn for 3 days, except groups H,1,J,K,L,M where freshly isolated spleen cells were transferred i.v. 
c) Increase above background (injected with medium) is shown in brackets. 
d) Lysis by recipient spleens (containing donor-derived cells) on LCMV-infected MC57G target 
cells. E:T ratio is 50: 1 in Exp.1 and 100: 1 in Exp.2. 
_ ,, 
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Table 4.8 Adoptive cell transfer of PMA/Cal/lL-2 stimulated LCMV-immune spleen cells: 
unsuppressed model. 
Exp. Group Priminga 
of donors 
1 A 17 weeks 
B 
C 
D 
E 7 days 
F unprimed 
2 G 4 weeks 
H 
J 7 days 
K unprimed 
PMA 
(h) 
24 
48 
72 
72 
48 
96 
48 
log10 cells / µI CSF 
i.v. i. e. 
3.60 (1. 7x) 4.08 (3.7x) 
3.32 (<1 .0x) 4.15 (4.4x) 
3.43 (1.1x) 4.22 (S.1x) 
3.54 (1.4x) 4.33 (6.6x) 
4.76 (24x) 4.16 (4.Sx) 
3.38 (1 .0x) 3.56 (1.0x) 
2.60 ( < 1.0x) 4.41 (17.0) 
3.43 (< 1.0x) 4.54 (22.9) 
3.31 (<1 .0x) 4.14 (9.1x) 
4.46 (10.2x) 4.1 7 (9.8x) 
3.45 ::=)1.ox) 3.58 (2.Sx) 
1 a) 86 mice were primed and stimulated as described in Table 4. 7. Number of t ransferred cells: 2 
x 107 i.v.; 1 x 107 i.e. in Exp.1. and 6 x 106 i.e. in Exp.2. 
b) Increase above background (injected w ith medium) is shown in brackets. 
_ , 
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(Table 4.8, groups E and J). However i.e. injection proved to be effective and in this case the 
transfer of PMA/Cal/lL-2 stimulated memory cells resulted in severe meningitis (Table 4.8, 
groups B,C,D,H). Incubating the cells with PMA / Cal/lL-2 for different periods before cell transfer 
gave results somewhat similar to those for the kinetics of development of CTL activity (Fig. 4. 7): 
stimulation with the drugs for more than 3 days did not increase the effectiveness of these cells 
on adoptive transfer. (Groups B,C,D,H vs. I). 
The phenotype of cells after different lengths of stimulation with PMA/Cal /l L-2 was also 
analysed and will be discussed in greater detail in Chapter 5. Expression of the Mel 14 marker, 
which has been suggested to be involved in the in vivo homing of lymphocytes (Dailey et al. 
1985) decreased during in vitro stimulation, and was relatively higher on acute or freshly isolated 
memory lymphocytes (Table 5.2). Whether this observation is relevant to the finding that i.v. 
injected, PMA + Cal stimulated cells are less able to accumulate on the site of infection needs 
more detailed analysis. 
4.2.6 Use of PMA and Cal to study T cell non-responsiveness. 
Mice infected with LCMV at birth develop a persisitent infection which is thought to result from 
immunological tolerance. LCMV-specific CTL and 0TH cannot be detected (Lehmann-Grube, 
1983) and this does not appear to be explained by deletion of LCMV-reactive T cell clones since 
anti-LCMV lgG antibody is produced (Oldstone, 1975; Oldstone et al. 1980; Ahmed and 
Oldstone, 1985). At about 1 % of peripheral CD4 + / CD8- lymphocytes is infected with the virus -
during persistent infection (Ahmed and Oldstone, 1987). It was of interest therefore to see if the 
absence of LCMV-specific CD4 + / CD8- cells results in 'specific tolerance' to LCMV among 
CD8 + / CD4- cells and whether this could be overcome by growing the cells in PMA and Cal in 
the presence of IL-2. 
Balb/ c mice were injected i.p. with the Armstrong strain of virus within 24h of birth. Spleen 
cells were collected 6 weeks later and stimulated with LCMV-infected st:mulator cells or with 
PMA/ Cal /l L-2, respectively. The lytic activity of these cells and also cells from LCMV-memory 
normal mice was determined against target cells infected with WE-3 or Armstrong virus strains. 
- ·· 
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Spleen cells from mice persistently infected with LCMV could not be stimulated in vitro with virus-
infected cells (Table 4.9.1) . Furthermore they did not express any CTL activity (above 
background) upon stimulation with PMA and Cal in the presence of IL-2, even when very high 
concentration of PMA and Cal were used. (Table 4.9.11) . 
Thus, the unresponsiveness of CTL is probably not due to a failure in the TCR-med iated 
activation of the phosphoinositide breakdown pathway, because the alternative method of 
activation with PMA and Cal did not restore the cytotoxic T cell response against LCMV. 
''· 
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Table 4.9.1. Specific stimulation of spleen cells from LCMV-carrier mice. 
Group Eff.a Stim.b % specific lysis c 
KD2SV + WE-3;KD2SV +Arm MC57G + WE-3;MC57G 
A 
B 
C 
D 
memory 
memory 
carrier 
carrier 
WE-3 
Arm. 
WE-3 
Arm. 
69 
57 
12 
6 
51 
46 
15 
14 
100 
86 
ND 
16 
a) memory: (B6 x Balb/c)F 1 mice primed with 1000 LD50 of WE-3 virus 4 weeks before the 
assay. Carrier: Balb/c mice primed i.p. with Arm. virus within 24 h of birth. 
21 
ND 
0 
0 
b) Specific restimulation of effectors was carried out with syngeneic, T cell-depleted spleen cells 
infected with the virus strain shown in the table, as described in 2.8, for 3 days. 
c) E:T ratio = 50:1 
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Table 4.9.11.Stimulation of spleen cells from LCMV carrier mice with PMA/Cal/lL-2. 
Group PMA Cald 
(ng/ml) 
E 
F 
G 
H 
J 
K 
L 
M 
1 
1 
1 
3 
3 
3 
g 
g 
g 
100 
300 
900 
100 
300 
900 
100 
300 
900 
KD2SV+WE-3 
C M 
7 
0 
10 
1 
2 
4 
2 
5 
13 
34 
20 
15 
27 
20 
16 
24 
13 
15 
% specific lysis9 
KD2SV+Arm 
C M 
12 
7 
10 
2 
7 
10 
8 
7 
7 
30 
24 
31 
22 
19 
26 
16 
21 
11 
d) Incubation for 3 days in the presence of 1 O % (v /v) El-4 sn also added 
MC57G+WE-3 
C M 
2 
0 
2 
2 
3 
10 
6 
9 
12 
52 
38 
41 
49 
36 
38 
39 
21 
16 
e) Effector:target ratio is 25:1 . C:carrier; M:memory (same as in Table 4.9.1.a). Spontaneous lysis 
of target cells was 34, 38 and 24%, respectively. Mean of triplicate samples is shown, S.E. being 
less than 5%. 
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4.3 Discussion 
Phorbol esters together with calcium ionophore have been found to be a convenient method 
of activating populations of T and B cells. This procedure has allowed a detailed analysis of the 
biochemical pathway involved in T cell activation. Prior to this study there has been no report on 
the specificity of T cells activated by these drugs. This chapter analysed the potential of PMA and 
Cal treatment to reactivate and grow anti-viral memory T cells while retaining antigen-specificity. 
Specific restimulation with virus of in vivo primed LCMV immune spleen cells usually resulted 
in slightly higher cytotoxic activity than that found following stimulation with PMA and Cal. 
However the latter T cells seemed to be more virus-specific than populations stimulated directly 
with virus, or with larger amounts of IL-2. High concentrations of IL-2 stimulate both antigen-
specific T cells expressing high affinity IL-2 receptors and also other cells identified as 
lymphokine activated killer cells (LAK) (Yron et al. 1980; Lotze et al. 1981 ). LAK cells share some 
characteristics with 'classical' CTL and NK cells, but it is likely that each arises from a different 
population of precursors (Grimm et al. 1983; Andriole et al. 1985). Recent studies have suggested 
that they also differ with respect to serological markers, kinetics of induction and sensitivity to 
irradiation: while LAK effector cells are Thy-1 +, LAK precursors are Thy-1-,la-, non-T, non-B 
lymphocytes (Rosenberg and Lotze, 1986), they require 3-7 days for generation, while NK cells 
only 1-2 days. LAK effector cells kill NK-resistant target cells, and can be induced from spleen 
cells of beige mice which do not have normal NK activity (Merluzzi et al. 1986). LAK cells are also 
resistant to treatment with anti-asialo GM1. 
Thus, stimulation of memory CTL with PMA and Cal resulted in intense proliferation and potent 
lytic activity, with a high degree of specificity of killing by unseparated, in vivo primed spleen 
cells. 
Both allo-immune (Truneh et al. , 1985; lsakov and Altman, 1985) and, as shown in th is 
chapter, virus-immune cells can be triggered with PMA and Cal to generate cytotoxic effector 
function only after in vivo priming. Thus requirements for induction of secondary T cell responses 
to viruses and alloantigens seem to be similar. Moreover it seems that the potent alloreactive 
response of unprimed T cells following stimulation with antigen does not simply reflect recent 
_ , 
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exposure to environmental antigens such as viruses, as these cells are not triggered to cytotoxic 
effector function by PMA and Cal. 
The frequency of CTL precursors was found to be about 1 /800 spleen cells, as determined by 
the antigen-independent method. This is in accord with pCTL frequencies found by other groups 
for vaccinia (see Chapters 3 and 6), influenza (Owen et al. 1982), and LCMV - determined by 
restimulation with virus - (Moskophidis et al. 1987) and indicates that CTL clones specific for the 
different antigenic determinants of the virus are probably represented at a distribution 
comparable to that found following specific restimulation. 
The fact that only primed CTL appear to be activated by PMA and Cal to kill appropiate target 
cells seems to be sufficient to explain the effect of these drugs in the induction of the secondary 
anti-viral and alloreactive responses. The possibility that antigen persists on APC of primed mice 
thereby accounting for the apparent specificity of the response cannot be exciuded. Studies on 
the clearance of LCM virus from the spleens or peripheral blood of acutely infected animals have 
shown that infectious virus can no longer be detected 8 days after infection (rev. by Buchmeier et 
al. 1980} but some cells, e.g. macrophages or dendritic cells are able to retain antigen for long 
periods and stimulate memory B cell responses (Mandel et al. 1980; Tew et al. 1980; Klaus et al. 
1980). However they represent a very small population ( < 1 %) of spleen cells, thus it seems to be 
less evident that they play a crucial role in the development of the secondary T cell response 
stimulated by PMA and Cal. The finding that J11 d- spleen cells and thymocytes can also be 
stimulated in the absence of antigen also support the conclusion that a contribution by APC is 
unlikely during stimulation of memory cells by PMA and Cal. 
Murine lymphocytic choriomeningitis (LCM) is the classsical model of T cell-mediated 
immunopathology in virus infections. Experimental models have been exploited in which the CTL 
activity of adoptively-transferred immune spleen cells - measured in vitro - correlated with their 
capacity to induce symptoms of LCM in virus infected (i.e.), CY-suppressed (Doherty et al. 1986; 
Allan and Doherty, 1985) or unsuppressed mice (Ceredig et al. 1987). The fatal neurological 
disease induced in the recipients by adoptively transferred immune spleen cells probably results 
from acute damage to functional cells in the central nervous system by virus-immune Lyt 2 + 
lymphocytes (Allan and Doherty, 1985; Doherty et al. 1986; Dixon et al. 1987.). 
,, 
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PMA and Cal stimulated LCMV immune spleen cells show similar virus-specific cytotoxicity as 
day 7 LCMV infected acute spleen cells. However, their ability to mediate inflammation in the 
CNS of LCMV infected, immunosuppressed mice remained less than that of acute, in vivo primed 
spleen cells or in some experiments even less than that of memory spleen cells not stimulated in 
vitro before the cell-transfer. The relatively long time (3 days) between cell transfer and evaluation 
of inflammation could be sufficient to allow the in vivo restimulation of some of the transferred 
memory cells. This delay could account for the in vivo activity of memory spleen cells not 
restimulated in vitro before cell transfer 
The relatively poor ability of PMA + Cal stimulated cells to mediate inflammation in the CSF 
could be explained by: (1) lmmunosuppression with 200 mg/kg CY probably does not eliminate 
all CTL precursors from the host animal (see in Chapter 3). The apparent absence of host cells in 
CSF as detected by FMF (Ceredig et al. 1986) could be due to depressed expression of the Thy.1 
antigen following the immunosuppression as described in Chapter 3. Spleen cells from acutely 
infected mice, but not PMA and Cal stimulated cells may contain or produce higher amount of 
factor(s) necessary to restore the development of CTL in the immunocompromised host. (2) 
Spleen cells stimulated in vitro have altered migration and homing characteristics, as shown 
previously for cloned T cells (Dailey et al. 1985), therefore PMA and Cal - stimulated cells may not 
show normal recirculation patterns. The results of i.e. cell transfer into unsuppressed mice seem 
to favour this but shows that PMA + Cal stimulated memory cells are able to induce severe 
inflammation in the CNS if introduced directly. 
Mice infected with LCMV in utero, neonatally or as immunocompromised adults become 
persistently infected with the virus. (Traub, 1938; rev. by Lehman-Grube, 1983; Buchmeier et al. 
1980; Oldstone et al. 1986). Persistant viral infections are medically significant, - an estimated 200 
million people are persistently infected with hepatitis B virus (Marion & Robinson, 1983) - and 
they can cause a number of chronic diseases (Wolinsky & Johnson, 1980). A variety of viruses 
are known to cause persistent infections in man. The classic model of viral persistence is 
infection of mice with LCMV. Although it !1as provided significant information about carrier status, 
the question of the mechanism of suppression of cell-mediated immunity and its role in 
persistance is still unresolved. Carrier status can be characterized by life-long production of 
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infectious virus, decreased expression of viral glycoproteins, complete lack or very low levels of 
CTL activity but unimpaired virus-specific B cell function (Buchmeier et al. 1980). Ahmed and 
Oldstone (1985) have shown that genetically different viral variants are responsible for the 
persistence of the virus and the suppression of the CTL response. The nature of this suppression 
can be explained by lymphotropic variants infecting and killing LCMV-specific CTL, or causing 
selective functional inactivation (Oldstone et al. 1982). Other possible explanations are: 
inappropriate presentation of the virus by infected T cells (Fink et al. 1983); inhibition of 
differentiation of CTL precursors (Rammense et al. 1982) or the presence of high concentrations 
of antigen in the environment of the responding CTL (Lamb et al. 1983; Matis et al. 1983; Ceredig 
et al. 1986). In the experiments shown in this chapter, the possibility that the presence of excess 
virus was in some way blocking signal transduction to CTLp, or memory CTL, was investigated. 
The finding - that PMA +Cal+ IL-2 treatment did not lead to the appearance of LCMV-specific CTL 
activity in spleen populations of LCMV carrier mice - could either mean that this population has 
been deleted, or that the suppression of function does not reflect a failure in the signal 
transduction of CTL that could be overcome by exposure to these drugs. Similarly, neonatally 
induced tolerance to alloantigen was not abrogated by this method of stimulation (see Chapter 
6). 
The stimulation protocol has numerous other possible applications. Koizumi et al. (1986) 
successfully stimulated T cells from MLR/1 mice, which carry an autoimmune disease that can be 
characterized by low surface antigen expression and IL-2 defects. xposure of spleen cells from 
this strain to phorbol ester and Cal resulted in significantly increased IL-2R expression, IL-2 
production and de nova DNA synthesis Miller (1986) also reported that phorbol ester and Cal had 
restorative effects on immunodeficiency in vitro due to aging. 
A procedure for the specific induction of tumor-reactive CTLp, in the absence of any precise 
knowledge of the nature of the tumor antigen, could also prove very useful. Therapy based on the 
selective expansion of specifically sensitized T cells in this way may have advantages over 
protocols depending on non-specific activation of lymphocytes with high concentrations of IL-2 
(Mule et al. 1985; Loveland et al. 1986; rev. by Rosenberg and Lotze, 1986). 
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However, since PMA cannot be metabolized, its effect is virtually irreversible (Kraft and 
Anderson, 1983). It would be worth considering the use of non-tumor-promoting activators of 
PKC, e.g. bryostatins (frenn et al. 1988) or synthetic diacylglycerol (DiC8) which can substitute 
for the effect of PMA (Manger et al. 1987). The latter cause a transient translocation of PKC which 
starts to disappear after about 30 min, so its effect might mimic the physiologic activation of PKC 
more closely. 
Taken together, the experiments discussed in this chapter showed that low concentrations of 
PMA and Cal stimulate the re-expression of specific lytic activity by in vivo primed, resting virus-
immune T cells. The reactivated cells killed virus-infected target cells with high specificity, and at 
similar frequency to those reactivated with virus- infected stimulator cells. Spleen cells treated by 
PMA and Cal were effective in adoptive cell-transfer experiments, however T cell 
unresponsiveness in persistently infected mice cannot be overcome by stimulating the cells with 
these drugs. 
Chapter 5 
Phenotypic and functional characterization of in vivo primed 
LCMV-immune T cell subsets 
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5.1 Introduction 
The previous chapter dealt with the stimulation of unseparated spleen cells from virus primed 
mice using a combination of PMA and Cal stimulation, a treatment which directly triggers, in the 
absence of antigen, the signal transduction pathway of T cells. This chapter considers whether 
the same signals can activate different T cell subsets and uses this antigen-independent 
activation to examine the role of these subsets in the development of the secondary anti-viral 
response of selected T cell populations. 
Phenotypic identification of memory CTL was also attempted. Most investigations which have 
searched for stable expression of growth factor receptors (Lowenthal et al. 1985; Trowbridge and 
Omari, 1981) or other cell surface antigens (Clement et al. 1984; Damle et al. 1985; Haynes et al. 
1981 ; Cotner et al. 1983) selectively on memory T cells have failed. Recently however in vitro 
stimulated human T cells have been shown to express the Ta1 activation marker (Hatler et al. 
1986) and 4F2 glycoprotein (Soumalainen, 1986). Furthermore, the Ta1 + subset was found to be 
enriched for T cells reacting to mumps and tetanus toxoid (Hafter et al. 1986) in individuals 
sensitized to these antigens. It was found that the Ly 24 molecule appears on the surface of in 
vitro activated T cells (Lynch et al. 1987), therefore in vivo generated anti-viral memory CTL were 
examined for the presence of Ly 24. 
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5.2 Results 
5.2.1 Phenotypic analysis of normal and memory spleen cells. 
Using single colour FMF, the level of expression of IL-2R, Lyt2 and L3T4 antigens was 
examined on spleen cells freshly isolated from normal and from LCMV-immune memory mice 
(Table 5.1 ). The ratio of Lyt2 + and L3T4 + cells was similar in memory and in naive mice, 
whereas the proportion of cells carrying the Ly 2_4 antigen was higher by about 10%, in each of 
two experiments, from virus - primed in comparison to 'naive' animals. Very low IL-2R (55 kd 
chain) expression was detected on spleen cells from both groups. Thus, immunization with LCMV 
does not seem to result in a significant phenotypic shift of T cell markers on splenic lymphoid 
cells 8-1 o weeks after priming although an increase in the number of cells expressing the Ly 24 
antigen appears to have occurred. 
Immediately following restimulation of spleen cells from LCMV-immune mice in vitro an 
apparent decrease in the number of cells expressing Thy-1, Lyt 2, L3T4 antigens occured. (Table 
5.2 A vs Band D vs F). In addition, there appeared to be a decrease in the number of T3 + cells 
and an increase in the expression of the IL-2 receptor. By 48-72 hr, expression of these markers 
had gradually increased (Table 5.2, 48 hr:G; 72 hr:C). In vitro stimulation also resulted in the 
appearance of the Ly 24 antigen on the surface of T cells (Table 5.2, 6th column) as described 
originally by Lynch et al. (1987). However the expression of the Mel 14 marker decreased 
markedly 24 h after the PMA treatment and remained low thereafter (last column, Table 5.2). 
5.2.2 The role of T cell subsets in the generation of the secondary CTL response. 
The role of L3T 4 + and L yt 2 + cells in the generation of a secondary anti-viral CTL response 
following stimulation with PMA and Cal was studied using negatively selected cell populations. 
Freshly isolated spleen cells from LCMV-immune mice were treated twice with monoclonal 
antibodies against either Lyt 2 or L3T4 plus complement, respectively. The efficacy of the 
Table 5.1 Phenotypic analysis of normal and memory spleen cells 
Lyt 2 
LCMV-primed 24.3 
normal 19.0 
% positive cellsb 
L3T4 
26.9 
26.2 
PC61 
0.8 
1.2 
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Ly 24 
28.5 
18.6 
a) Spleen cells of (CBAx86)F 1 normal or LCMV-immune mice, primed 6 weeks before assay. 
b) Cells were stained with biotinylated mAb to Lyt-2 or L3T4, followed by avidin-FITC or non-
biotinylated anti-lL-2R (PC61) or anti-Ly 24 mAb followed by sheep anti-rat-FITC, respectively. 
% positive cells refers to % cells staining above the corresponding control samples stained with 
either avidin-FITC or sheep anti-rat FITC alone. Results are representative of two experiments. 
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Table 5.2 Phenotypic analysis of memory spleen cellsa following stimulation with PMA 
and Cal. 
Gp. 
E.xp.1 A 
B 
C 
E.xp.2 D 
E 
F 
G 
treatm. 
(hr)b 
0 
24 
72 
0 
10 
24 
48 
% positive cellsc 
Thy1 T3 Lyt2 L3T4 PC61 Ly24 Mel14 
59.3 
28.4 
76.4 
63.7 
61.9 
35.0 
81.9 
35.6 31.6 
19.0 13.5 
57.3 33.0 
27.1 
19.3 
13.3 
50.8 
32. 7 25.4 40.5 36.8 
23.9 38.8 61 .0 7.3 
45.4 47.4 90.5 4.8 
a) 86 mice, primed with LCMV 1 O weeks before the assay. 
b) Incubation time with 1 ng/ ml PMA, 100 ng/ ml Cal and 2 % (v / v) EL-4 sn. 
c) The cells were stained with monoclonal antibodies (biotinylated in case of T3) and with 
sheep anti-rat-FITC (avidin-FITC for T3). 
120 
depletion was analysed by FMF and is shown on the first panel of Fig. 5.1. Stimulation with PMA 
and Cal for 3 days did not alter the ratio of Lyt 2 + to L3T4 + cells in the unseparated spleen 
population (Fig. 5.1 first row). However, in the negatively selected populations, the percentage of 
Lyt 2+ and L3T4 + cells increased about 3-fold with very few (1.4% L3T4 + and 2.7% Lyt 2+) cells 
of the depleted phenotype appearing after 3 days of culture (Fig.5.1 second and third rows). 
The requirements for stimulating the proliferation of the T cell subsets was measured using the 
MIT (Table 5.3 A-0) and [3H]-thymidine uptake assays (Table 5.3 E-H). The results obtained from 
these assays are similar, although the two methods measure slightly different parameters: MIT 
measures surviving cells, while thymidine measures proliferation.Thus, as also shown in the 
previous chapter, PMA and Cal in combination are sufficient to stimulate unseparated spleen 
cells from both naive and memory mice (Table 5.3 A,B and E,F, second column). The L3T4 + 
cells can be stimulated directly by the drugs to proliferate (Table 5.3 D & H), however the ability 
of Lyt 2 + cells to respond was much lower (Table 5.3 C & G, second column). Addition of 5 U /ml 
human recombinant IL-2 increased the proliferative capacity of cells in the PMA and Cal treated 
unseparated (Table 5.3 A,B and E,F third col.) and L3T 4 + cultures to some extent (1.14 and 1.03-
fold, respectively Table 5.3 D,H). In contrast, the proliferative capacity of the Lyt 2 + cells 
increased 2.3-fold when the culture was supplemented with exogenous IL-2. (Table 5.3 C & G). 
The same amount of IL-2 alone resulted in only a minor increase in proliferation for each 
population (Table 5.3 1st col. vs.4th col.). 
The lytic capacity of these subsets has also been measured (Table 5.4). Neither of the subsets 
can be stimulated with PMA and Cal to kill MHC-restricted target cells (Table 5.4 C,D) but, if 
exogeneous IL-2 is provided, the Lyt 2 + cells are able to mediate specific lysis (Table 5.4 C, 3d 
col.). The results suggest that stimulation of the lytic activity of Lyt 2 + cells by PMA and Cal is 
totally dependent on the presence of IL-2. 
1 21 
Phenotype of LC MY memory spleen ceUs 
before culture ofter culture b 
Lyt 2 i L3T4 Lyt 2 L3T4 
J: 
35.6% !\ 29.5% 49.6% 43.7 % 
unseparated ~ 
i C: 
!1 3 
31.4% 1.9% . : 91.8% 1.4 % g-: . 
I l ~ 
0 
-
n 
L3T4- a Cl 
"' 
-C 
1.4% ,, 32.3% 2.7% !~ 80.5% ~ : : j: 
-
log fluorescence intensity ( a. u. ) 
Fig. 5.1 Phenotypic analysis of negatively selected T cell subsets before and after 
stimulation with PMA+Cal + IL-2. 
a) CBAxB6) F 1 spleen cells, 6 weeks after priming with LCMV 
b) spleen cells were depleted by monoclonal antibody (RL 172, 3.168.8) ar.d complement 
treatment. 
c) cells were cultured for 3 days in the presence of 1 ng/ml PMA, 100 ng/ml Cal and 5 U / ml 
IL-2. Aliquots of viable cells obtained on ficoll-hypaque were stained with biotiny1ated 
antibodies and avidin-FITC. Dotted lines represent the binding of avidin-FITC alone. Percentage 
values represent the proportion of positive cells. 
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Table 5.3 Proliferation of T cell subsets upon PMA + Cal stimulation. 
Proliferation after cultureb with 
Group cellsa mediumPMA + Cal PMA+Cal +IL-2 IL-2 
(O.D. measured in MTT assay)c 
A normal unsep. 0.084 0.201 0.219 0.081 
B memory unsep. 0.060 0.168 0.158 0.060 
C memory Lyt 2 + 0.076 0.109 0.152 0.076 
D memory L3T 4 + 0.076 0.252 0.218 0.072 
([3H]-thymidine uptake, cpm x 1 o-3) 
E normal unsep. 0.5 18.7±3.6 23.7±0.6 0.7±0.1 
F memory unsep. 0.4 24.0±1.8 28.9±3.0 0.6±0.1 
G memory Lyt 2 + 0.5 6.9±1.1 15.3±4.6 0.9±0.1 
H memory L3T 4 + 0.4 27.1±1.4 28.1 ±0.8 0.8±0.2 
a) Spleen cells and depletion are the same as in Fig. 5.1 
b) 5x1 o4 cells/well were incubated for 48 hr with 1 ng/ml PMA, 100 ng/ml Cal and / or with 5 
U/ml IL-2. 
c) Mean of triplicate samples is shown, S.E. < 0.048. 
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Table 5.4 The role of IL-2 in the stimulation of lytic activity of T cell subsets by PMA+Cal. 
Group cellsa % specific lysis after incubationb 
mediumPMA + Cal PMA+Cal + IL-2 IL-2 
A normal unsep. ND.c ND. 5.1 5.3 
B memory unsep. 6.8 50.0 51 .9 28.8 
C memory L yt 2 + ND. 0 34.2 26.9 
D memory L3T 4 + ND. 0 3.7 0 
a) spleen cells were prepared as in Fig.5.1. 
b) 106 cells/ well were cultured in 24 well trays for 3 days with 1 ng/ ml PMA, 100 ng/ ml Cal 
and/ or 5 U/ ml IL-2. The targets are LCMV-infected MC57G cells, E:T ratio = 30:1. Mean of 
triplicate samples is shown, S.E. < 5%. 
c) not done 
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5.2.3 Expression of Ly 24 glycoprotein distinguishes memory and naive T cells. 
As unprimed Ly 24- lymphocytes become Ly 24 + upon in vitro antigenic or mitogenic 
stimulation, the question arose as to whether in vivo primed lymphocytes can also be 
distinguished from unprimed cells by expression of this marker. Nylon wool enriched spleen cells 
from mice primed with LCMV 8-10 weeks previously were stained with biotinylated Ly 24 antibody 
followed by avidin-FITC, and the level of Ly 24 expression determined by single color FMF (Fig. 
5.2 A). Cells were sorted by FMF to give about 20% Ly 24 + and 50% Ly 24- as described in Fig. 
5.2. The level of contamination was checked by re-running the samples after sorting. The forward 
light scatter profile of Ly 24 positive and negative subsets is shown on Fig. 5.2 B. The Ly 24 + 
cells tended to be slightly larger than the negative cells which could be due to the presence of 
-
more blast cells in this subset. Both populations were then cutured in the presence of PMA, Cal 
and IL-2 and their lytic activity checked against syngeneic, virus-infected target cells (Fig 5.3). 
The Ly 24 + population gave rise to all the LCMV- specific cytotoxic activity and seemed to be 
enriched in lytic activity in comparison to the unsorted cells. The lytic activity of unsorted but 
stained cells did not differ greatly from that of the unstained sample, indicating that the antibody 
and the sorting procedure probably had neither an inhibitory nor a stimulatory effect on the 
cytotoxic activity of these cells. 
The specificity of the killing was also studied using different target cells (Fig. 5.4). Ly 24 + cells 
killed their specific target type and also showed lectin-dependent lytic capacity against 
phytohemagglutinin (PHA) treated target cells while Ly 24- cells did not kill these targets. 
However, Ly 24- cells killed Con A treated target cells after culture in the presence of Con A (Fig. 
5.5) suggesting that this population contained T cells and has the capacity to be lytic under 
appropriate conditions. 
The results support the idea that in vivo primed T cells become Ly 24 + thus allowing selection 
of this functionally distinct subset through expression of this differentiation antigen. 
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A 8 
PGP-1 
-0 
+ 
fluorescence intensity (au.) forward light scatter intensity (au) 
Fig. 5.2 Ly 24 (Pgp) expression on LCMV-immune spleen cells. 
Spleen cells from (CBAx86) F 1 mice were harvested 80 days after priming with LCMV. A: 
Aliquots of cells were stained with biotiny1ated anti-Ly 24 antibody followed by avidin -
conjugated FITC. Of the nylon wool separated spleen cells 45.1 % were Ly 24 +. Cells between 
channels 1 and 20 were sorted into Ly 24- (56.6%) and between channels 60 and 255 into Ly 
24 + (20%) subpopulations. 
8: The forward light scatter analysis of the sorted T cell subsets. 
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Fig. 5.3 Functional differencies between Ly 24 + and Ly 24· populations of immune T 
cells. 
Spleen cells from (CBAxB6)F 1 mice primed with LCMV 1 O weeks before the assay were sorted 
into Ly 24 ( •) and Ly 24- ( O) populations. The sorted cells, the stained, unsorted ( ..,, ) and 
the original unstained population ( v') were cultured at 1 o4 cells/well for the Ly 24 + cells and 
3x1 o4 cells / well for the other groups. Cultures contained 1 ng/ml PMA, 100 ng/ml Cal and 1 O 
U/ ml IL-2. CTL activity against LCMV-infected-MC57G celrs was'=measured 6 days later. The 
average of duplicate samples is shown, S.E. < 5%. 
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Fig.5.4 Specificity of killing by Ly 24 + cells stimulated 
with PMA and Cal. 
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Ly 24 +, Ly 24- and stained, unsorted spleen cells obtained by FMF from (C8AxB6)F1 mice 
primed with LCMV 12 weeks before the assay, were cultured for 4 days at 1.5 x 1 o5 cells/ well. 
Cells from each group were pooled and their cytotoxic activity measured on different target 
cells (S.E. of mean of triplicate wells <3.3%). 
_ ,, 
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Targets: 
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Fig. 5.5 Lectin-dependent killing by the sorted T cells. 
Spleen cells from 86 unprimed mice were sorted into Ly 24 + (fill) and Ly 24· (filll) populations 
(unsorted cells:~) and cultured for 7 days at 2 x 1 o4 cells/ well in the presence of PMA and 
Cal as usual (A,8,C,D,E) or in the presence of 0.5 µg/ml Con A (F). The lytic activity was tested 
against PHA-treated (A-8) or Con A treated (0-F) P815 target cells. E:T ratio is 2.5: 1, mean of 
triplicate samples is shown. 
5.3 Discussion 
Despite their unique properties, such as increased frequency and the presence of high 
avidity antigen receptors, identification and separation of memory T cells by cell surface 
molecules has remained elusive. 
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The studies reported in this chapter demonstrate that the Ly 24 (Pgp 1) glycoprotein 
identifies a discrete subset of ny1on wool enriched spleen cells from in vivo primed LCMV 
immune mice. Ly 24 + cells have the capacity to give a specific CTL response in the absence of 
accessory cells upon stimulation with PMA +Cal+ I L-2. 
The experiments do not prove that increased Ly 24 expression on unseparated spleen cells 
following in vivo antigenic stimulus comes from transition of Ly 24- T cells into Ly 24 + T cells, 
as is the case following in vitro stimulation of thymocytes (Lynch et al. 1987). However, direct 
transition of cells from Ly 24- to Ly 24 + has been shown by Budd et al. (1987) confirming the 
previous obser1ations of Dumont et al. (1984) using 9F3 mAb. In the paper by Budd and 
colleagues (1987) immunization of mice 8 weeks previously with either H-2 alloantigens or with 
MSV resulted in an increased proportion of Ly 24 + cells among the Lyt 2 + spleen cells. 
Priming with the minor H antigen H-Y did not result in an increase in Ly 24 expression. Ly 24 + 
lymphocytes in 'normal' animals might represent a subset which has been primed due to 
naturally occuring infections, which is supported by the finding that the Ly 24 + subset contains 
larger cells which may be blasts. Previous determinations have shown that 10-20% of the total 
pool of splenic T lymphocytes in vivo are naturally activated cells. They tend to be larger and 
can be selectively grown in vitro by IL-2 (Pereira et al. 1985). Similarly, Lynch has found that 
proliferation of Ly 24 + but not Ly 24- cells can be induced by IL-2 in vitro (manuscript in prep.). 
The functional properties of the Ly 24- cells have also been studied: they did not kill virus 
infected syngeneic, allogeneic or lectin treated targets upon PMA stimulation, but lysed Con A-
treated targets when they were stimulated in the presence of Con A. Thus the sorted Ly 24-
cells did contain T cells. The role of Con A in mediating LDCC has been the subject of several 
investigations (Gately and Martz, 1977; Berke et al. 1981 a & b; Bonavida and Katz, 1985). It has 
been shown that LDCC and cell-mediated cytotoxicity (CMC) follow the same pathway of1ysis, 
but the exact mechanism is not clear. The possibilities are that the lectin ser1es as a 'glue' to 
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bring effector and target cells in close proximity; that it activates T cells (Bonavida et al. 19n; 
Green et al 1978}; or that it modifies MHC class I molecules (Berke et al 1981 a & b) or other 
structures on the targets (Bonavida and Katz, 1985). What is known is that virtually all mature 
CTL have the ability to mediate Con A-dependent killing. 
There are conflicting reports in the literature about the ability of tumor promoters and 
calcium ionophores to activate the helper and cytotoxic T cell subsets. It has been reported 
recently that these drugs stimulate cloned T helper cells to proliferate and to produce 
lymphokine, but do not activate cytotoxic T cell clones to mediate cytotoxic effector function 
(Albert et al. 1985; lsakov and Altman, 1986}. Truneh et al. (1985) obtained similar results with 
alloreactive T cell subsets enriched for Lyt2 + or L3T 4 + cells, respectively. In contrast, Berebbi 
et al. (1987) found that the drugs increased the ability of cloned CTL to form conjugates and 
mediate lysis not only of targets to which they were sensitised but also irrelevant targets. In 
addition they found similarities between PMA and Cal activation of lymphokine secretion from 
cloned helper cells and triggering of lysis by CTL The discrepancies between these reports 
may be explained by differencies in the concentration range of drugs used for stimulation and 
by differencies among CTL clones. It has also been suggested that the outcome of stimulation 
depends on the stage of the CTL cell cycle at the time of treatment (Ashwell et al. 1986). 
Antigenic stimulation and exposure to mitogens or PMA have all been shown to cause rapid 
downregulation of the T3 jTCR complex on a T cell hybridoma, T cell clones, thymic and 
peripheral T cells and T cell tumors (Ando et al, 1985; Cantrell et al. 1985; Weyand et al. 1987). 
This can be accompanied by parallel downregulation of the CD4 molecule (Weyand et al. 1987; 
Hoxie et al. 1986; Solbach, 1982). Similar consequencies following PMA treatment were 
observed on nylon wool enriched spleen cells (Table 5.2), but two colour FMF would be 
necessary to determine the exact phenotypic changes within the T cell subsets. The 
significance of the phosphorylation and downregulation process is not clearly understood, but 
it can be thought to reflect a negative-feedback mechanism that functions to reduce the 
surface expression of T3 jTCR complex after antigen recognition, thereby terminating further 
activation by antigen. Parallel downregulation of the CD4 molecules suggests that they may 
form a physical association with TCR (Fazekas de St.Groth et al. 1986). 
_ ... ,. 
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Budd et al. (1987a and b) have found that Ly 24 is expressed on both Lyt 2 + and L3T4 + 
peripheral T cells, with a slightly higher proportion of the former subset being positive. From 
studying these subsets it seems that, although the positively selected Ly 24 + population 
contains all the factors necessary to give rise to LCMV- specific secondary CTL activity upon 
PMA stimulation (Figs.5.4 & 5.5), the activation requirements are different for Lyt 2 + and 
L3T4 + cells. Thus, incubation with PMA and Cal does not induce CTL function of Lyt 2 + cells 
in the absence of IL-2 or IL-2 producing L3T4 + cells, though the lymphocytes may still 
proliferate. Whether proliferation of such Lyt 2 + L3T4- lymphocyte populations reflects 
endogeneous IL-2 production by Lyt 2 cells (Widmer and Bach, 1981; Kelso and Glasebrook, 
1984) has not been established. A logical interpretation of the experiments would be that any 
IL-2 originating from the Lyt 2 + subset is consumed to maintain cell division, and is insufficient 
to induce CTL function. Alternatively, cells other than the Lyt 2 + population may be 
proliferating, or lymphocyte division may be maintained by a different pathway (Koretzky et al. 
1983). Recent findings suggest that IL-4 plays an important role in stimulating some T cell 
subsets to proliferation. (Massmann et al. 1986). 
The observation that there are differences between Lyt 2 + and L3T 4 + T cells in the 
conditions necessary for stimulation indicate that there are differences in the signal 
requirements for activation of lymphokine production and cytotoxicity. L3T 4 + cells can be 
directly activated by PMA and Cal, however stimulation of Lyt 2 + cells is secondary to the 
release of I L-2 produced by L3T 4 + cells. The results also suggest that cytolytic function does 
not necessarily represent an end-stage of maturation (Mitchison and Pettersson, 1983; 
Bandeira et al. 1987). Alternatively, effector CTL may revert into non-cytolytic memory cells 
observed for cloned CTL (Orosz et al. 1985). 
-•,, 
Chapter 6 
Cytotoxic T cell response to recombinant vaccinia virus 
expressing the H-2Kd alloantigen. 
- .:_" I, 
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6.1 Introduction 
The available data on MHC-restricted and alloimmune T cell-responses suggest that virus-
immune and alloreactive T cell precursors occur at similar frequencies in virus primed and 
unprimed mice, respectively. The high frequency of T lymphocytes recognizing allelic variants of 
MHC products may be explained by a high degree of similarity between complexes composed of 
syngeneic MHC-products + peptide and foreign MHC gene products (Burakoff et al. 1978; von 
Boehmer et al. 1979; Sredni and Schwartz, 1980; Towns.end et al. 1985; Maryanski et al.1986; 
Bjorkman et al. 1987 a and b). Another explanation resulting from Jerne's hypothesis (1971) is 
that there are germ line-encoded receptors for both self and allogeneic MHC specificities. It has 
been suggested (von Boehmer et al. 1978) that high affinity self-reactive clones are eliminated 
during ontogeny, while allo-reactive clones remain at a high level. 
The results discussed in Chapter 4 and 5 suggest that alloreactivity does not result from 
previous encounters with environmental infectious agents. Furthermore, the lack of stimulation of 
alloreactivity from naive spleen cells by PMA and Cal indicates that alloreactive clones do not 
exist as activated cells in these mice. However, in contrast to primary MHC-restricted anti-viral T 
cell-responses, alloreactive CTLp can be activated at high frequencies in vitro. 
Thus, the conventional method for testing alloreactivity in mixed lymphocyte cultures does not 
distinguish between primary responses induced in vitro and secondary alloreactivity due to in 
vivo priming. Stimulation of memory cells in vitro in the absence of antigen with PMA and Cal 
provides a protocol for analysing the pCTL-frequency resulting from only the antigen used for in 
vivo priming. In this chapter, use is made of a recombinant vaccinia virus which contains the 
coding sequence for the H-2~ allo-antigen. Vaccinia can be engineered to express cloned 
genes encoding immunologically important proteins from a variety of unrelated viruses (Smith et 
al. 1983; Panicali et al. 1983; Bennink et al. 1984; Wiktor et al. 1984; Mackett et al. 1985; Andrew 
et al. 1987), tumor specific antigens (Lathe et al. 1987) anq histocompatibil ity antigens (Coupar et 
al. 1986). The vaccir.ia H-2~ recombinant virus has been shown in previous experiments to 
generate an H-2Kd-specific primary cytotoxic T cell response when injected into H-2 different 
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mice and to act as a target fo~ alloreactive and H-2~ -restricted vaccinia virus-specific cytotoxic 
T cells when used to infect allogeneic (H-2k) L929 cells (Coupar et al. 1986). 
The present experiments are concerned with determining whether there is a T cell repertoire 
for the recognition of H-2~ + vaccinia virus that is separate from that for H-2~ alone in H-2b 
mice. This has been tested at the clonal level using limiting dilution analysis, and has also been 
analyzed in H-2b mice made tolerant of H-2~ by injection of H-2dxb (F 1) cells as neonates. 
.... , .. 
134 
6.2 Results 
6.2. 1 Primary and secondary CTL responses against the recombinant virus. 
Priming 86 (H-2b) mice with the control vaccinia virus (V-TK") led to a potent anti-viral CTL 
response with comparable lysis of MC57G (H-2b) targets infected with V-~ and V-TK" (line 1, 
Table 6.1 ). There was also some lysis of the KD2SV (H-2d) vaccinia-infected target, but this was 
much less than that caused by syngeneic, virus-primed 8alb/c (H-2d) effectors (compare lines 1 
and 3, Table 6.1 ), and may represent non-specific cytotoxicity. Infection of 86 mice with V-~ did 
not, however, lead to higher levels of cytotoxicity for virus-infected (as compared with uninfected) 
targets (line 2, Table 6.1 ). Thus, for primary in vivo CTL tested in a bulk assay, exposure of H-2b 
mice to vaccinia virus carrying the H-2~ alloantigen does not allow the discrimination of a 
response to H-2~ - vaccinia virus from that to H-2~ alone. 
The secondary CTL response was measured 7 weeks later (Table 6:2)' following restimulation 
. 
with PMA and Cal in vitro by the method described in Chapter 4. As found for primary CTL, 
effectors primed with the recombinant virus had potent alloreactivity against H-2d targets and 
also against virus-infected H-2b targets (Table 6.2, 1st row). Third party H-2k target cells infected 
with vaccinia-TK"were not lysed. Very low levels of lysis (5-8%) were found when vacc-~ was 
used to infect the cells (Table 6.2, columns 5 and 6). 
6.2.2 Clonal distribution of the secondary response. 
The precursor CTL frequencies against virus or alloantigen were determined for mice primed 
with the V-~ virus construct following specific restimulation in vitro with antigen (Table 6.3) or by 
stimulation with PMA + Cal + IL-2 (Table 6.4). The latter method has been described in greater 
detail in the LCMV system (Chapter 4). 
The frequency of alloreactive CTLp in H-2b mice primed with V-~ and restimulated witl \ \ 
V1r1As- anft.c..1'e<l H-2.kl..o ~L S 
allogeneic cells is 1 / 438 compared with 1 / 451 for V-~ primed cells restimulated with and 
I\ 
- · ·" 
Table 6.1 Primary CTL response against recombinant 
vaccinia virus. 
Micea Priming % specific lysisc 
vacciniab H-2b 
TK" +~ V-~ V-TK" U V-~ V-TK" 
86 
86 
8alb/c+ 
+ 
+ 
36.1 
46.1 
21.9 
a) 2 mice/group, 6 days after priming 
b) 107 PFU virus i.v. 
32.6 10.7 
46.6 23.0 
11.9 4.7 
15.8 
50.2 
61.4 
14.1 
31.7 
43.9 
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u 
3.8 
42.3 
11.1 
c) 100:1 E:T ratio, results are calculated by linear regression of data at different E:T ratios. Mean 
of triplicate samples is shown, S.E. < 5%. The targets are MC57G (H-2b), and KD2SV (H-2d) 
cells, infected with the recombinant virus (V-~). the control virus (V-TK") or uninfected (U); 
spontaneous lysis less than 27%. 
_.,, 
,,; , 
Primingb 
vacc-~ 
vacc TK" 
H-2d cells 
Nil 
Table 6.2 Secondary CTL response following stimulation of 
recombinant virus primed spleen cells with PMA and Cal3 . 
% specific lysisc 
H-2b H-2d H-2k 
V-TK" u V-TK" u V-TK" V+ ~ 
20 0 36 38 0 8 
29 0 7 8 0 3 
1 1 46 44 0 5 
1 0 5 6 0 
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H-2kd 
u 
0 
0 
20 
0 
a) 5 days stimulation in the presence of 1 ng/ml PMA 100 ng/ml Cal and 5 U/ml IL-2. 
b) B6 mice were immunized with 1 O 7 PFU virus or 2 x 1 O 7 P815 cells i.v. 51 and 37 days before 
assay, respectively. 
c) MC57G (H-2b), KD2SV (H-2d), L929 (H-2k) and YAC (H-2a) target cells were used at 60:1 E:T 
ratio. Mean of triplicate samples is shown, S.E. < 5%. Abbreviations as in Table 6.1. 
o,1• 
Group 
A 
B 
C 
D 
E 
F 
G 
H 
J 
K 
Table 6.3 LOA of pCTL frequencies after antigen-specific 
restimulation in vitro. 
Primed In vitro Reciprocal frequenciesc 
with? 
V-Kd 
V-~ 
V-~ 
V-TK" 
V-TK-
P815 
P815 
nil 
nil 
V-TK" 
V-TK" 
stimulationb 
H-2Kkod 
H-2Kkod + vacc 
H-2b+vacc 
H-2Kkod 
H-2b+vacc 
H-2Kkod 
H-2Kkod + vacc 
H-2Kkod 
H-2Kkod + vacc 
H-2Kkod + vacc 
H-2b+vacc 
H-2d 
V-TK" u V-~ 
438 
295 4-'31. 
230 
512 
923 
318 
1190 
937 
137 
H-2b 
V-TK" 
643 
360 
995 
a) 86 (A-1) or (Balb/c X 86)F1 mice were primed with 107 PFU virus or 2 x 10
7 
cells i.v., for 12 or 
1 O weeks, respectively. 
b) 1 o5 gamma-irradiated stimulators/well, 8 day culture 
c) Calculated by linear regression, r> 0.9. 
Targets: KD2SV and MC57G cells, infected as in Table 6.1. 
Gp 
A 
B 
C 
D 
Priming 
with:b 
V-~ 
V-TK" 
P815 
Nil 
Table 6.4 LDA of pCTL frequencies after stimulation with 
PMA and Cal a. 
V-TK" 
394 
>6000 
298* 
>7000 
Reciprocal frequenciesc 
H-2d H-2b 
u V-TK" 
882 1384 
>6000 540 
322 N.D. 
> 7000 > 1 0000 
u 
N.D. 
>20000 
N.D. 
N.D. 
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> 18000 
N.D. 
>180000 
>250000 
a) 8 days incubation with 1 ng/ml PMA, 100 ng/ml Cal and saturating amounts of IL-2 (see 
Chapters 2 & 4). 
b) as in Table 6.3 
c) Calculated as described in Table 6.3, r>0.92, except* 0.864, and (> ) where linear regression 
analysis cannot be applied. Targets are as in Table 6.1. 
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tested on V-~ infected H-2b targets (Groups A and 8, Table 6.3). The frequency of self H-2b 
MHC-restricted T cells in these mice was slightly lower (1.643, group C, Table 6.3). V-TK" -
infected KD2SV target cells were lysed at a slightly higher level , when spleen cells from V-~ 
primed H-2b mice were restimulated with H-2d cells infected with vaccinia virus, than H-2b cells 
infected with V-~ (1 / 295 compared with 1 / 451 ). The frequency of self MHC-restricted anti-viral 
CTLp (1 / 643) is slightly lower than that from mice infected with vaccinia virus (1 / 360) while that 
of CTLp specific for uninfected H-2d targets (1 / 438) is of similar magnitude to that of mice 
injected with P815 (H-2~ cells (1 / 512), or from 'naive' mice stimulated in vitro with H-2~Dk cells 
(1 / 318). Stimulation of the different effectors with vaccinia TK" virus infected H-2~ antigen 
presenting cells resulted in about 1/ 1000 pCTL frequency when the H-2~ served as alloantigen 
on the surface of H-2b targets (Table 6.3, G and I) but the frequency was more than two-fold 
higher (1 / 451) when the H-2~ might have served as a restriction element as well (Table 6.3, 8) . 
The results in Table 6.4 show the pCTL frequencies due to in vivo priming either with virus (8) 
or alloantigen (C) or both, using the virus construct (A) and after restimulation with PMA and Cal. 
As mentioned previously, the main difference between the two approaches is that the 
conventional LOA uses allogeneic stimulator cells. Thus, while it measures mainly in vitro induced 
primary allo-immune effector-T cells there may also be some secondary lytic activity from 
effectors generated in vitro from in vivo primed CTL-precursors. Therefore, the results from 
antigen-independent stimulation, summarized in Table 6.4, could be considered to reflect the 
consequencies of priming with the recombinant virus more precisely. 
Priming 86 mice with V-~ led to a higher frequency of CTLp for virus-infected, as compared 
with uninfected, H-2d targets (2.2-fold, line 1, Table 6.4). This difference did not mean that the 
virus-infected targets were more susceptible to lysis by alloreactive T cells, as the frequency of 
CTLp assayed on uninfected targets was almost the same from mice primed with P815 cell s (line 
3, Table 6.4) . It thus seemed possible that there could be at least some T cells reactive to V-~. 
rather than to ~ alone, in the H-2b mice. 
The V-TK" virus was more potent at priming H-2b - restricted CTLp than was V-~ (1 / 540, 
compared with 1 / 1384, Table 6.2). This was also apparent following restimulation with vi rus-
infected cells (Groups C and E, Table 6.3) . This could simply reflect that V-TK" grows better and is 
- . . , 
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more immunogenic, or that the presence of ~ in some way skews the response away from H-2b 
+ vaccinia virus. 
The assumption that some CTL clones of V-~ primed 86 mice are specific to vaccinia in the 
context of H-2~ was checked by a well-split analysis at the clonal level (Fig. 6.1 ). Gradually 
increasing number of cells (200-400-800) were cultured in the presence of PMA and Cal as 
described previously (Chapter 4) and the cytotoxic activity of each well was tested against two 
targets. This approach gives more information about the CTL clones than LOA. At 200 and 400 
cells/well whore tho f)Fobabilitry, of 91onal.t¥ is high, aooording to the results iA Tabks 6.4, some 
clones from the recombinant virus primed mice showed minimal evidence of cytotoxicity for 
vaccinia-infected H-2d targets but not for uninfected cells (panel A, Fig. 6.1 ). The level of specific 
lysis is very low (slightly above the 5% limit), thus to show definitively that these cells are specific 
for H-2~ + virus it would be necessary to isolate the clones and characterise their fine-
specificity. In any case, these few, minimally potent CTLp cannot be considered to reflect the 
· presence of a significant repetoire for ~ + vaccina virus in H-2b mice. 
The well-split analysis can also distinguish between MHC-restricted and allo-immune clones. 
Effectors from vaccinia TK" virus primed mice were found to kill only virus-infected H-2b targets 
when analysed at 200 and 400 cells per well (panel C, Fig 6.1 ). When the clones of V-~ primed 
mice were split onto virus-infected H-2b and H-2d targets (panel B, Fig. 6.1 ), at 200 cells/well all 
the positive wells were functionally 'single positives', at 400 cells/well only 1 well seemed to show 
double specificity (11 %), whereas at 800 cells/well lysis in 19% of the positive wells was MHC-
restricted, 25% exhibited anti-allo killing, and the remaining wells had double specificity. The 
probability of clonality at this cell number is less than 1 (i.e. individual wells may contain more 
than 1 CTL precursor), the assay suggests that different clones are responsible for the MHC-
restricted and for the allo-immune CTL responses, respectively. 
6.2.3 Secondary response of mice t'oterant to H-2d 
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Fig.6.1 Specificity of pCTL at clonal level 
Effector spleen cells were cultured for 8 days in the presence of 1 ng/ml PMA, 100 ng/ml Cal and 
saturating amounts of IL-2. Wells were split in two and lytlc activity of cells measured against the 
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H-2b mice were tolerized to H-2~ by immunization with (H-2bxd) F 1 spleen cells 24 hr within 
birth. It was asked whether abrogation of the alloreactive response for H-2~ in H-2b mice would 
allow the emergence of precursors specific for H-2~ + vaccinia virus. 
None of 3 mice ( 4 to 6, Table 6.5) that showed lack of CTL effector function for H-2d were 
found to be specifically primed to H-2~ + vaccinia virus when spleen cells were expanded in 
vitro with PMA and Cal in the presence of IL-2 (H-2d target, Table 6.5). All three however, were 
primed to H-2b + virus (Table 6.5) 
It was also asked, whether there would be any differences for CTLp recognizing V-~ or V-TK" 
on H-2b targets in these mice. The frequency was slightly higher for one mouse that was tolerant 
of H-2d, and somewhat lower for a second animal (mice No 13 and 15, Table 6,6). The level of 
chimerism was also checked by FMF in these mice using the Ly 24.2 marker, which should be 
only present on the tolerising (Balb/c x 86) F 1 cells (Trowbridge et al. 1982). Less than 10% of 
spleen cells were of donor phenotype, and it was found that the number of these cells present 
was not a good indicator of tolerance (Table 6.6). 
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Mouse Toi. 
No. ind.a 
1-3 
4 + 
5 + 
6 + 
Table ,., Analysis of pCTL frequencies to recombinant 
vaccinia virus in H-2d-tolerant mice. 
% Ly 24.1 + % specificb reciprocal pCTL 
spl Thy lysis (H-2d) frequenciesc 
d b+V-TK" 
0 0 74.0 1002 735 
* 9.3 0 1.4 25600 469 
7.4 0.2 29.5 1420 192 
2.1 0 5.1 1451# 169 
1 43 
b+V~ 
380 
306 
145 
451 
a) Tolerance induction with2 x 107 (Balb/c x 86)F1 spleen cells i.v. within 24h of birth. 
b) Effectors primed in MLR with gamma-irradiated Balb/c spleen cells. Effector cells (3200/ well) 
were cultured for 8 days. Mean of 16 wells/group is shown, S.E. < 5%. 
c) Calculated as described (Chapter 2). r> 0.9, except for* (0.849) and # 0.884. Targets are 
KD2SV and MC57G, abbreviations as in Table 6.1. 
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Mouse Toi. 
No. ind.a 
1-3 
4 + 
5 + 
6 + 
7-9 
Table '-· Ssecondary CTL activity of H-2d tolerant mice 
against the recombinant vaccinia virus. 
% specific % specific lysisc 
lysis(H-2d)b H-2d 
+V-~ +V-TK" U 
A 8 C 
15 20 17 17 
0 3 4 3 
2 0 2 1 
0 0 0 0 
ND 22 22 0 
144 
H-2b 
+V-TK" u 
D E 
28 2 
36 6 
40 3 
29 3 
20 ND 
a) 1-6 86 mice, 7-9 (8alb/c x 86)F1 mice. 4-6: tolerance induction with 2 x 10
7 (8alb/c x 86) F1 
spleen cells injected within 24 h of birth. 
b) Effector cells were stimulated with gamma-irradiated 8alb/c spleen cells for 4 days, E/T ratio 
is 15:1. 
c) Effectors were stimulated with PMA and Cal for 4 days as described (Chapter 2) . Targets as 
listed in Table 6.1 . E:T ratio is 60:1. 
-· 
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6.3 Discussion 
Vaccinia recombinants expressing foreign antigens are potentially useful as live vaccines 
against a variety of viruses and also in the preventing the spread or cure of tumors carrying 
tumor-specific antigens (rev. by Moss, 1985; Lathe et al. 1987); The results in this chapter provide 
information about the general characteristics of the CTL response induced by a recombinant 
vaccinia virus. 
T cell memory induced by the virus construct containing H-2~ was found to be quantitatively 
and qualitatively similar in the case of MHC-restricted anti-viral and allo-immune responses. One 
possibility is that infection of mice with the recombinant virus results in a common pathway of 
antigen-processing and presentation for the viral proteins and for alloantigens. The proteins may 
be denatured and fragmented in the Golgi-apparatus and returned to the cell surface together 
with class I molecules (Morrison et al. 1986; Germain, 1986; Townsend et al. 1985). The idea 
would then be that different H-2b glycoproteins on the cell surface would present peptides 
derived from either the H-2~ molecule or from vaccinia virus. The alternative model is that 
processing of virus proteins is mediated via the above mechanism, while the H-2~ glycoprotein 
is fully expressed the surface of cells infected with V-~ (van Boehmer et al. 1979; Braciale et al. 
1981; Weiss et al. 1980). The fact that infection with V-~ primes for a secondary response to the 
~ molecule (as determined by stimulation with PMA + Cal + IL-2) expressed on H-2d targets 
might be thought to favour this idea. Otherwise, it would be necessary to argue that the same 
peptide derived from H-~ can associate with H-2b (i. e. Kb or ob) or H-2d (i.e. ~ . odor L d) 
glycoproteins, and that the T cell receptor can recognize this peptide regardless of the prese11ting 
MHC molecule. 
Experiments performed at the clonal level indicated that there is little, if any, repertoire for H-
2~ + vaccinia virus in H-2b mice. Further limiting dilution analysis in H-2b mice that are tolerant 
to H-2d would probably not have modified this conclusion, though this experiment would have 
been examined if suffic ient time had been available. However the results are in general accord 
with the idea that MHC-restricted T cell recognition is generally selected towards low affinity for 
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self MHC in the thymus (Zink8rnagel, 1978; Bevan and Fink, 1978; Doherty and Bennink, 1979) 
and that the odd cases of recognition of non-self MHC + virus represent an aberrant cross-
reactivity (Doherty and Bennink, 1979). Selective proliferation of the small number of clones with 
a low level of cytotoxicity for H-2d + vaccinia virus (Fig. 6.1) could have lead to such findings 
(Doherty and Bennink, 1979). 
Others have looked for clones which are specific for both viral antigen and alloantigen. T cell 
clones with dual reactivity to both self + antigen and also alloantigen have been described by 
Kaye and Janeway (1984) and Kanagawa and Nagasawa (1987). In these studies it was found 
that monoclonal antibodies to the TCR of these clones inhibited antigenic and allogenic 
stimulation. However, Kanegawa and Nagasawa (1987) found different mAb were required to 
inhibit recognition of self+antigen in comparison to alloantigen suggesting that different epitopes 
on the TCR recognised these antigens. 
The exact mechanism of neonatal tolerance induction and its maintenance is not known. It has 
been observed that unresponsiveness to alloantigen is associated with decreased helper and 
cytotoxic precursor T cell frequencies specific for the tolerogen (Nossa! and Pike, 1981; Carnard 
-a f\"" a re.. 
et al. 1984). The experiments summarized in Table 6.5 support these observations, sin€.0 the I..C.A. 
stwgi0s gf negnatally toleriaee ~iee et.lowed oAe AK lciAeties. TRi!! i! in accord with the suggestion 
that the decrease in precursor frequency is due to the removal of T cells by clonal deletion 
(Nossal, 1983; Wood et al. 1984). In contrast, others have found that tolerized cells can be 
reactivated in vitro (Heeg and Wagner, 1985) and that suppression can be 'infectious' (Fitch et al. 
1976; Gorczynski and MacRae, 1979; Vegh et al. 1980; Janossy et al. 1983). However, stimulation 
of the tolerized cells with PMA and Cal did not result in the appearance of clones reactive to the 
tolerogen, which seems to favour the clonal deletion theory, but it is not known what effect PMA 
and Cal stimulation would have on the putative active suppression. 
The experiments also deal with the differencies between alloantigen-specific CTL activity in 
unprimed or in in vivo primed mice, by utilizing an in vitro restimulation protocol in the absence 
of added antigen. This procedure maybe of practical value for analysing trcnsplantation systems. 
One application would be to follow cellular immunity in recipients after transplantation particularly 
where the number of cells available is low due to cytotoxic immunosuppressive agents. 
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Taken together.the experiments with recombinant vaccinia virus encoding the H-2~ 
alloantigen, showed no obvious differences between MHC-restricted anti-viral and allo-immune 
CTL-responses. It is possible that there could be some specific suppression of the ~ + virus 
repertoire in H-2b mice, but it would need to be argued that such suppressors can operate to 
overcome the effects of PMA + Cal + IL-2. It seems likely that T cells reactive to antigens other 
than foreign MHC glycoproteins are constrained by non-self antigens presented in the context of 
self MHC-glycoproteins encountered in the thymus. 
I 
Chapter 7 
General discussion 
-· 
148 
The main aim of this thesis was to examine the characteristics of cytotoxic T cell activation 
during viral infection. These studies have demonstrated that virus-primed cytotoxic T 
lymphocytes (CTLp) undergo differentiation in vivo and develop into primary effector cells, and 
also into memory cells creating the basis of a secondary CTL response. The primed cells can be 
characterised by their requirements for activation which differ from those of naive cells and by 
surface expression for the Ly 24 antigen. This discussion will examine the requirements for T cell 
activation in primary and secondary T cell responses. The ways in which these studies should be 
extended will also be considered. 
Cytotoxic T lymphocytes arise during the course of a cell-mediated immune response to viral 
infection. The properties of the primary anti-viral T cell response were studied following in vivo 
priming, as a potent primary CTL response to virus cannot be induced in vitro. The model of 
vaccinia infection of immunosuppressed mice, described in Chapter 3, provided information 
about the differentiation pathway of CTL, requirements for T cell activation and the need for T-T 
collaboration. 
Recognition of antigen is the first stage of T lymphocyte activation. Interaction of specific 
antigen receptors with antigen and MHC molecules leads to the expression of receptors for IL-2 
(Robb et al. 1981 and 1984, Smith and Cantrell, 1985). These activated cells can be induced to 
differentiate into effector CTL following exposure to IL-2 (Lalande et al. 1980; Gromo et al. 1987). 
Studies in this thesis found that a relative insufficiency of IL-2 can abrogate the differentiation 
of CTLp in vivo (Chapter 3). The lack of IL-2 mediated maturation, and perhaps proliferation, of 
the precursors is responsible for the unresponsiveness of CTL The conclusions are in accord 
with the results of Farrar and colleagues (1982) and Erard and colleagues (1985) who studied the 
minimal requirements for the growth and differentiation of lectin stimulated CTLp. The results also 
explain why administration of IL-2 to mice augments anti-viral immunity (Rouse et al. 1985; 
Hefeneider et al. 1983), but they are inconsistent with the idea that IL-2 does not have a role as T 
cell growth factor in vivo (Bandeira et al. 1987). The latt~r group found that naturally activated T 
lymphocytes (separated by cell size) failed to proliferate in the presence of recombinant IL-2. 
However their conclusion does not consider at least two published results: firstly, that cell size 
might not be the best criterion to distinguish primed from unprimed cells, as memory T cells 
-·.· 
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could be small lymphocytes (MacDonald et al. 1975); secondly: the sensitivity with which a T cell 
responds to I L-2 varies with the state of activation (Ashwell et al. 1986). Furthermore, recently 
primed T cells become transiently refractory to IL-2 after exposure to antigen or mitogen (Cantrell 
and Smith, 1983; Gull berg and Smith, 1986; Churilla and Braciale, 1987). 
Thus, the experiments in Chapter 3 support the idea that development of the primary anti-viral 
CTL response in vivo is IL-2 dependent. These findings do not exclude the possibility that the 
early phase of development of CTLp is IL-2 independent, or at least T helper cell independent 
according to Sprent and colleagues (1986a), or that other factors are also necessary, since the 
CTL response was restored only partially by IL-2. It has been reported recently, that IFN 'Y and IL-4 
might be also important in T cell activation. IFN-'Y augments CTL response indirectly, by 
increasing the expression of MHC molecules (Wong et al. 1983, 1984 a & b; Steeg et al. 1982; 
King and Jones, 1983) and also by synergising with the effect of IL-2 (Klein and Bevan, 1983; 
Simon et al. 1986). It might also have a direct effect on T cell differentiation (Chen et al. 1986). In 
addition, a role for IL-4 in the development of the primary alloreactive CTL response has been 
proposed recently (Widmer and Grabstein, 1987; Rocha and Bandeira, 1988). The precise role of 
these factors in the development of an anti-viral T cell response has to be established. 
The observation that the frequency of pCTL is not greatly affected by cyclophosphamide 
treatment, but that it is the development of these precursor cells which depends on the presence 
of IL-2 (Chapter 3) also raises the question of the necessity for T-T collaboration during the 
primary CTL response. From the experimental results it seems likely that the CD8 + CD4-
population is not able to produce sufficient IL-2 (and maybe other factors) necessary for 
proliferation and differentiation, thus these processes are dependent on the function of cos· 
CD4 + cells. This is comparable with the conclusions of others who found that T-T collaboration 1s 
necessary in primary alloreactive and anti-viral CTL- responses. However some experiments 
indicate that collaboration between T cell subsets is not always necessary (see Chapter 1, 
section 4.3). Although cos+ cells are thought to be capable of producing some IL-2 (Andrus et 
al. 1981; Kelso and Glasebrook, 1984; Heeg et al. 1987) although this is disputed (Rocha and 
Bandeira, 1988) and there are some CDS+ T cell clones which do not need and do not produce 
detectable amount of IL-2 but are able to proliferate upon antigenic stimulation (Moldwin et al. 
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1986; Widmer and Bach, 1981 ), the majority of CTL seem to require IL-2 production by CD4 + 
cells. Clonal amplification of the CTL response during acute viral infection, an IL-2 dependent 
process, is probably necessary to combat infection. Although the experiments in this thesis did 
not address the question of whether CTL dtfferentiation in vivo involves cell proliferation, the 
results of LOA studies (Chapters 3 and 6) suggest that the effector cells develop in this way: the 
frequency of virus-specific CTLp in normal mouse spleen was found to be about 1 /30000 -
1 /60000 which increases to about 1/1000 by 7 days after infection. Similar frequencies have 
been found by others (Owen et al. 1982; Moskophidis et al. 1987) and must involve clonal 
expansion. The published results in this field are rather controversial: previous in vitro studies 
have concluded that cell proliferation usually occurs during CTLp differentiation. However 
inhibition of cell-division with cytosine-arabinoside does not abolish the cytotoxic activity induced 
in a 24 hr MLC (MacDonald and Lees, 1980; Lefrancois et al. 1985). These studies seem to 
support the hypothesis of Mitchison and Petterson (1983) that derepression of genetic 
information is taking place instead of proliferative differentiation. In vivo experiments (Kimura and 
Wigzell, 1983) provided evidence that during allograft reaction in vivo CTL arise via a mechanism 
. 
circumventing blast formation and cellular proliferation. An explanation for these observations is 
that there are a high number of precursors present. However Denizot et al. (1986) came to the 
opposite conclusion and were also using an in vivo allogeneic system: they found specific, 
proliferating Ly 2 + conjugate-forming CTL in mouse peritoneal cavity 1 O days after injection of 
allogeneic tumor cells. Furthermore, in LCMV-infected mice relatively low doses of Cy 
administered 2-5 days after the virus, completely abrogated the effector function of CTL (Allan 
and Doherty, 1985). As Cy preferentially kills dividing cells, this experiment strongly suggests that 
cell proliferation is an important part of CTL differentiation during primary anti-viral immune 
response. 
The major part of this thesis deals with in vivo primed, virus-immune memory CTL From 
previously reported studies it has been known that these cells are quantitatively and qalitatively 
different from those in unprimed mice (MacDonald, 1982). The quantitative diffGrence is manifes 
as an increased precursor frequency (Ryser and MacDonald, 1979), while the qualitative changes 
' 
can be described as increased avidity of the antigen receptors which can be measured by the 
-· 
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level of resistance to inhibition of CTL-activity with anti-CDS antibody (MacDonald et al. 1982). 
The results in Chapters 4 and 5 add two more points to the characterization of memory T cells as 
will be discussed below. 
Previous studies on memory T cells have investigated mainly in vitro primed, alloreactive CTL 
These cells, derived from long-term MLC, become small and cytolytically inactive after 9 days of 
the culture (MacDonald et al. 1975). They re-express specific cytolytic activity upon restimulation 
with the original antigen (MacDonald et al. 1975). Proliferation of CTL occurs reaching a peak 
after 3-4 days. Supernatants derived from restimulation of primary alloreactive cultures can also 
cause re-expression of cytolytic activity (Ryser et al. 1978; Wagner and Rollinghoff, 1978). 
Purified IL-2 in the absence of added antigen can also induce in vitro - (Ochoa et al. 1986) and in 
vivo - primed (Lefrancois et al. 1984) memory CTL to re-express cytolytic activity. 
It has been demonstrated by lsakov and Altman (1985) that PMA and Cal stimulates IL-2R 
expression, IL-2 production and cytolytic activity of 14 day primary MLR cells, but not the 
cytolytic activity of CDS+ clones. Truneh et al. (1985) found that T lymphocytes from mice 
primed with allogeneic cells can proliferate and lyse allogeneic target cells after in vitro 
stimulation with ionomycin plus phorbol ester. Based on the results in Chapters 4,5 and 6 it can 
be concluded that CTL primed in vivo with foreign MHC or non-MHC antigens can be stimulated 
to proliferate with low concentrations of PMA and Cal, increase expression of IL-2 receptor and to 
express highly specific cytotoxic activity in the presence of IL-2. This method of the stimulation is 
a convenient procedure for restimulation in the absence of antigen and accessory cells. 
However.it also has the potential to distinguish between primed and unprimed cells, as cytotoxic 
activity cannot be induced by this protocol from unprimed CTL even if they are present at a 
relatively high frequency, as is the case with alloreactive cells. The explanation for this difference 
between alloreactive and primed anti-viral CTL would need a more sophisticated analysis to allow 
comparison of the pathways of signal transduction, or targets for phosphorylation, in cells 
activated by different procedures. 
The results in Chapter 5 concerning the l!..-2 dependent development of the secondary CTL 
response are in agreement with the findings of others (see above). The lymphokine is produced 
by CD4 + cells, depletion of this population completely abolished the development of cytotoxic 
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activity, but not the proliferation, of the CD8 + population. In the presence of IL-2, antibody to the 
IL-2 receptor completely blocked the proliferation of the undepleted cells. It would be worth 
examining whether the proliferation of the CD8 + subset in the absence of detectable cytotoxic 
activity is IL-2 independent or whether the CD8 + cells are able to produce some IL-2 and 
(perhaps) other factors, which would support only the proliferation but not the differentiation of 
these cells. 
The similarities between in vitro and in vivo primed lymphocytes in the requirements for, and 
characteristics during, activation suggested that T cells isolated from virus-primed mice might be 
identified by expression of the Ly24 + antigen which has been shown to be expressed on T cells 
following in vitro stimulation (Lynch et al. 1987). The experiments (Chapter 5) have shown that 
virus-immune memory T cells are enriched in the Ly24 + subset. The findings are in accord with 
the results of Budd et al. (1987 a and b) who have shown that alloimmunization, priming with 
Moloney sarcoma virus (MSV) or immunization with H-Y antigen greatly enriched the antigen-
specific CTLp in the Ly24 + population. A comparable situation may apply in man.in that T cells 
enriched for the Ta1 antigen have the potential to respond to tetanus toxoid and mumps antigens 
in bulk culture (Hafter et al. 1986). lntrestingly Ta1, like Ly24, is stably expressed by activated T 
cells and its molecular weight is similar to murine Ly 24 (Fox et al. 1984). 
However the experiments in Chapter 5, and also those published by Budd et al. (1987 a and b) 
were performed only with spleen cells from one strain of mice (86). Some results suggest, that 
the use of Ly 24 antigen to identify in vivo generated memory cells phenotypically may be 
restricted by mouse strain (Lynch, unpublished). 
The results obtained from restimulation of T cells from mice primed with a recombinant 
vaccinia virus containing the H-2~ gene (Chapter 6) suggest that distinct T cell clones are 
responsible for self-MHC-restricted anti-viral and anti-allo killing,. The experiment raises the 
question of how the antigens are presented: is the ~ molecule presented as the intact 
glycoprotein (van Boehmer et al. 1979; Weiss et al. 1980; Braciale et al. 1981 ), or is it fragmented 
and expressed in tl1e context of self-MHC molecules, as for viral (Townsend et al. 1985) and HLA 
(Maryanski et al. 1986; Pala et al. 1988) antigens? One way of answering this question would be 
to analyse the T cell repertoire of mice primed with the recombinant vaccinia virus by isolating 
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large number of T cell clones, or to immunoprecipitate and identify the molecules expressed or. 
the surface of cells infected with the virus-complex. Another possibility is to see if H-2 negative F9 
target cells are lysed by CTL specific for vaccinia virus + H-2~ when infected with the 
recombinant vaccinia virus. 
In conclusion, the data presented in this study have shown that development of primary and 
secondary anti-viral CTL response is an IL-2 dependent process, involves T-T interaction and 
results in the appearance of primed or memory T cells which are at a much higher frequency than 
unprimed virus-immune CTLp, and differ from these: a) in requirements for the stimulation of 
cytotoxic activity, b) in the appearance of a distinct surface marker, Ly 24. 
Bibliography 
154 
Abbas, A.K., Haber, S. and Rock, K.L 1985 Antigen prenentation by lymphocytes II. 
Specifictyy and properties of antigen-presenting B lymphocytes and function of 
immunoglobulin receptors. J. lmmunol. 135:1661 
Acres, R.B., Conlon, P.J., Mochizuki, D.Y. and Gallis, B. 1986 Rapid phosphorylation and 
modulation of the T4 antigen on cloned helper T cells induced by phorbol 
myristate acetate or antigen. J. Biol. Chem. 261: 1621 O 
Acuto, 0., Fabbi, M., Smart, J., Poole, C.B., Protentis, J., Royer, H.D., Schlossman, S. and 
Reinherz, E.L 1984 Purification and NH-2 terminal amino acid sequencing of the 
B subunit of a human T-cell antigen receptor. Proc. Natl. Acad. Sci. 81 :3851 
Acuto, 0., Campen, T.J., Roger, H.D., Hussey, R.E., Paola, H.C.B. and Reinherz, E.L 1985 
Molecular analysis of T cell receptor (Ti) variable region M gene expression. 
Evidence that a single TiB v gene family can be used in formation of V domains 
on phenotypically and functionally diverse T cell population. J. Exp. Med. 
161 :1326 
Ada, G.L, Leung, K-N. and Ertl, H. 1981 An analysis of effector T cell generation and function 
in mice exposed to influenza A or Sendai viruses. lmmunol. Rev. 58:5 
Adkins, B., Mueller, C., Okada, C.Y., Reicher, A.A., Weissman, I.Land Spangrude, G.J. 1987 
Early events in T-cell maturation. Ann. Rev. lmmunol. 5:325 
Ahmed, R. and Oldstone, M.B.A. 1985 Viral persistence: Role of virus variants and T cell 
immunity. Banbury Report 22 p223 
Albert, F., Hua, C., Truneh, A., Pierres, M. and Schmitt-Verhulst, A-M. 1985 Distinction 
between antigen receptor and IL-2 receptor triggering events in the activation of 
alloreactive T cell ciones with calcium ionophore and phorbol ester. J. lmmunol. 
134:3649 
Allan, J.E. and Doherty, P.C. 1985 Consequences of cyclophosphamide treatment in murine 
lymphoctyic choriomeningities: evidence for cytotoxic T cell replication in vitro. 
Scand. J I mmunol. 22:367 
Allan, J.E. and Doherty, P.C. 1986 Natural killer cells contrubute to inflammation but do not 
appear to be essential for the induction of clinicaJ lymphocytic choriomeningitis. 
Scannd. J. lmmunol. 34:153 
Allen, P.M. 1987 Antigen processing at the molecular level 
I mmunol. Today 8:270 
Allen, P.M. and Unanue, E.R. 1984 Differential requirements for antigen processing by 
macrophages for lysozyme-specific T-cell hybridomas. J. lmmunol. 132:1077 
Allen, P.M., Matseuda, G.R., Evans, R.J., Dunbar, J.B., Marshall, G.R. and Unanue, E.R. 1987 
Identification of the T-cell and la contact residues of a T-cell antigenic epitope. 
Nature 327:713 
Allen, P.M., Matsueda, G.R., Mater, E. and Unanue, E.R. 1985a Specificity of the T-cell 
r\Ceptor: two different determinants are generated by the same peptide and the I-
A molecule. J.lmmunol. 135:368 
Allen, P.M., McKean, D.J., Beck, B.N., Sheffield, J. and Glimcher, LH. 1985b Direct evidence 
that a class II molecule and a simple globular protein generate multiple 
determinants. J. Exp. Med. 162: 1264 
155 
Ando, I., Hariri, G., Wallace, D. and Beverly, P. 1985 Tumor promoter phorbol esters induce 
unresponsiveness to antigen and expression of interleukin 2 receptor on T cells. 
Eur. J. lmmunol. 15:196 
Ando, H. and Hurme, M. 1981 Self-MHC restricted cytotoxic T cells responses without thymic 
influence. Nature 289:492 
Andrew, M.E., Coupar, B.E.H., Boyle, D.S. and Ada, G.L 1987 The roles of influenza virus 
haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus 
recombinants. Scand. J. lmmunol. 125:21 
Andriole, G.L, Mule, J.J., Hansen, C.T., Linehan, W.M. and Rosenberg, S.A. 1985 Evidence 
that lymphokine-activated killer cells and natural killer cells are distinct based on 
an analysis of congenitally immunodeficient mice. J.lmmunol. 135:2911 
Andrus, L, Prowse, S.J. and Lafferty, J.K. 1981 lnterteukin-2 production by both by Ly2+ 
and by Ly2-T-cell subsets. Scand. J. lmmunol. 13:297 
Anon, 1981 Some antineoplastic and immunosuppressive agents. IARC monographs 26: 165. 
Ashwell, J.D., Robb, R.J. and Malek, T.R. 1986 Proliferation of T lymphocytes in response to IL-
2 varies with their state of activation. J. lmmunol. 137:2572 
Babbitt, B.P., Allen, P.M., Matsudea, G., Haber, E. and Unanue, E.R. 1985 The binding of 
immunogenic peptides to la histocompatibility molecules. Nature 317:359. 
Baenziger, J., Hangartner, H., Zinkernagel, R,M. and Cole, G.A. 1986 Induction or prevention 
of immunopathological disease by cloned cytotoxic T cell lines specific for 
lymphocytic choriomeningitis. Eur. J. lmmunol. 16:387 
Ballas, Z.K. 1986 Lymphokine-activated killer cells (LAK) I. differential recovery of LAK, NK and 
CTL after sublethal dose of CY. J. lmmunol. 137:2380 
Bandeira, A., Larsson, E-L, Forni, L, Pereira, P. and Coutinho, A. 1987 "In vivo" activated 
splenic T cells are refractory to interleukin 2 growth "in vitro". Eur. J. lmmunol. 
17:901 . 
Bank, I. and Chess, L 1985 Peturbation of the T 4 molecule transmits a negative signal to T 
cells. J. Exp. Med. 162:1294 
Bank, I, DePinho, R.A., Brenner, M.B., Cassimers, J., Alt, F.W. and Chess, L 1986 A functional 
T3 molecule associated with a novel heterodimer on the surface of 
immature human thymocytes. Nature 322: 179 
Barber, T.A. and Alter, B.J. 1978 Ultrastructure of effector-target cell interaction in secondary 
cell-mediated lympholysis. Scand J. lmmunol. 7:57 
Barclay, A.N. and Mayrhofer, G. 1981 Bone marrow origin of la-positive cells in the medulla of 
rat thymus. J. Exp. Med. 153:1660 
Bennink, J.R and Doherty, P.C. 1978 Different roles govern help for cytotoxic T cells and B 
cells. Nature 276:829 
Bennink, J.R. Yewdell, J.W. Smith, G.L, Moller, C. and Moss, B. 1984 Recombinant vaccinia 
virus primes and stimulates influenza hemagglutinin-specific cytotoxic T cells. 
Nature 311 : 578 
Berke, G., Hu, V., McVey, E. and Clark, W.R. 1981a T lymphocyte-mediated cytolysis. I.A 
156 
common mechanism for target recognition in specific and lectin-dependent 
cytolysis. J. lmmunol. 127:n6 
Berke, G., McVey, E., Hu. V and Clark, W.R. 1981b T lymphocyte-mediated cytolysis II. Role of 
target cell histocompatibility antigens in recognition and lysis. J. lmmunol. 
127:782 
Berrebi, G., Takayama, H. and Sitkovsky, M.V.1987 Antigen-receptor interaction requirement 
for conjugate formation and lethal-hit triggering by cytotoxic T lymphocytes can 
be bypassed by protein kinase C activators and Ca-ionophores. Proc Natl. Acad. 
Sci. 84: 1364 
Berkower, I., Buckenmeyer, G.K. and Berzofsky, J.A. 1985a Synthetic peptide contains a 
complete epitope recognized by T cell clones and this epitope is selectively 
presented by I-E0 transfectants. Fed. Proc. Fed. Am. Soc. Exp. Biol. 44: 1312 
Berkower, I., Kawamura, H., Matis, LA. and Berzofsky, J.A. 1985b T cell clones to two major T 
cell epitopes of myoglobin: effect of I-A/1-E restriction on epitope dominance. J. 
I mmunol. 135:2628 
Berridge, M.J. and Irvine, R.F. 1984 Inositol triphosphate, a novel second messenger in cellular 
signal transduction. Nature 312:315 
Bevan, M.J. 1987 Antigen recognition. Class discrimination in the world of immunology. Nature 
325:192 
Bevan, M.J. and Fink, P .J. 1978 The influence of thymus H-2 antigens on the specificity of 
maturing killer and helper cells. lmmunol. Rev. 42:3 
Bich-Thuy, LT., Dukovich, M., Peffer, N.J., Fauci, A.S., Kehrt , J.H. and Greene, W.C. 1987 
Direct activation of human resting T cells by IL-2: the role of an IL-2 receptor 
distinct from the Tac protein. J. lmmunol. 139:1550 
Biddison, W.E., Hansen, T.H. Levy, R.8. and Doherty, P.C. 1987 Involvement of H-2L gene 
products in virus immune T cell recognition. Evidence for an H-2L restricted T-cell 
response. J. Exp.Med. 148:1678 
Bismuth, G., Moreau, J-L, Somme, G., Duphot, M., Dautry-Varsat, A., Robb, R.J. and Theze, J. 
1985 Regulation of interleukin 2 (IL-2) receptor expression. IL-2 as an inducing 
signal for the expression of its own receptor on a murine T helper cell line. Eur J. 
lmmunol. 15:723 
Bjorkmann, P.J., Saper, M.A. Samraoui,B., Bennett, W.S. , Strominger, J.L and Wiley, D.C. 
1987a Structure of the human class I histocompatibility antigen, HLA.-A2. Nature 
329:506 
Bjorkman, P.J., Saper, M.A. , Samraoui, B., Bennett, W.S., Strominger, J.L, arid Wiley, D.C. 
1987b The foreign antigen binding site and T cell recognition regions of class I 
histocompatibility antigens. Nature 329:512 
Bland en, R. V. 1970 Mechanisms of recovery from a generalised viral infection: Mousepox. I 
The effects of anti-thymocyte serum. J. Exp. Med. 132: 1035 
Blanden, R.V. and Gardner, I.D. 1976 The cell-mediated immune response to ectromelia virus 
infection. I. kinetics and characteristics of the primary effector T cell response in 
vivo. Cell. lmmunol. 22:271 
Blanden, R.V. Bowern, N.A., Pang, T.E. Gardner, I.D. and Parish, C.R. 1975 Effects of thymus-
157 
independent (B)-cells and the H-2 gene complex on antiviral function of immune 
thymus-0erived (f) cells. Aust. J. Exp. Biol. Med. Sci. 53: 187 
Blankenhorn, E.P. and-Douglas, T.C. 1972 Location of the gene for theta antigen in the mouse. 
J. Hered. 63:259 
Bluestone, J.A., Pardall, D., Sharrow, S.O. and Fowlkes, B.J. 1987 Characterization of murine 
thymocytes with CD3-associated T-cell receptor structures. Nature 326:82. 
Boehmer, Von H., Hengartner, H., Nabholz, M., Lernhardt, W., Schrier, M.H. and Haas, W. 
1979 Fine specificty of a continuously growing killer cell clone specific for Hy 
antigen. Eur. J. lmmunol. 9:590 
Boehmer, Von, H., Haas, W, and Jerne, N.K. 1978 Major histocompatibility complex-linked 
immune-responsiveness is acquired by lymphocytes of low-responder mice 
differentiating in thymus of high-responder mice. Proc. Natl. Acad. Sci. 75:2439 
Bonavida, B, and Katz, J. 1985 Studies on the induction and expression of T cell mediated 
immunity. X:J. Role of non-MHC papain-sensitive target structures and Lyt-2 
antigens in allogeneic and xenogeneic lectin-0ependent cellular cytotoxicity 
(CDCC). J. lmmunol. 135:1616 
Bonavida, B., Robins, A. and Saxon, A. 1977 Lectin-0ependent cellular cytotoxicity in man. 
Transplantation 23:261 
Borst, J., Alexander, S., Elder, J., Terhorst, C. 1983 The T3 complex on human T lymphocytes 
involves four structurally distinct glycoproteins. J. Biol. Chem. 258:5135 
Borst, J., Van De Griend, R.J., Van Oostveen, J.W., Ang, S. L , Melief, C.J., Seidman, J.G. and 
Bolhuis, R.LH. 1987 AT-cell receptor/CD3 complex found on cloned functional 
T lymphocytes. Nature 325:683 
Braciale, T.J., Andrew, M.E. and Braciale, V.L 1981 Simultaneous expression of H-2 restricted 
and alloreactive recognition by a cloned line of influenza virus-specific cytotoxic T 
lymphocytes. J. Exp. Med. 153:137 
Brandhuber, B.J., Boone, T., Kenney, W.C. and Mckay, D.S. 1987 Three-0imensional structure 
of interteukin-2. Science 238: 1707 
Brenner, M.B., McLean, J., Dialynas, D.P., Strominger, J.L, Smith, J.A., Owen, F.L, Seidman, 
J.G., Ip, S., Rosen, F. and Krangel, M.S. 1986 Identification of a putative second 
T-cell receptor. Nature 322: 145 
Brenner, M.8., McLean, J., Scheft, H., Riberdy, J., Ang, S.R. L, Seidman, J.G., Devlin, P. and 
Kranger, M.S. 1987 Two forms of the T-cell receptor protein found on peripheral 
blood cytotoxic T lymphocytes. Nature 325:689 . 
Bruce, J., Symington, F.W., McKearn, T.J. and Sprent, J. 1981 A monoclonal antibody 
discriminating between subsets of T and B cells. J. lmmunol. 127:2496 
Brunner, K.T., Mauel, J., Rudolf, H. and Chapuis, B. 1970 Studies of allograft immunity in mice 
I. Induction, development and in vitro assay of cellular immunity. Immunology 
18:501 
Buchmeier, M.J., Welsh,R,M., Dutko F.J. and Oldstone M.B.A. 1980 The virology and 
immunobiology of lymphocytic choriomeningitis infections. Adv. lmmunol. 30:275 
Budd, R.C., Cerottini, J-C., Horvath, C., Bron, C. , Pedrazzini, T., Howe, R.C. and MacDonald, 
158 
H.R. 1987a Distinction of virgin and memory T lymphocytes. Stable acquisiton of 
the Pgp-1 glycoprotein concomitant with antigenic stimulation. J. I mmunol. 
138:3120 
Budd, R.C., Cerottini, J-C., MacDonald, H.R. 1987b Phenotypic identification of memory 
cytolytic T lymphocytes in a subset of lyt 2+ cells. J. lmmunol 138:1009 
Buller, R.M.L, Holmes, D.L, Higin, T., Foedenction, T.N. and Morse, H.C. 1987 Induction of 
cytotoxic T-cell response in vivo in the absence of T4 helper cells. Nature 328:77 
Burakoff, S.J., Finberg, A., Glimcher, L, Lemonnier, F., Benacerraf, 8. and Cantor, H. 1978 
The biological significance of alloreactivity. The ontogeny of T cell sets specific for 
alloantigens or modified self-antigens. J. Exp. Med. 148: 1414 
Buus, S., Colon, S., Smith, C., Freed, J.H. Miles, C. and Grey, H.M. 1986 Interaction between a 
"processed" ovalbumin peptide and la molecules. Proc. Natl. Acad. Sci. 83:3968 
Byrne, J., Ahmed, R. and Oldstone, M.B.A. 1986 Biology of cloned cytotoxic T lymphocytes 
specific for lymphocytic virus. J. lmmunol. 133:433 
Cantor, H. and Boyse, E.A. 1976 Regulation of cellular and humeral immune responses by T 
cell subclasses. Cold Spr. Hbr. Symp. Quant. Biol. 41 :23 
Cautrell, D.A. and Smith, K.A. 1983 The transient expression of interleukin 2 receptors. 
Consequences for T cell growth. J. Exp. Med. 158: 1895 
Cantrell, D.A., Davies, A.A. and Crumpton, M.J. 1985 Activators of protein kinase C down-
regulate and phosporylate the T3jT-cell antigen receptor complex of human T 
lymphocytes. Proc. Natl. Acad. Sci. 82:8158 
Carnard, C., lshizaka, S.T. and Stutman, 0. 1984 Early loss of precursors of CTL and IL-2 
producing cells in the development of neonatal tolerance to alloantigens. J. 
lmmunol. 133:45 
Carp, A.I., Davidson, A.I. and Merz, P.A. 1971 A method for obtaining cerebrospinal fluid from 
mice. Res. Vet. Sci. 12:499 
Ceredig, A. and Corradin, G. 1986 High antigen concentration inhibits T cell proliferation but 
not interleukin 2 production: examination of limiting dilution microcultures and T 
cell clones. Eur. J. lmmunol. 16:30 
Ceredig, A., Dialynas, D.P., Fitch, F.W.,and MacDonald, H.R. 1983 Precursors of T cell growth 
factor producing cells in the thymus: ontogeny, frequency and quantitative 
recovery in a subpopulation of phenotypically mature thymocytes defined by 
monoclonal antibody GK1 .5. J. Exp. Med. 158: 1654 
Ceredig, R., Lowenthal, J., Nabholz, M. and MacDonald, H.R. 1985 Expression of interleukin 2 
receptors as a differentiation marker on intrathymic stem cells. Nature 314:98 
Ceredig, R., Allan, J.E., Tabi, S., Lynch, F and Doherty, P.C. 1987 Phenotypic analysis of the 
inflammatory exudate in murine lymphocytic choriomeningitis. J. Exp. Med. 
165:1539 
Cerottini, J-C., Engers, H.D., MacDonald H.R. and Brunner, K.T. 1974 Generation of cytotoxic 
T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in 
mixed lymphocyte culture. J. Exp. Med. 140:703 
Chen, L, Tourvieille, B., Burns, G.F., Bach, F.H., Mathieu -Mahul, D., Sasportes, M. and 
159 
Bensussan, A. 1986 Interferon: a cytotoxic T lymphocyte differentiation signaJ. 
Eur. J. lmmunol. 16:767 
Chieu, Y., lwashina, M., Kaplan, K.B., Elliott, J.I and Davis, M.M. 1987 A new T-cell receptor 
gene located within the alpha locus and expressed early in T-cell differentiation. 
Nature 327:6n 
Chunilla, A.M. and Braciale, V.L 1987 Lack of IL-2 - dependent proliferation despite significant 
expression of high-affinity I L-2 receptor on murine cytotoxic T Lymphocyte clones 
agter antigenic stimulation. J. lmmunol. 138:1338 
Clement, LT., Grossi, C.E. and Gartland, G.L 1984 Morphologic and phenotypic features of 
the subpopulation of Leu-2 + cells that suppresses B cell differentiation. J. 
lmmunol. 133:2461 
Cleveland, W.L and Erlanger, B.F. 1985 Hypothesis: The MHC-restricted T-cell receptor as a 
structive with two multistate allosteric combining sites. Mal. lmmunol. 21 :1037 
Cohen, A. and Schlesinger, M. 1970 Absorption of guinea pig serum with agar. 
Transplantation 1 O: 130 
Cohen, F.E. Kosen, P.A., Kuntz, 1.0., Epstein, LB., Ciardelli, T.L and Smith, K.A. 1986 
Structure-activity studies of interleukin 2. Science 234:349 
Cotner, T., Williams. J.M., Christenson, L, Shapiro, H.M., Strom, T.B. and Strominger, J. 1983 
Simultaneous flow cytometric analysis of human T cell activation antigen 
expression and DNA content. J. Exp. Med. 157:461 
Coupar, B.E.H:ftndrew, M.E., Boyle, D.S. and Blanden, R.V. 1986 Immune responses to H-
2K- antigen expressed by recombinant vaccina virus. Proc. Natl. Acad. Sci. 
83:7879 
Cresswell, P. 1985 Intracellular class II HLA antigens are accessible to transferin -
neuraminadase conjugates internalized by receptor-mediated endocytosis. Proc. 
Natl. Acad. Sci. 82:8158 
Crispe, I.N. and Bevan, M. 1987 Expression and functional significance of the Jlld marker on 
mouse thymocytes. J. lmmunol. 138:2013 
Crispe, I.N., Moore, M.W., Hussmann, LA., Smith, L, Bevan, M. and Shimonkevitz, R.P. 1987 
Differentiation potential of subtsets of CD4- 8- thymocytes. Nature 329:336 
Dailey, M.O., Gallatin, W.H. and Weissman, I.L 1985 The in vivo behaviour of T cell clones. 
Altered migration due to loss of the lymphocyte surface homing receptor. J. Mol. 
Cell. I mmunol. 2:227 
Damle, N.K., Mohagheghpour, N., Kansas, G.S. , Fishuild, D.M and Engleman, E. G. 1985 
lmmunoregulatory T cell circuits in man. ldentrfication of a distinct T cell 
subpopulation of the helper /inducer lineage that amplifies the development of 
alloantigen, specific suppressor T cells. J. I mmunol. 134:235 
Davidson, W.F. and Parish, C.R. 1975 A procedure for removing red cells and dead cells from 
lymphoid cell suspensions. J. lmmunol. Methods. 7:291 
Davignon, D., Martz, E., Reynolds, T. , Kurzinger, K., and Springer, T.A. 1981 Monoclonal 
antibody to a novel lymphocyte function- associated antigen (LFA-1 ): Mechanism 
of blockade of T lymphocyte-mediated killing and effect on other T and B 
lymphocyte functions. J. lmmunol. 127:590 
1 6 0 
De Usi, C. and Berzofsky, J.A. 1985 T-cell antigenic sites tend to be amphipathic structures. 
Proc. Natl. Acad. Sci. 82:7048 
Dembic, Z., Bannwarth, W., Taylor, B.A.,and Steinmetz, M. 1985 The gene encoding the T-cell 
receptor chain maps close to the Np-2 locus on mouse chromosone 14. Nature 
314:271 
Dembic, Z., Haas, N., Weiss, S., McCubrey, J., Kiefer, H., Von Boehmer, H. and 
Steinmetz, M 1986 Transfer of specificity by immune L and B T -cell receptor 
genes. Nature 320:232 
Dembic, L Haas, W., Lamoyska, R., Parnes, T., Steinmetz, M., Boehmer, H.von. 1987 
Transfection of the CDS gene enhances T-cell recognition. Nature 326:510 
Denizot, F., Wilson, A., Battye, F., Berke, G. and Shortman, K. 1986 Clonal expansion of T-
cells: A cytotoxic T-cell response in vivo that involves precursor cell proliferation. 
Proc. Natl. Acad. Sci. 83:6809 
Devos, R., Plaetinck G. and Fiers, W. 1984 Induction of cytolytic cells by pure recombinant 
human Interleukin 2. Eur. J. lmmunol. 14: 1057 
Dialynas, D.P., Wilde, D.S., Marrack, P., Pferres A., Wall, K.A. , Havran, W. , Otten, G. and Fitch, 
F.W. 1983 Characterization of the murine antigenic determinant, designated 
L3T 4a, recognized by monoclonal antibody GKi.5. Expression of L3T 4a by a 
functional T cell clone appears to correlate with class II MHC antigen-reactivity. 
lmmunol. Rev. 74:29 
Dixon, J.E., Allan, J.E. and Doherty, P.C. 1987 The acute inflammatory process in murine 
lymphocytic choriomeningitis is dependent on Lyt 2 + immune T cells. Cell. 
lmmunol. 107:8 
Doherty, P. C. 1973 Quantitative studies of the inflammatory process in fatal viral meningoence 
phalitis. Am. J. Pathol. 73:607 
Doherty, P. C. and Bennink, J. R. 1979 Vaccinia-specific cytotoxic T-cell responses in the 
context of H-2 antigens not encountered in thymus may reflect aberrant 
recognition of a virus-H-2 complex. J. Exp. Med. 149: 150 
Doherty, P.C. and Allan, J.E. 1986 Differential effect of hybrid resistance on targeting effector 
T cells to spleen and brain. lmmunogenetics 24:409 
Doherty, P.C. , Allan, J.E., Dixon, J.-E., Tabi, Z. and Ceredig, R. 1986 Characteristics of the CSF 
inflammatory exudate in murine lymphocytic choriomeningitis.l n proceedings of : 
Workshop on cellular and humoral components of CSF in Multiple Sclerosis. 
Henlhoef, Belgium A. Lowenthal and J. Raus eds. , Plenum press. 
Doherty, P.C., Effros, R.B. and Bennink, J. 1977a Cell mediated immunity in virus-infections: 
influenza virus and the problem of self-non-self discrimination. Perspect. Viral. 
10:73 
Doherty, P.C. , Gotze, D., Trinchieri, G. and Zinkernagel, R.M 1976 Models for recognition of 
virally modified cells by immune thymus-derived lymphocytes. lmmunogenetics 
3:517 
Doherty, P.C. , Effros, R.8. and Bennink, J. 1977b Heterogeneity of the cytotoxic response of 
thymus-derived lymphocytes after immunization with influenza vi ruses. Proc. Natl. 
Acad. Sci. 749:1209 
161 
Doherty, P.C., Korngold, R., Schwartz, D.M and Bennink, J.R. 1981 The development and loss 
of virus-specific thymus competence in bonemarrow chimeras and normal mice. 
lmmunol. Rev. 58:37 
Doherty, P.C. and Allan, J.E. 1984 Participation of cyclophosphamide resistant T cells in 
murine lymphocytic choriomeningitis. Scand. J. lmmunol. 21 :127 
Dongworth, D.W., Gotch, F.M., Hildreth, J.E.K, Morris, A., McMichael, A.J. 1985 Effects of 
monoclonal antibodies to the and B chains of the human lymphocyte function-
associated (H-LFA-1) antigen on T lymphocyte function. Eur. J. lmmunol. 15:888 
Dukovich, M., Wano, Y., Bich-Thny, LT., Katz, P., Cullen, B.R., Kehr, J.H. and Greene, W.C. 
1987 A second human interteukin-2 binding protein that may be a component of 
high-affinity interteukin-2 receptors. Nature 327:518 
Dumont, F.J., Habbersett, R.C. and Nichols, E.A.1984 A new lymphocyte surface antigen 
defined by a monoclonal antibody (9F3) to the T cell population expanding in 
MRL/Mp-lpr/lpr mice. J. lmmunol. 133:809 
Dunlop, M.B.C. and Blanden, R.V. 1976 Secondary cytotoxic cell response to lymphocytic 
choriomenigitis virus. I. Kinetics of induction in vitro and yields of effector cells. 
lmmunol. 31 :171 
Dunlop, M.B.C. and Blanden, R.V. 1977 Mechanism of expression of cytotoxic T cell 
responses in murine lymphocytic choriomenigitis virus infection. J. Exp. Med. 
145:1131 
Durum, S.K., Schmidt, J.A. and Oppenheim, J.J. 1985 lnterteukin 1: an immunological 
perspeciive. Ann. Rev. lmmunol. 3:263 
Dustin, M.L, Rothlein, R., Bhan, A.K., Dinarello, C.A. and Springer, T.A. 1976 A natural 
adherence molecule (ICAM-1 ): induction by IL-1 and interferon gamma, tissue 
distribution, biochemistry and function. J. lmmunol. 137:248 
Dutton, R.W., Penfili, P., Swain, S.L 1978 Alloreactivity, the development of the T cell 
repertoire and the understanding of T cell function. lmmunol. Rev. 42:20 
Effros, R. B., Bennink, J. and Doherty, P. C. 1978 Characteristics of secondary cytotoxic T-cell 
responses in mice infected with influenza A viurses. Cell. lmmunol. 36:345 
Emmrich, F., Strittmatter, U. and Eichmann, K. 1986 Synergism in the activation of human CDS 
differentiation antigen. Proc. Natl. Acad. Sci. 83:8298 
Ennis, F.A., Martin, W.J., Verbonitz, M.W. and Butchko, G.M. 1977 Specificity studies on 
cytotoxic thymus- derived lymphocytes reactive with influenza virus-infected cells: 
Evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc. Natl. 
Acad. Sci. 7 4:3006 
Erard, F, Nabholz, M. and MacDonald, H.R. 1985a Antigen stimulation of cytotoxic T 
lymphocyte precursors: minimal requirements for growth and acquisition of 
cytolytic activity. Eur. J. lmmunol. 15:798 
Erard, F., Corthesy, P., Nabholz, M., Lowenthal, J.W., Zaech, P., Plaetinek, G. and MacDonald, 
H.R. 1985b Interleukin 2 is both necessary and sufficient for the growth and 
differentiation of lectin stimulated cytotoxic T lymphocyte precurors. J. lmmunol. 
134:1644 
Farrar, J.J., Fuller-Farrar, J., Simon, P., Hilfiker, M.L, Stadler, B.M. and Farrar, W.L 1980a 
162 
Thymoma production of T cell growth factor (interfeukin 2). J. lmmunol. 125:2555 
Farrar, W.L, Mizel, S.S. and Farrar, J.J. 1980b Participation of lymphocyte activating factor 
(interfeukin 1) in the induction of cytotoxic T cell responses. J. lmmunol. 124: 1371 
Farrar, J.J., Beupamin, W.R., Hilfiker, M.L, Howard, M., Farrar, W.L and Fuller-Farrar, J. 1982 
The biochemistry, biology and role of interf eukin 2 in the induction of cytotoxic T 
cell and antibody-forming B cell responses. lmmunol. Rev. 63:129 
Fazekas de St. Groth, B., Gallagher, P. and Miller, J.F.A.P. 1986 Involvement of Lyt-2 and L3T4 
in activation of hapten-specific Lyt-2+ L3T4+ T-cell clones. Proc. Natl. Acad. Sci. 
83:2594 
Fichtner, A.T., Anderson, S., Mage, M.G., Sharrow, S.0., Thomas Ill, C.A. and Kung, J.T. 1987 
Subpopulations of mouse Lyt2+ T cells defined by the expression of an Ly-6-
linked antigen, 8482. J. lmmunol. 138:2024 
Fitch, F.W., Engers, H.D., Cerottini, J-C. and Brunner, K.T. 1986 Generation of cytotoxic T 
lymphocytes in vitro VII. Suppressive effect of irradiated MLC cells on CTL 
response. J. lmmunol. 116:716 
Fink, P.J., and Bevan, M.J. 1978 H-2 antigens of the thymus determine lymphocyte specificity. 
J. Exp. Med. 148:766 
Fink, P.J., Weissman, I.Land Bevan, M.J. 1983 Haplotype-specific suppression of cytotoxic T 
cell induction by antigen inappropriately presented on T cells. J. Exp. Med. 
157:141 
Fox, D.A., Hussey, R.E., Fitzgerald, K.A., Acuto, 0., Poole, C., Palley, L, Daley, J.F., 
Schlossman, S.F. and Reinherz, E.L 1984 Ta1, a novel 105 kd human T c911 
activation antigen defined by a monoclonal antibody. J. I mmunol. 134: 1250 
Fox, D.A., Hussey, R.E., Fitzgerald, K.A., Bensussan, A., Daley, J.F., Schlossman, S.F. and 
Reinherz, E.L 1985 Activation of human thymocytes via the 50 kd TII sheep 
erythrocyte binding protein induces the expression of interleukin 2 receptors on 
both T3+ and T3- populations. J. lmmunol. 134:330 
Gabert, J., Langlet, C., Zamoyska, R., Parnes, J.R., Schmitt-Verhulst, A-M., Malissen, B. 1987 
Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-
2 genes. Cell 50:545 
Gallatin, W.M., Weissman, I.Land Butcher, E.C. 1983 A cell-surface molecule involved in 
organ-specific homing of lymphocytes. Nature 304:30 
Gardner, I.D. and Blanden R.V. 1976 The cell-mediated immune response to ectromelia virus 
infection II. Secondary response in vitro and kinetics of memory T cell production 
in vivo. Cell. I mmunol. 22:283 
Gately, M.K. and Martz, E. 1977 Comparative studies on the mechanisms of non specific Con 
A-dependent cytolysis and specific T cell-mediated cytolysis. J. lmmunol. 
119:1711 
Gay, D., Maddon, P., Sekaly, R., Talle, M.A., Godfrey, M., Long, E., Goldstein, G., Chess, L, 
Axel, R., Kappler, J. and Marrack, P. 1987 Functional interaction between human 
T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. 
Nature 328:626 
Germain, R.N. 1986 The ins and outs of antigen processing and presentation. Nature 322:687 
163 
Gillis, S., Ferm. M.M., Ou, W. and Smith, K.A. 1978 T cell growth factor: parameters of 
production and a quantitative microassay for activity. J. I mmunol. 120:2027 
Glasebrook, A.L, Kelso, A. and MacDonald, H.R. 1983 Cytolytic T lymphocyte clones that 
proliferate autonomously to specific alloantigen stimulation. II. Relationship of the 
Lyt-2 molecular complex to cytolytic activity, proliferation, and lymphokine 
secretion. J. lmmunol. 130:1545 
Goding, J. and Walker, I.D. 1980 Allelic forms of 82-microglobulin in the mouse. Proc. Natl. 
Acad. Sci. n:7395 
Goldstein, J.L, Brown, M.S., Anderson, R.W., Russell, D.W. and Schneider, W.J.A. 1985 
Receptor-mediated endocytosis: concepts emerging from the LDL receptor 
system. Rev. Cell. Biol. 1: 1 
Goodman, LS. and Gilman, A.G. 1975 The Pharmacological Basis of Therapeutics eds: 
Gilman, A.G., Goodman, LS., Rall, LS. and Murad, F. 7th Edn, 55:1255 
Macmillan, New York 
Gorczynski, R.M. and MacRae, S. 1979 Suppression of cytotoxic response to 
histoincompatible cells. 1. Evidence for two types of T lymphocyte-derived 
suppressors acting at different stages in the induction of a cytotoxic response. J. 
lmmunol. 122:737 
Gorman, S.D.,Tourvielle, B. and Parnes, J.R. 1987 Structure of the mouse gene encoding CD4 
and an unusuaJ transcript in brain. Proc. Natl. Acad. Sci. 84:7644 
Green, W.R., Ballas, Z.K. and Henney, C.S. 1987 Studies on the mechanism of lymphocyte-
mediated cytolysis. XI. the role of lectin in lectin-dependent cell-mediated 
cytotoxicity. J. lmmunol. 121 :1566 
Greenberg, M.E. and Ziff, E.8. 1984 Stimulation of 3T3 cells induces transcription of the c-fos 
protooncogene. Nature 311 : 433 
Greenstein, J.L and Burakoff, S.J. 1987 The role of L..3T4 (CD4) in T cell activation. Ann. Inst. 
Past. 138: 134 
Greenstein, J.L, Kappler, J., Marrack, P. and Burakoff, S.J. 1984 The role of l..3T4 in 
recognition of la by a cytotoxic, H-2Dd-specific T cell hybridoma. J. Exp. Med. 
159:1213 
Greenstein, J.L, Malissen, B. and Burakoff, S.J. 1985 Role of l..3T4 in antigen-driven activation 
of a class I-specific T-cell hybridoma. J. Exp. Med. 162:369 
Grimm, E.A., Robb, R.J., Roth, J.A., Neckers, LM., Lachman, LB., Wilson, D.J. and 
Rosenberg, S.A. 1983 Lymphokine activated killer cell phenomenon. Ill. Evidence 
that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into 
lymphokine-activated killer cells. J. Exp. Med. 158:1356 
Gromo, G., lnverardi, L, Geller, R.L, Alter, B.J. ,and Bach, F.M. 1987 The stepwise activation of 
cytotoxic T lymphocytes. lmmunol. Today. 8:259 
Grossi, C.E. Zicca, A., Cadoni, A. , Mingari, M.C., Moretta, A. and Moretta, L 1983 
Ultrastructural characteristics of human T cell clones with various cytlytic 
activities. Eur. J. lmmunol. 13:670 
Guimezanes, A. and Schmitt-Verhulst, A-M. 1985 Inhibition of helper function with anti-Lyt-2 or 
anti-L..3T 4 monoclonal antibodies depending on stimulating antigens. Eur. J. 
164 
lmmunol. 15:1187 
Gull berg, M. and Smith, KA. 1986 Regulation of T cell autocrine growth: T 4 + cells become 
refactory to interleukin 2. J. Exp. Med. 163:270 
Gunter, K.C., Malek, T.R. and Shevach, E.M. 1984 T cell-activating properties of an anti-Thy-1 
monoclonal antibody. Possible analogy to OKT3/Leu-4. J. Exp. Med. 159:716 
Gunter, K.C., Germain, R.N., Kroczek, A.A., Saito, T., Yokoyama, W.M., Chan, C., Weiss, A. and 
Shevach, E.M. 1987 Thy-1 mediated T-cell activation requires co-expression of 
CD3/Ti complex. Nature 326:505 
Haars, R., Kronenberg, M., Gallatin, W.M., Weissman, I.L Owen, F.L and Hood, L 1985 
Rearrangement and expression of T-cell antigen receptor and gamma genes 
during thymic development. J. Exp. Med. 164:1 
Habu, S., Okumura, K., Diamanstein, T., Shevach, E.M. 1985 Expression of interleukin 2 
receptor on murine fetal thymocytes. Eur. J. lmmunol. 15:456 
Hatler, D.A., Fox, D.A., Benjamin, D. and Weiner, H.L 1986 Antigen reactive memory T cells 
are defined by Ta. J. lmmunol. 137:414 
Hapel, A., Bablaman, R. and Cole, G.A. 1978 Inductive requirements for the generation of virus 
specific T lymphocytes. I. Nature of the host cell-virus interaction that triggers 
secondary post virus-specific cytotoxic T lymphocyte induction. J. lmmunol. 
121 :1820 
Hardt, C., Diamanstein, T. and Wagner, H. 1985 Signal requirements for the in vitro 
differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators 
promote preactivation of CTL-precursors, clonal growth and differentiation into 
cytotoxic effector cells. Eur. J. lmmunol. 15:472 
Haskins, K., Kubo, R., White, J., Pigeon, M., Kappler, J. and Marrack, P. 1983 The major 
histocompatibility complex-restricted antigen receptor on T cells. I Location with a 
monoclonal antibody. J. Exp. Med. 157: 1149 
Havran, W.L, Lancki, D.W., Moldwin, R.L, Dialynas, D.P. and Fitch, F.W. 1988 
Characterization of an anti-Ly-6 monoclonal antibody which defines and activates 
cytotoxic T lymphocytes. J. lmmunol. 140:1034 
Haynes, A.O. 1981 Human T lymphocyte antigens as defined by monoclonal antibodies. 
lmmunol. Rev. 57:127 
Haynes, B.F., Hemler, M.E., Mann, D.L, Eisenbarth, G.S., Shelhamer, J., Mostowski, H.S., 
Thomas, C.A., Strominger, J.L and Fauci, A.S. 1981 Characterization of a 
monoclonal antibody (4F2) that binds to human monocytes and to a subset of 
activated lymphocytes. J. I mmunol. 126: 1409 
Hayry, P. and Defendi, V. 1970 Mixed lymphocyte cultures produce effector cells: model in 
vitro for allograft rejection. Science 168:133 
Heeg, K. and Wagner, H. 1985 Analysis of immunological tolerance to major histocompatibility 
complex antigens. I. High frequencies of tolerogen-specific cytotoxic T 
lymphocyte percursors in mice neonatally tolerized to class I major 
histocompatibility complex antigens. Eur. J. lmmunol. 15:25 
Heeg, K., Steeg, C., Hardt, C. and Wagner, H. 1987 Identification of interleukin-2 producing T 
helper cells within murine Lyt2 + T lymphocytes: frequency, specificity and clonal 
165 
segregation from Lyt 2 + precursors of cytotoxic T lymphocytes. Eur. J. lmmunol. 
17:229 
Hefeneider, S.H., Conlon, J., Henney, C.S. and Gillis, S. 1983 In vivo IL-2 administration 
augments the generation of aHoreactive cytolytic T-lymphocytes and resident 
natural killer cells. J. lmmunol. 130:222 
Heitzmann, H. and Richards, F.M. 1974 Use of the avidin-biotin complex for specific staining of 
biological membranes in electron microscopy. Proc. Natl. Acad. Sci. 71 :3537 
Hemminki, K. 1985 Binding of metabolites of cyclophosphamide to DNA in a rat liver 
microsomal system and in vivo in mice. Cancer Res. 45:4237 
Henkart, P.A. 1985 Mechanism of lymphocyte-mediated cytotoxicity. Ann. Rev. lmmunol. 3:31 
Ho, M. 1980 Role of specific cytotoxic lymphocytes in cellular immunity against murine 
cytomegalovirus. Infect. lmmunol. 27:767 
Hollander, N., Pillemer, E., Weissman, I.L 1981 Effects of Lyt antibodies on T-cell functions: 
Augmentation by anti-Lyt-1 as opposed to inhibition by anti-Lyt-2. Proc. Natl. 
Acad. Sci. 78: 1148 
Hood, L, Steinmetz, M., Malissen, 8. 1983 Genes of the major histocompatibility complex of 
the mouse. Ann. Rev. lmmunol. 1 :529 
Hokin, LE. 1985 Receptors and phosphoinositole-generated second messengers. Ann. Rev. 
8iochem. 54:205 
Howard, M., Farrar, J., Hilfiker, M., Johnson, 8., Takatsu, K., Hamaoka, T. and Paul, W.E. 1982 
Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. 
Exp. Med. 155:914 
Hoxie, J.A., Mathews, D.M., Callahan, K.J., Cassel, D.L and Cooper, R.A. 1986 Transient 
modulation and internalization of T 4 antigen induced by phorbol esters. J. 
I mmunol. 137: 1194 
Hurme, M., Sihvola, M. and Bang, B. 1982 During lymphatic regeneration precursors for major 
histocompatibility complex-restricted cytotoxic T cells appear before alloreactive 
precursors. J. Exp. Med. 155:327 
Hynes, R.O. 1987 lntegrins: a family of cell surface receptors. Cell 48:549 
Ihle, J.N., Keller, J., Oroszlan, S., Henderson, LE., Copeland, T.D., Fitch, F., Prystowsky, M.B., 
Goldwasser, E., Schrader, J.W., Palaszynski, E., Dy, M., and Lebel, B. 1983 
Biologic properties of homogeneous interleukin 3. I Demonstration of WEHl-3 
growth factor activity, mast cell growth facer activity P-cell stimulating factor 
activity, colony-stimulating factor activity, and histamine producing cell-
stimulating factor activity. J. lmmunol. 131 :282 
Imboden, J.B. and Stobo, J.D. 1985 Transmembrane signalling by the T cell antigen receptor. 
Perturbation of the T3-antigen receptor complex generates inositol phosphates 
and releases calcium ions from intracellular stores. J. Exp. Med. 161 :446 
lsakov, N. and Altman, A. 1985 Tumor promoters in conjunction with calcium ionophores 
mimic antigenic stimulation by reactivation of alloantigen-primed immune T 
lymphocytes. J. lmmunol. 135:3674 
Jacobson, K., O'Dell, D., Holifield, B., Murphy, T.L and August, J.T. 1984a Redistribution of a 
166 
major cell surface glycoprotein during cell movement. J. Cell. Biol. 99:1613 
Jacobson, K., O'Dell, D., August, J.T. 1984b Lateral diffusion of an 80 000 dalton glycoprotein 
in the plasma membrane of murine fibroblasts: relationships to cell structure and 
function. J. Cell. Biol. 99: 1624 
Janossy, T., Vegh, P., Ta'bith, K., Erdos,E. and Petri, G. 1983 Suppressor cells in mouse 
allograft tolerance. Transplant. Proc. 15:859 
Jenkinson, E.J., Van Ewijk, W. and Owen, J.J.T. 1981 Major histocompatibility complex 
antigen expression on the epithef ium of the developing thymus in normal and 
nude mice. J. Exp. Med. 153:280 
Jerne, N.K. 1971 The somatic generation of immune recognition. Eur. J. lmmunol. 1 :1 
Jones, B. 1983 Evidence that the Thy-1 molecule is the target for T cell mitogenic antibody 
against brain-associated antigens. Eur. J. lmmunol. 13:678 
Julius, M.H., Simpson, E. and Herzenberg, LA. 1973 A rapid method for the isolation of 
functional thymus-derived immune lymphocytes. Eur. J. lmmunol. 3:645 
Kanagawa, 0. 1983 Three different signals are required for the induction of cytolytic T 
lymphocytes from resting precursors. J. lmmunol. 131 :606 
Kanagawa, 0 . and Nagasawa, R. 1987 Dissociation of alloantigen recognition from self major 
histocompatibility complex-restricted recognition of cytolytic T lymphocytes by 
monoclonal anti-receptor antibodies. J. lmmunol. 139:3991 
Kappler, J.W., Skidmore, 8., White, J., Marrack, P. 1981 Antigen-inducible, H-2 restricted 
interf eukin-2 producing T cell hybridomas. Lack of independent antigen and H-2 
recognition. J. Exp. Med. 153:1198 
Kappler, J.W., Kubo, R., Haskins, K., Hannum, C., Marrack, P., Pigeon, M., McIntyre, B., 
Allison, J. and Trowbridge, I. 1983 The major histocompatibility complex-
restricted antigen-receptor on T cells in mouse and man. V Identification of 
constant and variable peptides. Cell. 35:295 
Kaye, J. and, Janeway, C.A. 1984 The alpha and beta subunits of murine T cell antigen/ la 
receptor have a molecular weight of 31000 in the absence of N-linked 
glycosylation J. lmmunol. 133:2291 
Kelso, A. and Glasebrook, A.L 1984 Secretion of interleukin 2, macrophage-activating factor, 
interferon, and colony-stimulating factor by alloreactive T lymphocyte clones. J. 
lmmunol. 132:2924 
Kelso, A., Glasebrook, A.L, Kanegawa, 0. and Brunner, K.T. 1982 Production of macrophage 
activating factor by T lymphocyte clones and correlation with other lymphokine 
activities. J I mmunol. 129:550 
Kimura, S. , Tada, N., Nakayama, E. and Hammerling, U. 1980 Studies of the mouse Ly-6 
alloantigen system. I serological characterization of mouse L y-6 alloantigen by 
monoclonal antibodies. lmmunogenetics 11 :373 
Kimura, S., Tada, N., Liu-Lam, Y. and Hammerfing, U. 1984 Studies of the mouse Ly-6 
alloantigen system. II complexities of the Ly-6 region. lmmunogenetics 20:47 
King, D.P. and Jones, P.P. 1983 Induction of la and H-2 antigens on a macrophage cell line by 
immune interferon. J. lmmunol. 131 :315 
167 
Klaus, G.G.B., Humphrey, J.H., Kunk1, A. and Dongworth, D.W. 1980 The follicular dendritic 
cell: its role in antigen presentation in the generation of immunological memory. 
lmmunol. Rev. 53:3 
Klein, J. 1981 The histocompatibility-2 (H-2) complex. In: The mouse in biomedical research. 
Eds. Foster, H.L, Small, J.D. and Fox, J.G. Academic Press. Vol 1 p119 
Klein, J.R. and Bevan, M.J. 1983 Secretion of immune interferon and generation of cytotlytic T 
cell activity in nude mice are dependent on interleukin 2: age associated 
endogenous production of interleukin 2 in nude mice. J. lmmunol. 130: 1780 
Klein, J.R., Raulet, D.H. Pasternack, M.S. and Bevan M.J. 1982 Cytotoxic T lymphocytes 
produce immune interferon in response to antigen or mitogen. J. Exp. Med. 
155:1198 
Koenig S., Gendelman, H.E., Orenstein, J.M., Dal Canto, M.C., Pezeshkpour, G.H., Yungbluth, 
M., Janetta, F., Aksamit, A., Martin, M.A. and Fauci, AS. 1986 Detection of AIDS 
virus in macrophages in brain tfssue from AIDS patients with encephalopathy. 
Science 233: 1089 
Koizumi, T., Nakao, Y.,Matsui, T., Katakamin, Y., Nakagawa, T. and Fujita, T. 1986 Synergistic 
induction by calcium ionophore and phorbol ester of interteukin-2 (11-2) receptor 
expression, IL-2 production, and proliferation in autoimmune MRL/Mp-Lpr mice. 
Immunology 59:43 
Konaka, Y., Norcross; M.A., Maino, V.C. and Smith, R.T. 1981 Anti-Thy-I-mediated T cell 
activation. Role of soluble factors and expression of interleukin 2 receptors on T 
cells. Eur. J. lmmunol. 11 :445 
Koretzky, G.A., Daniele, R.P., Greene, W.C. and Nowell, P.C. 1983 Evidence for an interleukin-
independent pathway for human lymphocyte activation. Proc. Nat. Acad. Sci. 
80:3444 
Kourilsky, P., Chaouat, G., Rabourdin-Combe, C. and Claverie, J-M. 1987 Working principles in 
the immune-system implied by the "peptidic self1 model. Proc. Natl. Acad. Sci. 
84:3400 
Kraft, A.S. and Anderson, W.B. 1983 Phorbol-esters increase the amount of Ca2 +, 
phospholipid-dependent protein kinase associated with plasma membrane. 
Nature 301 :621 
Krangel , M.S., Bierer, B.E., Devlin, P., Clabby, M., Strominger, J.L, McLean, J. and Brenner, 
M.B. 1987 T3 glycoprotein is functional although structurally distinct on human T-
cell receptor T lymphocytes. Proc. Natl. Acad. Sci. 84:3817 
Kranz, D.M., Saito, H., Disteche, C.M., Swisshelm, K.,Pravtcheva, D., Ruddle, F.H., Eisen, H.N., 
Tonegawa, S. 1985 Chromosomal locations of the murine T-cell receptor alpha-
chain gene and the T-cell gamma gene. Science 227:941 
Krensky, AM, Sanchez-Madrid, F., Robbins, E. , Nagy, AJ., Springer, T.A. and Burakoff, S.J. 
1983 The functional significance, distribution and structure of LFA-1 , LFA-2, and 
LFA-3: cell surface antigens associated with CTL-target interactions. J. lmmunol. 
131:611 
Krensky, AM., Robbins, E., Springer, T.A and Burakoff, S.J. 1984 LFA-1 , LFA-2 and LFA-3 
antigens are involved in CTL-target conjugation. J. lmmunol. 132:2180 
Krensky, AM., Sanchez-Madrid F., Robbins, E. , Nagy, J.A., Springer, T.A and Burakoff, S.J. 
168 
1986 The functional significance, distribution, and structure of LFA-1 , LFA-2 and 
LFA-3: cell surface antigens associated with CTL-target interactions. J. lmmunol. 
131:611 
Kroczek, R.A., Gunter, K.C., Germain, R.N. and Shevach, E.M. 1986. Thy-1 functions as a 
signal transduction molecule in T lymphocytes and transfected B lymphocytes. 
Nature, 322;181 
Kronenberg, M., Siu, G., Hood, LE. and Shastri, N. 1986 The molecular genetics of the T-cell 
antigen receptor and T-cell antigen recognition. Ann. Rev. lmmunol. 4:529 
Kronke, M, Leonard, W.J., Depper, J.M. and Greene, W.C. 1985 Sequential expression of 
genes involved in human T lymphocyte growth and differentiation. J. Exp. Med. 
162:1593 
Kruisbeek, A.M. and Longo, D.L 1985 Acquisition of MHC-restriction specificities: role of 
thymic stromal cells. Surv. lmmunol. Res. 4:110 
Kruisbeek, A.M., Sharrow, S.O., Mathieson, B.J. and Singer, A. 1981 The H-2 phenotype of the 
thymus dictates the self-specificity expressed by thymic but not splenic cytotoxic 
T lymphocyte precursors in thymus-engrafted mice. J. lmmunol. 127:2168 
Kruisbeek, A.M., Sharrow, S.O and Singer, A. 1983 Differences in the MHC-restricted self-
recognition repertoire of intra-thymic and extra-thymic cytotoxic T lymphocyte 
precursors. J. lmmunol. 130: 1027 
Kumagai, N., Benedict, S.H., Mills, G.B. and Gelfand, E.W. 1987 Requirements for the 
simultaneous presence of phorbol esters and calcium ionophores in the 
expression of human T lymphocyte proliferation-related genes. J. lmmunol. 
139:1393 
Kumar, A., Moreau, J-L, Gibert, M. and Theze, J. 1987 Internalization of Interleukin 2 (IL-2) by 
high affinity IL-2 receptors is required for the growth of IL-2 dependent T cell lines. 
J. lmmunol. 139:3680 
Kurzinger, K., Reynolds, T., Germain, R.N., Davignon, D., Martz, E. and Springer, T.A. 1981 A 
novel lymphocyte function-associated antigen (LFA-1 ): Cellular distribution, 
quantitative expression, and structure. J. I mmunol. 127:596 
Lalande, M.E.,.McCutcheon, M.J. and Miller, R.G. 1980 Quantitative studies on the precursors 
of cytotoxic lymphocytes VI. Second signal requirements of specifically activated 
precursors isolated 12h after stimulation. J. Exp. Med. 151: 12 
Lamb, J.R., Skidmore, B.J. , Green ,N., Chiller, J.M. and Feldmann, M. 1983 Induction of 
tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides 
of influenza hemagglutinin. J. Exp. Med. 157: 1434 
Lancki, D.W., Lorber, M.I., Loken, M.R., Fitch, F.W. 1983 A clone-specific antibody that inhibits 
cytolysis of a cytotoxic T-cell clone. J. Exp. Med. 157:921 
Lanier, LL, Ruitenberg, J.J., Allison, J.P. and Weiss, A. 1986 Distinct epitopes on the T cell 
antigen receptor of MPB-ALL tumor cells identified by monoclonal antibodies. J. 
I mmunol. 137:2286 
Lanzavecchia, A. 1986 Is the T-cell receptor involved in T-cell killing? Nature 319:778 
Larsson, E.L, lscove, N.N. and Coutinho, A. 1980 Two distinct factors are required for 
induction of T-cell growth. Nature 283:664 
169 
Lathe, R., Kieny, M.P., Gerlinger, P., Clertant, P., Guizani, I., Cuzin, F., and Chambon, P. 1987 
Tumour prevention and rejection with recombinant vaccinia. Nature 326:878 
Ledbetter, J.A. and Herzenberg, LA. 1973 A rapid method for the isolation of functional 
thymus-derived murine T lymphoctes. Eur. J. lmmunol. 3:645 
Ledbetter, J.A., Evans, R.L, Lipinsky, M.,Cunningham-Rundles, C., Good, R.A. and 
Herzenberg, LA. 1981 Evolutionary conservation of surface molecules that 
distinguish lymphocyte helper /inducer and cytotoxic/suppressor subpopulations 
in mouse and man. J. Exp. Med. 153:310 
Ledbetter, J.A., June, C.H.,Martin, P.J., Spooner, C.E., Hansen ,J.A. and Meier, K.E. 1986 
Valency of CD3 binding and internalization of the CD3 cell-surface complex 
control T cell responses to second signals: distinction between effects on protein 
kinase C, cytoplasmic free calcium and proliferation. J. lmmunol. 136:3945 
Lee, N.E., D'Eustachio, P., Prabtcheva, D., Ruddle, F., Hedrick, S.M. and Davis, M.M. 1984 
Murine T cell receptor B chain is encoded on chromosome 6. J. Exp. Med. 
160:905 
Lefrancois, L, Klein, J.R., Peatkan, V. and Bevan, M.J. 1984 Antigen-independent activation of 
memory cytoxic T cells by interleukin 2. J. lmmunol. 132:1845 
Lehmann-Grube, F. 1983 Lymphocytic chriomeningitis virus. In: The mouse in biomedical 
research Vol.II. Ed. Foster, H.L, Small, J.D. and Fox, J.G. Academic Press, New 
York p231 
Leo, 0., Foo, M., Sachs, D.H., Samelson, LE. and Bluestone, J.A. 1987 Identification of a 
monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. 
84:1374 
Lesley, J. and Trowbridge, I.S. 1982 Genetic characterization of a polymorphic murine cell-
surface glycoprotein. lmmunogenetics 15:313 
Lesley, J., Trotter, J. and Hyman, R. 1985a The Pgp-1 antigen is expressed on early fetal 
thymocytes I mmunogenetics 22: 149 
Lesley, J., Hyman, R. and Schulte, R. 1985b Evidence that the Pgp-1 glycoprotein is expressed 
on thymus homing progenitor cells of the thymus. Cell. lmmunol. 91 :397 
Lew, A.M., Pardall, D.M., Maloy, W.L, Fowlkes, B.J., Kruisbeek, A., Cheng, S.-F., Germain, 
R.N., Bluestone, J.A., Schwartz, R.H. and Coligan, J.E. 1986 Characterization of T 
cell receptor gamma chain expression in a subset of murine thymocytes. Science 
234:1401 
Lichtmann, A.H., Kurt-Jones, E.A. and Abbas, A.K. 1987 B-cell stimulatory factor 1 and not 
interleukin 2 is the autocrine growth factor for some helper T lymphocytes. Proc. 
Natl. Acad. Sci. 84:824 
Littman, D.R. and Gettner, S.N. 1987 Unusual intron in the immunoglobulin domain of the 
newly isolated murine CD4 (L3T4) gene. Nature 325:453 
Lotze, M.T., Grimm, E.A., Mazumder, A., Strausser, J.L, Rosenberg, S.A. 1981 In vitro growth 
of cytotoxic human lymphocytes. IV. Lysis of fresh and cultured autologous 
tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res. 
41 :4420 
Loveland, B., Hunt, R. and Malkovsky, M. 1986 Autologous lymphoid cells exposed to 
170 
recombinant interleukin-2 in vitro in the absence of antigen can induce the 
rejection of long-term tolerated skin grafts. lmmunol. 59:159 
Low, M.G. and Kincade, P.W. 1985 Phosphatidyiinositol is the membrane-anchoring domain of 
the Thy-1 glycoprotein. Nature 318:62 
Lowenthal, J.W., Howe, R.C., Ceredig, A. and MacDonald, H.R. 1986 Functional status of 
interleukin 2 receptors expressed by immature (Lyt-2- L3T4l thymoctyes. J. 
lmmunol. 137:2579 
Lynch, F. and Ceredig, A. 1988 Ly-24 (Pgp-1) expression by thymocytes and peripheral T 
cells. lmmunol. Today 9:7 
Lynch, F., Chaudri, G., Allan, J.E., Doherty, P.C. and Ceredig, A. 1987 Expression of Pgp-1 (or 
Ly24) by subpopulations of mouse thymocytes and activated peripheral T 
lymphocytes. Eur. J. I mmunol. 17: 137 
MacDonald, H.R. 1982 Differentiation of cytolytic T lymphocytes. lmmunol. Today 3:183 
MacDonald, H.R. and Lees, R.K. 1980 Dissociation of differentiation and proliferation in the 
primary induction of cytolytic T lymphocytes by alloantigens. J. lmmunol. 
124:1308 
MacDonald, H.R. and Erard, F. 1986 Activation requirements for resting T lymphocytes. In 
Curr. Top. Micro. lmmunol. 126:187 
MacDonald, H.R., Sordat, B., Cerottini, J-C. and Brunner, K.T. 1975 Generation of cytotoxic T 
lymphocytes in vitro. IV. Functional activation of memory cells in the absence of 
DNA synthesis. J. Exp. Med. 142:622 
MacDonald, H.R., Cerottini, J-C., Ryser, J-E., Maryanski, J.L, Taswell, C., Widmer, M.B. and 
Brunner, K.T. 1980 Quantitation and cloning of cytolytic T lymphocytes and their 
precursors. lmmunol. Rev. 51 :93 
MacDonald, H.R., Thiernesse, N. and Cerottini. J-C. 1981 inhibition of T cell-mediated cytolysis 
~y monoclonal antibodies directed against Lyt-2: heterogeneity of Inhibition at the 
clonal level. J. lmmunol. 126:1671 
MacDonald, H.R., Glasebrook, A.L, Bron, C., Kelso, A. and Cerottini, J.C. 1982 Clonal 
heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T 
lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors. 
lmmunol. Rev. 68:89 
Machy, P., Truneh, A., Gennaro, D. and Hoffstein, S. 1987 Major histocompatibility complex 
class I molecules internalized via coated pits in T lymphocytes. Nature 328:724 
Mackett, M., Yilma, T., Rose, J.K. and Moss, B. 1985 Vaccinia virus recombinants: Expression 
of VSV genes and protective immunization of mice and cattle. Science 277:433 
Maddon, P.J., Molineaux, S.M., Maddon, D.E., Zimmerman, K.A., Godfrey, M., Alt, F.W. , Chess, 
L and Axel, A. 1987 Structure and expression of the human and mouse T 4 genes. 
Proc. Natl. Acad. Sci. 84:9155 
Malek, T.R. and Ashwell , J.D. 1985 Interleukin 2 upregulates expression of its receptor on a T 
cell clone. J. Exp. Med. 161 :1575 
Malek, T.R., Ortega, G., Chan, C., Kroczek, A.A. and Shevach. E.M. 1986 Role of Ly-6 in 
lymphocyte activation II. Induction of T cell activation by monoclonal anti-ly-6-
171 
antibodies J. Exp. Med. 164:709 
Malissen, B., Rebai, N., Uabeuf, A. and Mawas, C. 1982 Human cytotoxic T cell structures 
associated with expression of cytolysis. I. Analysis at the clonal level of the 
cytolysis-inhibiting effect of 7 monoclonal antibodies. Eur. J. lmmunol. 12:739 
Mandel, T.E., Phipps, R.P., Abbot, A. and Tew, J.G. 1980 The follicular dendritic cell: long term 
antigen retention during immunity. lmmunol. Rev. 53:29 
Manger, B., Weiss, A., Imboden, J., Laing, T. and Stobo, J.D. 1987 The role of protein kinase C 
in transmembrane signaling by the T cell antigen receptor complex. J. lmmunol. 
139:2755 
Marion, P.L and Robinson, W.S. 1983 Hepadna viruses: hepatitis Band related viruses. Curr. 
Top. Micro. lmmunof. 105:99 
Maryanski, J.L, Pala, P., Corradin, G., Jordan, B.R. and Cerottini, J-C. 1986 H-2-restricted 
cytotolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature 
324:578 
Marrack, P., Endres, R., Schimonkevitz, R., Zlontnik, A., Dialynas, D., Fitch. and Kappler, J. 
1983 The major histocompatibility complex-restricted antigen receptor on T cells. 
II. Role of the L3T4 product. J. Exp. Med. 158:1077 
Masson, D., Zamai, M. and Tschopp, J. 1986 Identification of granzyme A isolated from 
cytotoxic T-lymphocyte-granules as one of the proteases encoded by CTL-
specific genes. FESS 208:84 
Mathieson, B.J. and Fowlkes, B.J. 1984 Cell surface antigen expression on thymocytes: 
development and phenotypic differentiation of intrathymic subsets. lmmunol. Rev. 
82:141 
Matis, LA., Glimcher, LH., Paul, W.E. and Schwartz, R.H. 1983 Magnitude of response of 
histocompatibility-restricted T-cell clones is a function of the product of the 
concentrations of antigen and la molecules. Proc. Natl. Acad. Sci. 80:6019 
Matzinger, P. 1981 A one-receptor view of T-cell behaviour Nature 292:497 
Mentzer, S.J., Barbosa, J.A. and Burakoff, S.J. 1985 T3 monoclonal antibody activation of 
nonspecific cytolysis: a mechanism of CTL inhibition. J. I mmunol. 135:34 
Mentzer, S.J., Smith, B.R., Barbosa, J.A., Crimmins, M.A., Herrmann, S.H. and Burakoff, S.J. 
1987 CTL adhesion and antigen recognition are discrete steps in the human CTL-
target cell interaction. J. lmmunol. 138:1325 
Merigan, T.C. 1981 Virology and immune mechanisms. Cancer, 47:1091 
Merluzzi, V.J., Smith, M.D. and Last-Barney, K 1986 Similarities and distinctions between 
murine natural killer cells and lymphokine-activated killer cells. Cell. I mmunol. 
100:563 
Merluzzi, V.J., Welte,K., Savage,D.M., Last-Barney, K. and Mertelsmann. R. 1983 Expansion of 
cyclophosphamide-resistant cytotoxic precursors in vitro and in vivo by purified 
human interleukin-2. J. lmmunol. 131 :806 
Merluzzi, V.J., Welte, K., Mertelsmann, R.H., Souza, L, Boone, T. and Last-Barney, K. 1984 
Rescue of anti-influenza A virus cytotoxic T lymphocyte responses in 
chemotherapy-suppressed mice. J. Viral. , 51 :20 
172 
Meuer, S.C., Fitzgerald, K.A., Hussey, R.E., Hodgdon, J.C., Schlossmann, S.F. and Reinherz, 
E.L 1983 clonotypic structures involved in antigen-specific human T-cell function. 
Relationship to the T3 molecular complex. J. Exp. Med. 157:705 
Meuer, S.C., Schlossman, S.F. and Reinherz, E.L 1982b Clonal analysis of human cytotoxic T 
lymphocytes T4+ and T8+ effector T cells recognize products of different major 
histocompatibility complex region Proc. Natl. Acad. Sci. 79:4395 
Meuer, S.C., Hussey, R.E., Hodgdon, J.C., Hercend, T., Schlossman, S.F. and Reinherz, E.L 
1982a Surface structures involved in target recognition by human cytotoxic T 
lymphocytes. Science 218:471 
Meuer, S.C., Hussey, R.E., Cantrell, D.A., Hodgdon, J.C., Schlossman, S.F., Smith , K.A. and 
Reinherz, E.L 1984 Triggering of the T3-Ti antigen-receptor complex results in 
clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. 
Proc. Natl. Acad. Sci. 81: 1509 
Michell, B. 1983 Ca2 + and protein kinase C: two synergistic cellular signals. Trends Biochem. 
Sci. 8:263 
Miller, A.A. 1986 Immunodeficiency of ageing: restorative effects of phorbol ester combined 
with calcium ionophore. J. lmmunol. 137:805 
Mills, G.B., Cheung, R.K., Grinstein, S. and Gelfand, E.W. 1985 Increase in cytosolic free 
calcium concentration is an intracellular messenger for the production of 
interleukin 2 but not for expression of the interleukin 2 receptor. J. lmmunol. 
134:1640 
Mitchison, N.A. and Petterson, S. 1983 Does clonal selection occur among T cells? Ann. 
lmmunol. (Inst. Pasteur) 1340:37 
Mlzuochi, T., Golding, H., Rosenberg, A.S., Gllmcher, LH., Malek, T.R. and Singer, A. 1985 
Both L3T4+ and Lyt 2+ helper T cells initiate cytotoxic T lymphocyte responses 
against allogenic major histocompatibility antigens but not against trinitrophenyl 
modified self. J. Exp. Med. 162:427 
Moldwin, R.L, Lancki, D.W., Herold, KC. and Fitch, F.W. 1986 An antigen receptor-driven, 11-2-
independent pathway for proliferation of murine cytotoxic clones. J. Exp. Med. 
163:1566 
Moretta, A., Pantaleo, G., Mingari, M.C., Moretta, L and Carattini, J.C. 1984 Clonal 
heterogeneity in the requirement for T3, T 4 and Ta molecules in human cytolytic T 
lymphocyte function. J. Exp. Med. 159:921 
Moretta, A., Olive, D., Poggi, A., Pantaleo, G., Mawas, C. and Moretta, L 1986 Modulation of 
surface Tll molecules induced by monoclonal antibodies: analysis of the 
functional relationship between antigen-dependent and antigen independent 
pathways of human T cell activation. Eur. J. lmmunol. 16: 1427 
Moretta, A., Poggi, A., Olive, D., Fortis, C., Pantaleo, G and Moretta, L 1987 Selection and 
characterization of T cell variants lacking molecules involved in T-cell activation 
(T3 T-cell receptor, T 44 and T11): Analysis of the functional relationship among 
different pathways of activation. Proc. Natl. Acad. Sci. 84: 1654 
Morrison, LA. , Lukacher, A.E, Braciale, V.L Fan, D.P. and Braciale, T.J. 1986 Differences in 
antigen presentation to MHC class 1-and class II-restricted influenza virus-specific 
cytolytic T lymphocyte clones. J. Exp. Med. 163:903 
173 
Moskophidis, D., Cobbold, S.P., Waldmann, N. and Lehmann-Grube, F. 1987 Mechanism of 
recovery from acute virus infection: treatment of lymphocytic chorio-meningitis 
virus-infected mice with monoclonaJ antibodies reveals that Lyt 2 + T lymphocytes 
mediate clearance of virus and regulate the antiviral antibody response. J. Viral. 
61 :1867 
Mosmann, T.R., Bond, M.W., Coffman, R.L, Ohara, J. and Paul, W.E. 1986a T cell and mast 
cell lines respond to B-cell stimulatory factor 1. Proc. Nat. Acad. Sci. 83:5654 
Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A and Coffman, R.L 1986b Two types 
of murine helper T cell clone. I. Definition according to profiles of lymphokine 
activities and secreted proteins. J. lmmunol. 136:2348 
Mosmann, T.R. and Coffman, R.L 1987 Two types of mouse helper T cell clones. lmmunol. 
Today 8:223 
Moss, B. 1985 Vaccinia virus expression vector: a new tool for immunologists. lmmunol. Today 
6:243 
Mule, J.J., Shu, S. and Rosenberg, S.A. 1985 The anti-tumor efficacy of lymphokine-activated 
killer cells and recombinant Interleukin 2 in vivo. J. lmmunol. 135:646 
Mullbacher, A. and Blanden, R.V. 1979 Cross-reactivity patterns of murine cytotoxic T 
lymphocytes. Cell. lmmunol. 43:70 
Muller, R., Bravo, A. and Burckhardt, J. 1984 Induction of C-fos gene and protein by growth 
factors precedes activation of c-myc. Nature 312:716 
Nabel, G., Galli, S.J., Dvorak, A.M., Dvorak, H.F. and Cantor, H. 1981 Inducer T lymphocytes 
synthesize a factor that stimulates proliferation of cloned mast cells. Nature 
291 :332 
Nabholz, M., Engers, H.R., Collavo, D. and North, M. 1978 Cloned T-cell lines with specific 
cytolytic activity. Curr.Top. Micro. lmmunol. 81 :176 
Nakayama, E., Shiku, H., Stockert, E., Oettgen, H.J. and Old, LJ. 1979 Cytotoxic! cells: Lyt 
phenotype and blocking of killing activity by Lyt antisera. Proc. Natl. Acad. Sci. 
76:1977 
Nathan, C.F., Murray, H.W., Wiebe, M.E. and Rubin, B.Y. 1983 Identification of interferon- as 
the lymphokine that activates human macrophage oxidative metabolism and 
antimicrobial activity. J. Exp. Med. 158:670 
Nel, A.E., Wooten, M.W. and Galbraith, R.M. 1987 Molecular signaling mechanisms in T-
lymphocyte activation pathways: a review and future prospects. Clin. I mmunol. 
I mmunopath. 44: 167 
Nishizuka, Y. 1984 The role of protein kinase C in cell surface signal transduction and tumour 
promotion. Nature 308:693 
Nossal, G.J.V. 1983 Cellular mechanisms of immunologic tolerance. Ann. Rev. lmmunol. 1 :33 
Nossa!, G.J.V. and Pike, B.L 1981 Functional clonal deletion in immunological tolerance to 
MHC complex antigens. Proc. Natl. Acad. Sci. 78:3844 
Ochoa, A.C., Gromo, G., Wee. S-L and Bach F.H. 1986 Regulation of lytic function by 
recombinant IL2 and antigen. Curr. Top. Micro. lmmunol. 126:155 
174 
Ohashi, P.S., Mak, T.W., Van den Elsen, P., Yanagi, Y., Yoshikai, Y., Calman, A.F., Stobo, J.D. 
and Weiss, A. 1985 Reconstitution of an active surface T3jT-cell antigen receptor 
by DNA transfer. Nature 316:606 
Oldstone, M.B.A. 1975 Virus neutralization and virus-induced immune complex disease. Progr. 
Med. Viral. 19,84 
Oldstone, M.8.A. 1986 lmmunotherapy for virus infection. Arenaviruses:epidemiology, Curr. 
Top. Micro lmmunol 134:211 
Oldstone, M.8.A., Buchmeier, M.J., Doyle, M.V. and Tishon, A. 1980 Virus-induced immune 
complex disease:specific anti-viraJ antibody and C1 q binding material in the 
circulation during persistent lymphocytic choriomeningitis virus infection. J. 
lmmunol. 124:831 
Oldstone, M.8.A., Sinha, Y.N., Blount, P., Tishon, A., Rodrigues, M., von Wedel, R., and 
Lampert, P.W. 1982 Virus-induced alterations in homeostasis leading to disease 
alterations in differatiated but not vital function of infected cells in vivo. Science 
218:1125 
Oppenheim, J.J., Mizel, S.S. and Meltzer, M.S. 1979 Biological effects of lymphocyte and 
macrophage-derived mitogenic amplication factors. In "Biology of the 
lymphokinesS. Cohen, E. Pick, J.J. Oppemheim, Eds Academic Press, New York, 
p 291 
Orosz, C.G., Scott, J.W., Gillis, S. and Finke, J.H. 1985 Reversal of phorbol ester-mediated 
reduction of cloned T lymphocyte cytolysis by interleukin 2. J. lmmunol. 134: 1640 
Owen J., Allouche, M. and Doherty, P.C. 1982 Limiting dilution analysis of the specificity of 
influenza-immune cytotoxic cells. Cell. lmmunol. 67:49 
Owens, T. and Fazekas de St. Groth, B. 1987 Participation of L3T4 in T cell activation in the 
absence of class II major histocompatibility complex antigens. Inhibition by anti-
L3T 4 antibodies is a function both of epitope density and mode of presentation of 
anti-receptor antibody. J. lmmunol. 138:2402 
Paetkan, V., Bleackley, R.C., Riendeau, D. and Hormishy, D.G. 1985 Toward the molecular 
biology of IL-2 Contemp Topics Mol. lmmunol. 10:35 
Palacios, R. and Martinez-Maza, 0. 1982 Is the E receptor on human T lymphocytes a 
· "negative signal receptor'? J. lmmunol. 129:2979 
Panicali, D., Davis, S.W., Weinberg, R.L and Paoletti, E. 1983 Construction of live vaccines by 
using genetically engineered poxviruses: biological activity of recombinant 
vaccinia virus expressing influenza virus hemagglutinin. Proc. Natl. Acad. Sci. 
80:5364 
Pantaleo, G., Olive, D., Poggi, A., Pozzan, T., Moretta, L and Moretta, A. 1987a Antibody-
induced modulation of the CD3/T cell receptor complex causes T cell 
refractivness by inhibiting the early metabolic steps involved in T cell activation. J. 
Exp. Med. 166:619 
Pantaleo , G., Olive, D., Poggi, A., Kozumbo, W.J. , Moretta, L and Moretta, A. 1987b 
Transmembrane signalling via the T-11 dependent pathway of human T-cell 
activation. Evidence for the involvement of 1,2- diacylglycerol and inositol 
phosphates. Eur. J. lmmunol. 17:55 
Pardall, D.M., Fowlkes, B.J., Bluestone, J.A., Kruisbeek, A., Maloy, W.L , Coligan, J.E. and 
175 
Schwartz, R.H. 1987 Differential expression of tvvo distinct T-cell receptors during 
thymocyte development. Nature 326:79 
Parham, P. 1984 A repulsive view of MHC restriction. lmmunol. Today 5:89 
Parish, C.R. and Mullbacher, A. 1983 Automated colourimetric assay for T-cell cytotoxicity. J. 
lmmunol. Methods 58:225 
Pasternack, M.S., Verret, C.R., Liu, M.A. and Eisen, H.N. 1986 Serine esterase in cytolytic T 
lymphocytes. Nature 322:740 
Pereira, P., Larsson, E-L, Forni, L, Bandeira, A. and Countinho, A. 1985 Natural effector T 
lymphocytes in normal mice. Proc. Natl. Acad. Sci. 82:7691 
Pernis, 8. 1985 Internalization of lymphocyte membrane components. lmmunol. Today 6:45 
Pernis, B. and Axel, R. 1985 A one and a half receptor model for MHC-restricted antigen 
recognition by T lymphocytes. Cell 41 : 13 
Pevnitsky, LA., Telegin, Y.L, Zhirnov, G.F., Mazurov, AV. and Viktorov, V.V. 1985 Sensitivity to 
immunodepressant action of cyclophosphamide: analysis of interstrain 
differencies in mice. Int. J. lmmunopharmacol. 7:875 
Pfizenmaier, K., Jung, H., Starzinski-Powitz, A., Rollinghoff, M. and Wagner, H. 1977 The role 
of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific 
cytotoxic T lymphocytes. J. lmmunol. 119:939 
P~izemaier, K., Starzinski-Powitz, A., Rollinghoff, M. and Wagner, H. 1977a T cell mediated 
cytotoxicity against herpes simplex virus-infected target cells. Nature 265:630 
Phillips, M.L, Naquet, P. and Delovitch, T.L 1986 Antigen associates with la molecules in 
antigen-presenting B cells. Ann. Inst. Pasteur 1370:309 
Pierres, A., Naquet, P., Van Agthoven, A. et al 1984 A rat anti-mouse monoclonal antibody (H-
129. 19) inhibits the proliferation of la-reacive T cell clones and dehineates tvvo 
phenotyically distinct (T4+, Lyt-2,3- and T4-, Lyt 2,3+) subsets among anti-la 
cytolytic T cell clones. J. lmmunol. 132:2775 
Qin, S., Cobbold, S., Tighe, H., Benjamin, R. and Waldmann, H. 1987 CD4 monoclonal 
antibody pairs for immunosuppression and tolerance induction. Eur. J. lmmunol. 
17:1159 
Rammensee, H.G., Robinson, P.J., Crisanti, A. and Bevan, M.J. 1986 Restricted recognition of 
82-microglobulin by cytotoxic T lymphocytes. Nature 319:502 
Rao, A., Weng-Ping Ko, W., Faas, S.J. and Cantor, H. 1984 Binding of antigen in the absence 
of histocompatibility proteins by arsenate reactive T-cell clones. Cell 36:879 
Raulet, D.H. and Bevan, M.J. 1982 A differentiation factor required for the expression of 
cytotoxic T-cell function. Nature 296: 754 
Raulet, D.H., Garman, R.D., Saito, H. and Tonegawa, S. 1985 Developmental regulation of T 
cell receptor gene expression. Nature 314: 103 
Reed, J.C., Nowell, P.C. and Hoover, R.G. 1985a Regulation of c-myc mRNA levels in normal 
human lymphocytes by modulators of cell proliferation. Proc. Natl. Acad. Sci. 
82:4221 
176 
Reed, J.C., Tadmori, W., Kamoun, M., Koretzky, G., Nowell, P.C. 1985b Suppression of 
interleukin 2 receptor acquisition by monoclonal antibodies recognizing the SOkd 
protein associated with the sheep erythrocyte receptor on human T lymphocytes. 
J. lmmunol. 134:1631 
Reem, G.H. and Yeh, N-N. 1984 Interleukin 2 regulates expression of its receptor and 
synthesis of gamma interferon by human T lymphocytes. Science 225:429 
Reif, A. and Allen, J.M. V. 1964 The AKR thymic antigen and its distribution in leukemias and 
nervous tissues. J. Exp. Med 120:413 
Reinherz, E.L, Meuer, S., Fitzgerald, K.A., Hussey, R.E., Levine, H. and Schlossman, S.F. 1982 
Antigen recognition by human T lymphocytes is linked to surface expression of 
the T3 molecular complex. Cell 30:738 
Reiser, H., Yeh, E.T.H., Gramm, C.F., Benacerraf, B. and Rock, K.L 1986 Gene encoding T-
cell-activating protein TAP maps to the Ly-6 locus. Proc. Nati. Acad. Sci. 83:2954 
Reske-Kunz, AB., Von Steldern, D., Rude, E. and Diamantstein, T. 1986 Regulation of 
interleukin 2 receptor expression by interleukin 2. Scand. J. lmmunol 23:693 
Robb, R.J. 1984 lnterteukin 2: the molecule and its function. lmmunol. Today 5:203 
Robb, R.J. and Greene, W.C. 1987 Internalization of interleukin 2 is mediated by the B chain of 
the high-affinity interleukin 2 receptor. J. Exp. Med. 165: 1201 
Robb, R.J., Munck, A and Smith, K.A. 1981 T-cell growth factor receptors: quantitation, 
specificity and biological relevance. J. Exp. Med. 154: 1455 
Robb, R.J., Greene, W.C. and Rusk, C.M. 1984 Low and high affinity cellular receptors for 
interleukin 2: implications for the level of Tac antigen. J. Exp. Med. 160: 1126 
Robb, R.J., Rusk, C.M., Yodoi, J. and Greene, W.C. 1987 lnterfeukin 2 binding molecule 
distinct from the Tac protein: analysis of its role in formation of high-affinity 
receptors. Proc. Nati. Acad. Sci. 84:2002 
Rocha, B. and Bandeira, A. 1988 Umiting dilution analysis of interteukin-2 producing mature T 
cells. Interleukin 2 secretion is an exclusive property of L3T4+ lymphocytes. 
Scand. J. lmmunol. 27:47 
Rock, K.L, Yeh, E.T.H., Gramm, C.F., Haber, S.1, Reiser, H. and Benaceraff. B. 1986 TAP, a 
novel T cell activating protein involved in the stimulation of MHC restricted T 
lymphocytes J. Exp. Med. 163:315 
Roitman, C.M., Benedict, S.H., Cheung, R.K. and Gelfand, E.W. 1987 Induction of human B-cell 
proliferation and differentiation by the combination of phorbol ester and 
ionomycin. Eur. J. lmmunol. 17:701 
Rosenberg, AS. and Lotze, M.T. 1986 Cancer immunotherapy using IL-2 and IL-2 activated 
lymphocytes. Ann. Rev. lmmunol. 4:681 
Rosenberg, AS., Mizuochi, T. and Singer, A 1986 Analysis of T-cell subsets in rejection of Kb 
mutant skin allografts differing at class I MHC. Nature 322:829 
Rosenberg, AS., Mizuochi, T., Sharrow, S.O. and Singer, A 1987 Phenotype, specificity and 
function of T cell subsets and T cell interactions involved in skin allograft rejection. 
J. Exp. Med. 165:1296 
177 
Rosenthal, A.S. 1978 Determinant selection and macrophage function in genetic control of the 
immune response. lmmunol.Rev. 40:135 
Rothlein, R., Dustin, M.L, Marlin, S.D. and Springer, T.A. 1986 A human intercellular adhesion 
molecule (ICAM-1) distinct from LFA-1. J. lmmunol. 137:1270 
Rouse, R.V., Van Ewijk, W., Jones, P.P. and Weissman, 1.L 1979 Expression of MHC antigens 
by mouse dendritic cells. J. lmmunol 122:2508 
Rouse, B.T., Miller, LS., Turtinen .Land Moore. R.N. 1985 Augmentation of immunity to 
herpes simplex virus by in vivo administration of Interleukin 2. lmmunol. 134:926 
Royer, H.D., Acuto, 0., Fabbi, M., Tizard, R., Ramachandran, K., Smart, J.E., Reinherz, E.L 
1984 Genes coding the TiB subunit of the antigen/MHC receptor undergo 
rearramgement during intrathymic ontogeny prior to surface T3-Ti expression. 
Cell 39:261 
Rupp, F., Brecher, J., Giedlin, M.A., Mosmann, T., Zinkernagel, R.M., Hengartner, H. and Joho, 
R.H. 1987 T-cell antigen receptors with identical variable regions but different 
diversity and joining region gene segments have distinct specificities but cross-
reactive idiotypes. Proc. Natl. Acad. Sci. 84:219 
Russell, J.H. 1983 Internal disintegration model of cytotoxic lymphocyte-induced target 
damage lmmunol. Rev. 72:97 
Ryser, J.E., Cerottini, J-C. and Brunner, K.T. 1978 Generation of cytolytic T lymphocytes in 
vitro. IX. Induction of secondary CTL responses in primary long-term MLC by 
supernatants from secondary MLC. J. lmmunol. 120:370 
Ryser, J-E. and MacDonald, H.R. 1979 Limiting dilution analysis of alloantigen-reactive T 
lymphocytes. Ill. Effect of priming on precursor frequencies. J. lmmunol. 123:128 
Ryser, J-E., Rungger-Brandle, E., Chaponnier, C., Gabbiani, G. and Vassalli, P. 1982 The area 
of attachment of cytotoxic T lymphocytes to their target cells shows high motility 
and polarization of actin but not myosin. J. lmmunol. 128:1159 
Saito, H., Kranz, D.M., Takagaki, Y., Hayday, A., Eisen, H.N., Tonegawa, S. 1984 A third 
rearranged and expressed gene in a clone of cytotoxic T lymphocytes. Nature 
312:36 
Saizawa, K., Rojo, J. and Janeway, C.A. 1987 Evidence for a physical association of CD4 and 
the CD3: : B T-cell receptor. Nature 328:260 
Samelson, LE., Harford, J.B. and Klausner, R.D. 1985a Identification of the components of the 
murine T cell antigen receptor complex. Cell, 43:223 
Samelson, LE., Harford, J., Schwartz, R.H. and Klausner, R.D. 1985b A 20-kDa protein 
associated with the murine T-cell antigen receptor is phosphorylated in response 
to activation by antigen or Concanavalin A. Proc. Natl. Acad. Sci. 82:1969 
Samelson, LE., O'Shea, J.J., Luong, H., Ross, P., Urdahl, K.B., Klausner, R.D. and Bluestone, 
J. 1987 T cell antigen receptor phosphorylation induced by an anti-receptor 
antibody. J. lmmunol. 139:2708 
Sanchez-Madrid, F., Krensky, AM., Ware, C.F., Robbins, E., Strominger, J.L, Burakoff, S.J. 
and Springer, T.A. 1982 Three distinct antigens associated with human T 
lymphocyte-mediated cytolysis LFA-1, LFA-2 and LFA-3. Proc. Natl. Acad. Sci. 
79:7489 
178 
Sanchez-Madrid, F., Simon, P., Thompson, S. and Springer, T.A. 1983 Mapping of antigenic 
and functional epitopes on the -and 8- subunits of two related mouse 
glycoproteins involved in cell interactions. LFA-1 and MAC-1 . J. Exp. Med. 
158:586 
Sanderson, C.J., Hall. P.J., and Thomas, J.A. 19n The mechanism of T cell mediated 
cytotoxicity. IV. Studies on communicating junctions between cells in contact. 
Proc. Roy. Soc. Lend. 8 196:73 
Sarmiento, M., Glasebrook, A.Land Fitch, F.W. 1980 lgG or lgM monoclonal antibodies 
reactive with different determinants on the molecular complex bearing Lyt 2 
antigen block the T cell-mediated cytolysis in the absence of complement. J. 
lmmunol. 125:2665 
Schlick, E., Ruffmann, R., Chirigos, M.A., Welker, R.D. and Herberman, R.8. 1985 In vivo 
modulation of myelopoiesis and immune functions by maleic anhydride divinyl 
ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated 
with cyclophosphamide. Cancer Res. 45: 1108 
Schmitt-Verhulst, A.M., Guimezanes, A., Boyer, C., Poenie, M., Tsien, R., Bufferne, M., Hua, C. 
and Leserman, L 1987 Pleiotropic loss of activation pathways in a T-cell receptor 
-chain deletion variant of a cytolytic T-cell clone. Nature 325:628 
Schrader, J.W. and Edelman, G.M. 1977 Joint recognition by cytotoxic T cells of inactivated 
Sendai virus and products of the major histocompatibility complex. J. Exp. Med. 
145:523 
Schrader, J., Battye, F., Scollay, R. 1982 Expression of Thy-1 antigen is not limited to T cells in 
cultures of mouse hemopoietic cells. Proc. Natl. Acad. Sci. 79:4161 
Schrader, J.W., Clark-Lewis, I., Crapper, R.M. and Wong, G.W. 1983 P-cell stimulating factor: 
characterization, action and multiple lineages of bone-marrow-derived cells and 
role in oncogenesis. lmmunol. Rev. 76:79 
Schwartz, R.H. 1985 T-lymphocyte recognition of antigen in association with gene products of 
the major histocompatibility complex. Ann. Rev. lmmunol. 3:237 
Schwartz, R.H. 1986 Immune response (Ir) genes of the murine major histocompatibility 
complex. Adv. lmmunol. 38:31 
Selvaraj, P., Plunkett, M.L, Dustin, M., Sanders, M.E., Shaw, S. and Springer, T.A. 1987 The T 
lymphocyte glycoprotein CO2 binds the cell surface ligand LFA-3. Nature 
326:400 
Senik, A., Pozzo Hebrero, F. and Levy, J.P. 1975 Secondary specific immune response in vitro 
to MSV tumor cells. Int. J. Cancer 16:946 
Sette, A., Buus, S., Colon, S., Smith, J.A., Miles, C. and Grey, H.M. 1987 Structural 
characteristics of an antigen required for its interaction with la and recognition by 
T cells. Nature 328:395 
Sewell, W.A., Brown, M.H., Owen, M.J., Fink, P.J., Kozak, C.A. and Crumpton, M.J. 1987 The 
murine homologue of the T lymphocyte CO2 antigen: molecular cloning, 
chromosome assignment and cell surface expression. Eur. J. I mmunol 17: 1 O 15 
Shackelford, D.A. and Trowbridge, I.S. 1984 Induction of expression and phoshorylation of the 
human interleukin 2 receptor by a phorbol diester. J. Biol. Chem. 259: 11706 
179 
Shaw, S., Ginther Luce, G.E.G., Quinones, A., Gress, R.E., Springer, T.A. and Sanders, M.E. 
1986 Two antigen-independent adhesion pathways used by human cytotoxic T-
cell clones. Nature 323:262 
Shaw, G.M., Harper, M.E., Hahn, B.H. et al. 1985 HTLV-111 infection in brains of children and 
adults with AIDS encephalopathy. Science 227:1 n 
Sherman, L 1982 Recognition of conformational determinants on H-2 by cytolytic T 
lymphocytes. Nature 292:511 
Shevach, E,M., Chan, C., Karty, P., Ortega, G. and Malek, T.R. 1986 Role of the Ly-6 antigen 
system in T cell activation. Fed. Proc. 45: 1131 
Shimonkevitz, R., Luescher, B., Cerottini, J-C. and MacDonald, H.R. 1985 Clonal analysis of 
cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen 
expression: correlation between antigen density and requirement for Lyt-2/3 
function. J. lmmunol. 135:892 
Siegel, J.P., Sharon, M., Smith, P.L and Leonard, W.J. 1987 The IL-2 receptor B chain (p70): 
Role in mediating signals for L.AK, NK and proliferative activities. Science 238:75 
Siliciano, R.F., Pratt, J.C., Schmidt, R.E., Ritz, J., Reinherz, E.L 1985 Activation of cytolytic T 
lymphocyte and natural killer cell function through the T11 sheep erythrocyte 
binding protein. Nature 317:428 
Simon, M.M., Landolfo, S., Diamantstein, T. and Hochgeschwender, U. 1986 Antigen- and 
Lectin-sensitized murine cytolytic T lymphocyte-precursors require both 
interleukin 2 and endogenously produced immune ( ) interferon for their growth 
and differentiation into effector cells. Curr. Topic. Micro. lmmunol. 126:173 
Simone, C.B. and Henkart, P. 1980 Permeability changes induced in erythrocyte ghost targets 
by antibody-dependent cytotoxic effector cells: evidence for membrane pores. J. 
lmmunol. 124:954 
Singer, A., Hathcock, K.S. and Hodes, R.J. 1982 Self recognition in allogenic thymic chimeras. 
Self recognition by T helper cells from thymus-engrafted nude mice is restricted 
to the thymic H-2 haplotype. J. Exp. Med. 155:339 
Singer, K.H., Wolf, LS., Lobach, D.F., Denning, S.M., Tuck, D.T., Robertson, AL and Haynes, 
B.F. 1986 Human thymocytes bind to autologous and allogeneic thymic epithelial 
cells in vitro. Proc. Natl. Acad. Sci. 83:6588 
Sleckman, B.P., Peterson, A. , Jones, W.K., Foran, J.A., Greenstein, J.L, Seed, B. and Burakoff, 
S.J. 1987 Expression and function of CD4 in a murine T-cell hybridoma. Nature 
328:351 
Smith, G.L, Mackett, M. and Moss, B. 1983 Infectious vaccinia virus recombinants that 
express hepatitis B virus surface antigen. Nature 302:490 
Smith, K.A. 1987 The two-chain structure of high affinity IL-2 receptors. lmmunol. Today 8:11 
Smith, K.A. and Cantrell, D.A. 1985 Interleukin 2 regulates its own receptors. Proc. Natl. Acad. 
Sci. 82;864 
Smith, K.A., Gilbride, K.J. and Favata, M.F. 1980a Lymphocyte activating factor promotes T 
cell growth factor production by cloned murine lymphoma cells. Nature 287:853 
Smith, K.A., Lachman, LB., Oppenheim, J.J. and Favata, M.F. 1980b The functional 
180 
relationship of the interleukins. J. Exp. Med. 151: 1551 
Snodgrass, H.R. , Dembic, Z., Steinmetz. M., Von Boehmer, H. 1985 Expression of T-cell 
antigen receptor genes during fetal development in the thymus. Nature 315:232 
Solbach, W. 1982 Tumor-promoting phorbol esters selectively abrogate the expreession of the 
T 4 differentiation antigen expressed on normal and malignant (Sezary) T helper 
lymphocytes. J. Exp. Med. 156: 1250 
Suomalainen, H.A. 1986 The monoclonal antibodies Trop-4 and 4F2 detect the same 
membrane antigen that is expressed at an early stage of lymphocyte activation 
and is retained on secondary lymphocytes. J. lmmunol. 137:422 
Spits, H., Yssel, H., Voordouw, A. and de Vries, J.E. 1985 The role of Ta in the cytotoxic activity 
of cloned cytotoxic T lymphocyte lines specific for class II and class I major 
histocompatibility complex antigens. J. lmmunol. 134:2294 
Spits, H. Schooten, van W., Keizer, H., Seventer, van G., Rijn, M., Van de Terhosrst, C. and 
Vries, J.E. de. 1986 Alloantigen recognition is preceded by nonspecific adhesion 
of cytotoxic T cells and target cells. Science 232:403 
Sprent, J. 1978 Role of H-2 gene products in the function of T helper cells from normal and 
chimeric mice in vivo. lmmunol. Rev. 42:108 
Sprent, J. and Schaefer, M. 1985 Properties of purified T cell subsets. I In vitro responses to 
class 1. vs. class II H-2 alloantigens. J. Exp. Med. 162:2068 
Sprent, J., Schaefer, M., Lo, D. and Korngold, R. 19868 Functions of purified L3T4+ and Lyt2+ 
cells in vitro and in vivo. lmmunol. Rev. 91 :195 
Sprent, J., Schaefer, M., Lo, D., Korngold, R. 1986b Properties of purified T cell subsets. II. in 
vivo responses to class I vs class II differences. J. Exp. Med. 163:998 
Springer, T.A., Davignon, D., Ho, M-K., Kurzinger, K., Martz, E. and Sanchez-Madrid, F. 1982 
LFA-1 and Lyt-2,3 molecules associated with T lymphocyte- mediated killing; and 
MAC-1 , and LFA-1 homologue associated with complement function. lmmunol. 
Rev. 68:171 
Springer, T.A., Dustin, M.L, Kishimoto, T.K. and Martin, S.D. 1987 The lymphocyte function-
associated LFA-1, CO2, and LFA-3 molecules: cell adhesion receptors of the 
immune system. Ann. Rev. lmmunol. 5:223 
Sredni, B. and Schwartz, R.H. 1980 Alloreactivity of an antigen-specific T-cell clone. Nature 
287:855 
Staerz, U.D., Rammensee, H-G., Benedetto, J.0. and Bevan, M.J. 1985 Characterization of a 
murine monoclonal antibody specific for an allotypic determinant on T cell 
antigen receptor. J. I mmunol. 134:3994 
Starr, S.E. and Allison, A.C. 1977 Role of T lymphocytes in recovery from murine 
cytomegalovirus infection. Infect. lmmunol. 17:458 
Steeg, P.S., Moore, R.N., Johnson, H.M. and Oppenheim, J.J. 1982 Regulation of murine 
macrophage la antigen expression by a lymphokine with immune interferon 
activity. J. Exp. Med. 156: 1780 
Stevenson, M., Zhang, X. and Volsky, D.J. 1987 Downregulation of cell surface molecules 
during non cytopathic infection of T cells with human immunodeficiency virus. J. 
181 
Viral. 61:3741 
Stewart, W.E. 1981 The Interferon system (Springer-Verlag, Vienna) 
Stitz, L, Althage, A., Hengartner, H. and Zinkernagel, R.M. 1985 Natural killer cells vs cytotoxic 
T cells in the peripheral blood of virus-infected mice. J. lmmunol. 134:598 
Streicher, H.Z., Berkower, I.J., Busch, M., Gurd, F.R.N. and Berzofski, J.A. 1984 Antigen 
conformation determines processing requirements for T-cell activation. Proc. Natl. 
Acad. Sci. 81 :6831 
Swain, S.L, Dialynas, D.P., Fitch, F.W. and English, M. 1984 Monoclonal antibody to L3T4 
blocks the function of T cells specific for class II major histocompatibility complex 
antigens. J. lmmunol. 132:1118 
Symington, F.W. and Hakomori, S-1. 1984 Hematopoietic subpopulations express cross-
reactive, lineage-specific molecules detected by monoclonal antibody. Mal. 
lmmunol. 21 :507 
Tadmori, W., Leed, J.C., Nowell, P.C. and Kamoun, M. 1985 Functional properties of the 50 kd 
protein associated with the E-receptor on human T lymphocytes: Suppression of 
IL-2 production by anti-p50 monoclonal antibodies. J. lmmunol. 134:856 
Takada, S. and Engleman, E.G. 1987 Evidence for an association between CDS molecules and 
the T cell receptor complex on cytotoxic T cells. J. lmmunol. 139:3231 
Takano, T. 1977 Structure of myoglobin at 2.0A resolution. I. Crystallographic refinemment of 
metmyoglobin from sperm whale. J. Mal. Biol. 110:537 
Takayama, H., Trenn, G., Humpfrey, W., Bluestone, J.A., Henkart, P.A. and Sitkovsky, M.V. 
1986 Antigen receptor-triggered secretion of a trypsin-type esterase from 
cytotoxic T lymphocytes. J. I mmunol. 138:566 
Takeshita, T. and Conner, M.K. 1984 Accumulation and persistence of cyclophoshamide-
induced sister chromatide exchange in murine peripheral blood lymphocytes. 
Cancer Res. 44:3820 
Tahiguchi, T., Matsui, H., Fujuta, T., Takaoka, C., Kashima, N., Yoshimoto, R. and Hamuro, J. 
1983 Structure and expression of a cloned cDNA for human interleukin-2. Nature 
302:305 
Taswell, C., MacDonald, H.R. and Cerottini, J-C. 1979 Limiting dilution analysis of alloantigen-
reactive lymphocytes. II. Effect of cortisone and cyclophosphamide on cytolytic T 
lymphocyte precursor frequencies in the thymus. Thymus 1: 119 
Terhorst, C., Agthoven, van A., Reinherz, E. and Schlossman, S. 1980 Biochemical analysis of 
human T lymphocyte differentiation antigens T 4 and TS. Science 209:520 
Tertain, G., Yung, Y-P., Guy-Grand, D. and Moore, M.A.S. 1981 Long-term in vitro culture of 
murine most cells. I. Description of a growth factor-dependent culture technique. 
J. lmmunol. 127:788 
Tew, J.G., Phipps, R.P. and Mandel, T.E. 1980 The maintenance and regulation of the humeral 
immune response: persisting antigen and the role of follicular antigen-binding 
dendritic cells as accessory cells. lmmunol. Rev. 53: 175 
Tite, J.P., Powell, M.B. and Ruddle, N.H. 1985 Protein-antigen specific la-restricted cytoiytic T 
cells: analysis of frequency, target cell susceptibility and mechanism of cytolysis. 
182 
J. lmmunol. 135:25 
Tite, J.P., Sloan, A. and Janeway, C.A. 1986 The role of L3T4 in T cell activation: L3T4 may be 
both an la-binding protein and a receptor that transduces a negative signal. J. 
Mal. Cell. lmmunol. 2:179 
Townsend. AR., Gotch, F.M. and Davey.J. 1985 Cytotoxic T cells recognize fragments of the 
influenza nucleoprotein. Cell 42:457 
Traub, E. 1938 Factors influencing the persistence of choriomeningitis virus in the blood of 
mice after clinical recovery. J. Exp. Med. 68:229 
Trowbridge, I.S. and Omary, M.B. 1981 Human cell surface glycoprotein related to cell 
proliferation is the receptor for transferrin Proc. Natl. Acad. Sci. 78:3039 
Trowbridge, I.S., Lesley, J., Schulte, R., Hyman, R. and Trotter, J. 1982 Biochemical 
characterization and cellular distribution of a polymorphic murine cell-surface 
glycoprotein expressed on lymphoid tissues. lmmunogenetics 15:299 
Truneh, A., Albert, F., Goldstein. P. and Schmitt-Verhulst, A-M. 1985 Ca-ionophore plus 
phorbol ester can substitute for antigen in the induction of cytolytic T 
lymphocytes from specifically primed precursors. J. lmmunol. 135:2262 
Tschopp, F. Masson, D. and Stanley, K.K. 1986 Structural/functional similarity between 
proteins involved in complement-and cytotoxic T-lymphocyte-mediated cytolysis. 
Nature 322:8310 
Tsenn, G., Takayama, H., Hu-U, J., Paul, W.E. and Sitkovsky, M.V. 1984 B cell stimulatory 
factor 1 (IL-4) enhances the development of cytotoxic T cells from Lyt2 + resting 
murine T lymphocytes. J. lmmunol. 140:1101 
Tsuda, M., Kozak, R.W., Goldman, C.K. and Waldman, T.A. 1987 Contribution of a p75 
interleukin 2 binding peptide to a high affinity interleukin 2 receptor complex. 
Proc. Natl. Acad. Sci. 83:9694 
Turk, J.L and Parker, D. 1982 Effect of cyclophosphamide on immunological control 
mechanisms. lmmunol. Rev. 65:99 
Unanue, E.R. 1981 The regulatory role of macrophages in antigenic stimulation. Part two: 
symbiotic relationship between lymphocytes and macrophages. Adv. lmmunol. 
31 :1 
Unanue, E.R. 1984 Antigen-presenting function of the macrophage Ann. Rev. lmmunol. 2:395 
Van Ewijk, W., Rouse, R.V. and Weissmann, 1.L 1980 Distribution of H-2 microenvironments in 
the mouse thymus. lmmunoelectron microscopic identification of I-A and H-2K 
bearing cells. J. Histochem and cytochem. 28: 1089 
Van Ewijk, W., Jenkinson, E.J. and Owen, J.J.T. 1982 Detection of Thy 1, T-200, Lyt-1 and Lyt-
2 bearing cells in the developing lymphoid organs of the mouse embryo in vivo 
and in vitro Eur. J. lmmunol. 12:262 
Van Seventer, G.A., Kuijpers, K.C. van Lier, R.A.W., de Groot, E.R., Aarden, LA. and Melief, 
C.J.M. 1987 Mechanism of inhibition and induction of cytolytic activity in 
cytotoxic T lymphocytes by CD3 monoclonal antibodies. J. lmmunol. 139:2545 
Van Wauwe, J.P. and Goossens, J.G. 1981 Mitogenic actions of orthoclone OKT3 of human 
peripheral blood lymphocytes effects of monocytes and serum components. Int. 
183 
J. lmmunopharmacol. 3:203 
Van Wauwe, J.P. De May, J.R. and Gossens, J.G. 1980 OKT3: a monoclonal antihuman T 
lymphocyte antibody with potent mitogenic properties. J. lmmunol. 124:2708 
Vegh, P., Erdos, E., Janossy, T. and Petri, G. 1980 Studies on the mechanism of 
transplantation tolerance. I Do suppressor cells play a role in the induction and 
maintance of neonatal transplantation tolerance? Cell. lmmunol. 55:265 
Vohr, H-W. and Hunig, T. 1985 Induction of proliferative and cytotoxic responses in resting 
Lyt-2 + T cells with lectin and recombinant IL-2. Eur. J. lmmunol. 15:3327 
Vollger, LW., Tuck, D.T., Springer, T.A., Haynes, B.F., Singer, K.H. 1987 Thymocyte binding to 
human thymic epithelial cells is inhibited by monoclonal antibodies to CD-2 and 
LFA-3 antigens. J.lmmunol. 138:358 
Wagner, H. and Hardt, C. 1986 Heterogeneity of the signal requirements during the primary 
activation of resting Lyt 2 + CTL precursors into clonally developing CTL: Current 
Topics Microbol.lmmunol. 126:143 
Wagner, H. and Rollinghoff, M. 1978 T cell interactions during in vitro cytotoxic allograft 
responses. Soluble products from activated Lyt-1 + T cells trigger autonomously 
antigen-primed Ly-23 + T cells to cell proliferation and cytolytic activity. J. Exp. 
Med. 148:1523 
Walden, P., Nagy, Z.A. and Klein, J. 1985 Induction of regulatory T-lympocyte responses by 
liposomes carying major histocompatibility complex molecules and foreign 
antigen. Nature 315:327 
Walden, P., Nagy, Z.A. and Klein, J. 1986 Antigen presentation by liposomes: inhibition with 
antibodies. Eur. J. lmmunol. 16:717 
Walker, C.M., Paetkau, V., Rawls, W.E. and Rosenthal K.L 1985 Abrogation of anti pichinde 
virus cytotoxic T cell memory by CY and restoration by coinfection or IL-2. J. 
lmmunol. 135:1401 
Walker, I.D., Hogarth, P.M., Murray, B.J. et al. 1983 Ly antigens associated with T cell 
recognition and effector function. lmmunol. Rev. 82:47 
Walker, I.D., Murray, B.J., Hogarth, P.M., Keldo, A. and McKenzie, I.F.C. 1984 Comparison of 
thymic and peripherel T cell Ly-2/3 antigens. Eur. J. lmmunol. 14:906 
Wang, H-M. and Smith, K.A. 1987 The interleukin 2 receptor. Functional consequences of its 
bimolecular structure. J. Exp. Med 166: 1055 
Wassmer, P., Chan, C. Logdberg, Land Shevach, E.M. 1985 Role of the L3T4-antigen in T cell 
activation. II. Inhibition of T cell activation by monoclonal anti-L3T4 antibodies in 
the absence of accessory cells. J. lmmunol 135:2237 
Watanabe, M., Wegmann, D.R., Ochi, A. and Hozumi, N. 1986 Antigen prensentation by a B-
cell line transfected with cloned immunoglobulin heavy-and light-chain genes 
specific for a defined hapten. Proc. Natl. Acad. Sci. 83:5247 
Watts, T.H. Brian, A.A. Kappler, J.W. Marrack, P. McConnell, H.M. 1984 Antiaen presentation 
by supported planar membranes containing affinity-purified I-A . Proc. Natl. 
Acad. Sci. 81 :7564 
Watts, T.H., Gaub, H.E. and McConnell, H.M. 1986 T-cell-mediated association of peptide 
184 
antigen and major histocompatibility complex protein detected by energy transfer 
in an evanescent wave-field. Nature. 320: 179 
Webb, M. Mason, D.W. and Williams, A.F. 1979 Inhibition of mixed lymphocyte response by 
monoclonal antibody specific for a rat T lymphocyte subset. Nature 282:841 
Weiss, A., Brunnner, K.T., MacDonald, H.R. and Carattini, J-C. 1980 Antigenic specificity of the 
cytolytic T lymphocyte response to murine sarcoma virus-induced tumors Ill. 
Characterization of cytolytic T lymphocyte clones specific for Moloney leukemia 
virus associated cell surface antigens. J. Exp. Med. 152: 121 O 
Weiss, A. and Stobo, J.D. 1984 Requirement for the coexpression of T3 and the T cell antigen 
receptor on a malignant human T cell line. J. Exp. Med. 160:1284 
Wells, M.A., Ennis, F.A. and Albrecht, P. 1981 Recovery from a viral respiratory infection. II. 
Passive transfer of immune spleen cells to mice with influenza pneumonia. J. 
lmmunol 126:1042 
Welsh, R.M. and Zinkernagel, R.M. 1977 Heterospecific cytotoxic cell activity induced during 
the first three days of acute lymphocytic chroiomeningitis in mice. Nature 268:646 
Welsh, R.M., Zinkernagel, R.M. and Hallenbeck, LA. 1979 Cytotoxic cells induced during 
lymphocytic chriomengitis infection of mice II. Specificities of the natural killer 
cells. J. lmmunol. 122:475 
Weyand, C.M. Goronzy, J. and Fathman, C.G.1987 Modulation of CD4 by antigenic activation 
J. lmmunol. 138:1351 
Widmer, M.B. and Bach, F.H. 1981 Antigen-driven helper cell-independent cloned cytolytic T 
lymphocytes. Nature. 294:750 
Widmer, M.B. and Grabstein, K.H. 1987 Regulation of cytolytic T-lymphocyte generation by B-
cell stimulatory factor. Nature 326:795 
Widmer, M.B., MacDonald, H.R., Cerottini, J-C. 1981 Limiting dilution analysis of alloantigen 
reactive T lymphocytes. IV. Ontogeny of cytolytic T lymphocyte precursors in the 
thymus. Thymus 2:245 
Wiktor, T.J., Macfar1an, A.I., Reagan, K.J. et al 1984 Protection from rabies by a vaccinia virus 
recombinant containing the rabies virus glycoprotein gene. Proc. Natl. Acad. Sci. 
81 :7194 
Wilde, D.S., Marrack, P., Kappler, J.W., Dialynas, D.P. and Fitch, F.W. 1983 Evidence 
implicating L3T4 in class II MHC antigen reactivity: monoclonal antibody GK1 .5 
(anti-L3T 4a) blocks class II MHC antigen-specific proliferation, release of 
lymphokines and binding by cloned murine helper T lymphocyte lines. J. 
lmmu ol. 131:2178 
Williams, A.F. and Gagnon, J. 1982 Neuronal cell Thy-1 glycoprotein: homology with 
immunoglobulin. Science, 216;696 
Williams, J.M., Ransil, B.J., Shapiro, H.M. and Strom, T.B. 1984 Accessory cell requirement for 
activation antigen expression and all cycle progression by human T lymphocytes. 
J. lmmunol. 133:2986 
Wilmer, J.L, Erexson, G.L and Kligerman, A.O. 1984 Sister chromatide exchange induction in 
mouse B- and T-lymphocytes exposed to cyclophosphamide in vitro and in vivo. 
Cancer Res. 44:880 
185 
Wolinsky, J.S. and Johnson, R.T. 1980 Role of viruses in chronic neurological diseases. In:" 
Comprehensive Virology.~ H. Fraenkel-Conrat and R. Wagner, eds. Plenum Publ. 
Corp. New York. 16:257 
Wong, G.H.W., Clark-Lewis, I., McKimm-Breshkin, J.L, Harris_, A.W. and Schrader, J.W. 1983 
interferon-y induces enhanced expression of la and H-2 antigens on B lymphoid, 
macrophage and myeloid cell lines. J. lmmunol. 131 :788 
Wong, G.W. H., Clark-Lewis, I., Harris, A.W. and Schrader, J.W. 1984a Effect of cloned 
interferon- on expression of H-2 and la antigens on cell lines of hemopoietic, 
lymphoid, epithelial fibroblastic and neuronal origin. Eur. J. lmmunol. 14:52 
Wong, G.H.W., Bartlett, P.F., Clark-Lewis, I., Battye, F.A nd Schrader, J.W.1984b Inducible 
expression of H-2 and la antigens on brain cells. Nature, 310:688 
Wood, P.J., Strome, P.G. and Stereilein, J.W. 1984 Cloned analysis of helper and effector T-
cell function in neonatal transplantation tolerance: clonal deletion of helper cells 
determines lack of in vivo responsiveness. lmmunogenetics 20:185 
Woodcock, J., Wofsy, D., Eriksson, E., Scott, J.H. and Seaman, W.E. 1986 Rejection of skin 
grafts and generation of cytotoxic T cells by mice depleted of L3T4+ cells. 
Transplantation 42:636 
Yang, H. and Welsh, R.M. 1986 Induction of alloreactive cytotoxic T cells by acute virus 
infection of mice J. lmmunol. 136:1186 
Yap, K.L and Ada, G.L 1977 Cytotoxic T cells specific for influenza virus-infected target cells. 
Immunology 32: 151 
Yap, K.L, Ada, G.L and McKenzie, I.F.C. 1978 Transfer of specific cytotoxic T lymphocytes 
protects mice inoculated with influenza virus. Nature 273:238 
Yeh, E.T.H., Revsen, H., Benaceraff, B. and Rock, K.L 1986 Expression of the T cell activating 
protein (TAP) in peripheral lympocyte subsets. Proc. Natl. Acad. Sci. 83:7424 
Yoshimoto, R., Kashima, N., Okada, K., Amikura, K. and Hamuro, J. 1985 Recombinant 
interleukin 2 differentiates alloantigen primed Lyt 2 + T cells into the activated 
cytotoxic state. Eur. J.lmmunol. 15:325 
· Yron, J., Wood, T.A., Spiess, P.J. and Rosenberg, S.A. 1980 In vitro growth of murine T cells. 
V. The isolation and growth of lymphoid cells infiltrating syngencic tumors. J. 
lmmunol. 125:238 
Zamoyska, R., Vollmer, A.C., Sizer, K.C., Uaw, C.W. and Parnes, J.R. 1985 Two Lyt-2 
polypeptides arise from a single gene by aJternative splicing patterns of mRNA. 
Cell 43:153 
Zinkernagel, R. M. 1978 Thymus and lymphomopoietic cells. Their role in T cell maturation in 
selection of T cells M-2-restriction-speicificity and in H-2-linked Ir gene control. 
lmmunol. Rev. 42:224 
Zinkernagel, R.M. and Doherty, P.C. 1974a Restriction of in vitro T cell-mediated cytotoxicity in 
lymphocytic chromiomeningitis within a syngneic or semi-allogeneic system. 
Nature 248:701 
Zinkernagel, R.M. and Doherty, P.C. 1974b Immunological surveillanace against altered self 
components by reunited T lymphocytes in lymphocytic choriomeningitis virus. 
Nature 251 :47 
I 
1.1 
1.1 
I 
Ji 
', 
II 
I 
[• 
l 
I 
186 
Zinkernagel, R.M. and Doherty, P.C. 1979 MHC- restricted cytotoxic T cells: studies on the 
biological role of polymorphic major transplantation antigens determining T-cell 
restriction-specificity, function and adaptable. Adv. I mmunol 27:51 
Zinkernagel, R.M. and Rosenthal, K.L 1981 Experiments and speculation on antiviraJ specificty 
of T and B cells. lmmunol. Rev. 58:131 
Zlotnik, A., Ransom, J., Frank, G., Fischer, F. and Howard, M. 1987 Interleukin 4 is a growth 
factor for activated thymocytes. possible role in T cell ontogeny. Proc. Natl. Acad. 
Sci. 84: 3856 
